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The Agrobacterium tumefaciens VirB/D4 type IV secretion system (T4SS) delivers 
oncogenic T-DNA and effector proteins to susceptible plant cells. This leads to the 
formation of tumors termed Crown Galls. The VirB/D4 T4SS is comprised of 12 subunits 
(VirB1 to VirB11 and VirD4), which assemble to form two structures, a secretion channel 
spanning the cell envelope and a T-pilus extending from the cell surface.  In A. tumefaciens, 
the VirB2 pilin subunit is required for assembly of the secretion channel and is the main 
subunit of the T-pilus. The focus of this thesis is to define key reactions associated with the 
T4SS biogenesis pathway involving the VirB2 pilin.  Topology studies demonstrated that 
VirB2 integrates into the inner membrane with two transmembrane regions, a small 
cytoplasmic loop, and a long periplasmic loop comprised of covalently linked N and C 
termini.  VirB2 was shown by the substituted cysteine accessibility method (SCAM) to adopt 
distinct structural states when integrated into the inner membrane and when assembled as 
a component of the secretion channel and the T-pilus.   The VirB4 and VirB11 ATPases 
were shown by SCAM to modulate the structural state of membrane-integrated VirB2 pilin, 
and evidence was also obtained that VirB4 mediates extraction of pilin from the membrane.  
A model that VirB4 functions as a pilin dislocase  by an energy-dependent mechanism was 
further supported by coimmunoprecipitation and osmotic shock studies. Mutational studies 
identified two regions of VirB10, an N-terminal transmembrane domain and an outer 
membrane-associated domain termed the antennae projection, that contribute selectively to 
T-pilus biogenesis.  Lastly, characterization of a VirB10 mutant that confers a ‘leaky’ 
channel phenotype further highlighted the role of VirB10 in gating substrate translocation 
across the outer membrane as well as T-pilus biogenesis. Results of my studies support a 
working model in which the VirB4 ATPase catalyzes dislocation of membrane-integrated 
pilin, and distinct domains of VirB10 coordinate pilin incorporation into the secretion channel 
and the extracellular T-pilus. 
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Chapter 1: Introduction 
 
 
 
 
NOTE: Crystal structure images were modeled in PyMOL. An educational-use program 
copy of PyMOL was obtained from http://pymol.org/ep, which states that images may be 
used for thesis/dissertation projects. All structural coordinates were obtained from the 
RCSB protein data base http://www.rcsb.org/pdb and individual identification numbers and 
specific references are included in the figure legends. Figure 1.1 was modified from figure 1 
in a previously published review article: “The versatile bacterial type IV secretion systems.” 
Nature Reviews Microbiology 1, 137-14; November 2003, (doi:10.1038/nrmicro753). I have 
been given permission by the publisher of Nature Reviews Microbiology, Nature Publishing 
Group, to reproduce this figure in print or electronically for the purposes of my dissertation 
(License Number 2544420868323). Figure 1.4 was modified from Figure 3 in “The T-pilus 
of Agrobacterium tumefaciens.” Trends Microbiol. 8, 361-69. (doi:10.1016/S0966-
842X(00)01802-3). I have been given permission by the publisher of Trends in 
Microbiology, Elsevier,  to reproduce this figure in print or electronically for the purposes of 
my dissertation (License Number 2551440934372). 
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I)  Type IV Secretion Systems  
 Bacterial Type IV secretion systems (T4SSs) represent a functionally diverse group 
of transporters dedicated to the movement of DNA or protein substrates across the cell 
envelope (1-3). They are linked to many important processes, such as the spread of 
antibiotic resistance (4-6), genomic plasticity (7), bacterial colonization, and the introduction 
of virulence factors into eukaryotic host cells (1, 8-14). T4SSs are widely distributed among 
both Gram-negative and Gram-positive bacteria (1, 4, 15), and they play a key role in the 
virulence of many bacterial pathogens (16-22).  These systems stimulate changes in basic 
host cellular processes that aid in the establishment of pathogenic or symbiotic 
relationships with the host (1, 16, 23, 24). All T4SSs identified assemble as multi-subunit 
machines that form a secretion channel spanning the cell envelope, and many T4SSs also 
encode a pilus or other surface protein(s) that mediates direct contact with target cells (15, 
16, 25-28). These systems have been grouped into three different ‘types’ based on 
function: 1) conjugation machines, systems that translocate DNA to recipient cells through 
direct cell-cell contact, 2) DNA uptake/release machines that translocate DNA to or from the 
milieu, and 3) effector translocation machines, which transport proteins and sometimes 
DNA to eukaryotic recipient cells (Fig. 1.1) (2, 15).  
 
II)  Agrobacterium tumefaciens Type IV Secretion System  
 The prototypical T4SS, the Agrobacterium tumefaciens VirB/D4 system, serves as 
an excellent model for defining substrates and substrate translocation signals, assembly 
pathways and architectures, and the dynamics of substrate movement through the T4SSs. 
The A. tumefaciens VirB/D4 T4SS is comprised of a secretion channel and an extracellular 
pilus called the T-pilus (2, 3, 29, 30) (Fig. 1.2). The secretion channel mediates the transfer 
of effector proteins and DNA across the cell envelope. The T-pilus functions mainly or 
exclusively as an attachment organelle to enable formation of productive contacts between 
A. tumefaciens and target cells. Though not required for substrate translocation, the T-pilus 
increases substrate transfer efficiencies (31, 32). 
III)   Infection Process 
 As with many bacterial pathogens, A. tumefaciens infects only at wound sites in a 
cell-cell contact dependent fashion (33, 34). Infection is initiated when bacteria sense an 
array of signals, including various plant cell wall precursors and acidic pH, that are present 
at a plant wound site (35). Signal perception is mediated by the VirA/VirG signal  
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Figure 1.1 Schematic of the role of type IV secretion systems in bacteria 
Three groups of type IV secretion systems depicted: 1) Conjugation, deliver plasmids or 
integrative and conjugative elements (ICEs) from donor cells to recipient cells 2) DNA 
uptake/release, mediate exchange of DNA with the extracellular milieu and, 3) Effector 
translocators, deliver DNA and/or protein substrates to eukaryotic cells and are directly 
involved in virulence (See (1, 16, 30, 36, 37)). This figure was modified from Figure 1 in 
“The versatile bacterial type IV secretion systems.” Nature Reviews Microbiology 1, 137-14; 
November 2003, (doi:10.1038/nrmicro753). 
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Figure 1.2 Schematic of the localization of the Agrobacterium tumefaciens VirB/D4 
type IV secretion components and the T-DNA secretion pathway 
The VirB1-VirB11 and VirD4 type IV secretion system (T4SS) components are shown 
according to their proposed localization and interactions.  Black arrows indicate the path of 
the translocating T-DNA. The T-DNA interacts directly with VirD4, VirB11, VirB6, VirB8, and 
finally VirB2-VirB9. P: periplasm; IM: inner membrane; OM; outer membrane. 
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transduction system (38). VirA detects signals released from wounded plant tissues and 
VirG activates transcription of the vir operon. The VirB/D4 system delivers an oncogenic 
nucleoprotein complex into plant cells, resulting in the formation of tumors called Crown 
Galls which can devastate agriculturally important crop species (1, 5, 39). 
The majority of genes required for tumorigenesis are found within pathogenic A. 
tumefaciens strains on large (~180kb) extrachromosomal elements called Tumor-inducing 
(Ti) plasmids (40, 41).  A. tumefaciens can conjugatively transfer the Ti-plasmid to 
Agrobacterium and Rhizobium recipients, and upon transfer these strains can now infect 
plants through T-DNA transmission (14, 41).  The Ti plasmid harbors the T-DNA and the 
virulence (vir) genes involved in T-DNA transfer to susceptible plant cells. The T-DNA 
carried on a separate region of the Ti-plasmid, is typically 10-30 kb in length and delimited 
by the left and right border repeat sequences. None of the T-DNA genes are required for its 
secretion, and therefore, all DNA between the border repeats can be excised and 
substituted with DNA of interest for delivery to plant or other eukaryotic target cells (42-44).  
The VirB proteins are encoded by the virB1 through virB11 genes expressed from a single 
promoter (1, 39).  VirB1 - VirB11 are mating pair formation proteins (mpf) that form the 
translocation channel and the T-pilus (5). The virD operon encodes the relaxase VirD2 
substrate and ancillary protein VirD1 required for excision of the T-DNA and its export from 
the bacterium, as well as the coupling protein VirD4 that functions as a receptor for the T-
DNA transfer intermediate and several independently translocated proteins (45, 46).  
 Following signal perception and vir gene induction, T-DNA is processed and 
exported across the A. tumefaciens cell envelope via the T4SS encoded by the virB operon.  
It then moves through the plant cell to the nucleus where it integrates into the plant genomic 
DNA. The virE operon encodes the single-stranded DNA-binding protein (SSB) VirE2 that 
interacts with the T-DNA, forming the T-complex.  VirE2 protects the T-DNA from 
cytoplasmic nucleases in the plant cell and mediates delivery of the T-DNA to the plant 
nuclear pore with the help of VirE3 (47-52). VirF, another translocated effector protein, 
appears to be involved in targeted proteolysis of VirE2 after its arrival in the host nucleus 
(53). Once integrated in the plant genome, the T-DNA genes are expressed and the protein 
products catalyze synthesis of novel amino acids, called opines. Opines are released from 
the plant cell and can be taken up and catabolized for use as carbon and energy sources 
by the infecting bacteria. The T-DNA genes also code for proteins that disrupt biosynthetic 
pathways of the plant hormones auxin and cytokinin.  The resulting hormonal imbalance  
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leads to uncontrolled cell proliferation and formation of the unorganized tumors, termed 
‘Crown Galls’ (40).  
 
IV)  Substrates Transferred by the Secretion Channel 
 A. tumefaciens uses the VirB/VirD4 T4SS to translocate the T-DNA as a single-
stranded DNA particle bound covalently at its 5’ end to the VirD2 relaxase.  A. tumefaciens 
also uses this T4SS to translocate protein substrates only.  These include the VirE2 SSB, 
VirE3, and VirF (54). The first evidence for protein translocation independently of T-DNA 
transfer derives from mixed infection experiments in which it was shown that the co-
infection of plants with two avirulent A. tumefaciens strains, one deleted of T-DNA but with 
an intact vir region, and a second mutated for virE2 or virF, resulted in tumorigenesis (55, 
56). More recent studies showed that protein substrates fused to reporter proteins such 
as the Cre recombinase (57) can mobilize the transfer of the reporter protein to target cells.  
Most T4SSs recognize substrates by detecting a signal sequence located within the protein 
components, e.g. relaxase or effector proteins. These ‘secretion’ signals are located close 
to the C termini and mainly consist of hydrophobic or positively-charged clusters of amino 
acids (15). 
 The T-DNA substrate was shown to form close sequential contacts with channel 
subunits along the secretion pathway (Fig, 1.2) (58). VirD4, termed a coupling protein or 
substrate receptor, initiates the transfer process by recruiting the T-DNA substrate to the 
T4SS.  Additional studies have also shown that VirD4 recruits protein substrates such as 
VirE2 to the secretion channel (45, 59). The DNA substrate next makes contacts with 
ATPase VirB11 (45), and VirB11 in turn transfers the substrate to the inner membrane-
associated subunits VirB6 and VirB8.  Finally, the T-DNA forms close contacts with the 
outer-membrane-associated VirB9 and the VirB2 pilin.  On the basis of these demonstrated 
T-DNA – T4SS subunit close contacts, it was proposed that the VirB/VirD4 secretion 
channel that spans the cell envelope is composed minimally of VirD4, VirB11, VirB6, VirB8, 
VirB2, and VirB9.  Other subunits are required for substrate transfer, and it is thought that 
some of these might form a scaffold for the assembly of the transenvelope channel.  One of 
these proposed scaffold proteins is VirB10, and recent findings suggest that VirB10 spans 
the entire Agrobacterium cell envelope and participates in energizing substrate transfer 
through the distal portion of the transfer channel  (58). 
 The VirB/D4 translocation system also mediates the conjugal transfer of RSF1010, 
a non-self-transmissible IncQ plasmid, into plant cells as well as between Agrobacterial 
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cells (60, 61). This transfer requires the plasmid’s origin of transfer (oriT) and the RSF1010-
encoded MobA nicking enzyme, suggesting that the VirB complex recognizes the IncQ 
transfer intermediate, capped at its 5’ end with MobA.  The RSF1010 transfer intermediate 
was shown to follow the same substrate transfer pathway as the T-DNA, and it also was 
shown to competitively interfere with T-DNA and VirE2 substrate binding to the VirD4 
receptor (62).  Taken together, these observations support the idea that the VirB/D4 T4SS  
is a multifunctional translocation apparatus that exports diverse substrates through 
recognition of amino acid sequence or structural motifs. The VirD4 substrate receptor and 
all VirB proteins except for the VirB1 transglycosylase are required for transfer of the VirD2-
T-strand and MobA-RSF1010 transfer intermediates, VirE2, and VirF (61, 63, 64).   
 
V)  General Architectural Features of VirB/D4 T4SS 
 The T4SSs of Gram-negative bacteria span the entire cell envelope and present 
substrates with a conduit to transit through the periplasm and bacterial membranes (2, 3, 
15, 30). Based on recent structural, functional, and biochemical studies, these proteins can 
be grouped by function/location (Fig. 1.2, see below for more detailed introduction).  There 
are three cytoplasmic-associated ATPases, VirB4, VirB11, and VirD4, which provide energy 
for substrate transfer and machine assembly (30, 45).  VirB6 through VirB10 and possibly 
VirB3 form the bulk of the channel scaffold that spans from the inner membrane to the outer 
membrane (2, 58, 65-67). VirB3, VirB6, and VirB8 all reside at the inner membrane and 
form portions of the base of the channel (58, 65, 66). VirB7, VirB9, and VirB10 interact to 
form a multi-subunit ‘core’ complex that spans the entire cell envelope (67, 68). VirB2 and 
VirB5 form part of the secretion channel but also polymerize to form the extracellular T-pilus 
(25, 69).   
 
VI)  Structure-Function Analysis of Type IV Secretion System Core Components 
 VirB7, VirB8, VirB9, and VirB10 are conserved among most T4SS of Gram bacteria 
(39, 70) and are postulated to comprise the T4SS ‘core’ subunits (67, 68, 71-73).  VirB7 is a 
small lipoprotein that stabilizes VirB9, partly through a disulfide crosslink (74, 75). VirB9 
subunits are hydrophilic but associated with the outer membrane. VirB8 and VirB10 are 
bitopic membrane proteins that both posses a globular periplasmic domain. The periplasmic 
domains of the A. tumefaciens and Brucella suis VirB8 subunits were solved by X-ray 
crystallography (76). VirB8 has been shown to be important for spatial positioning of the 
VirB proteins and may, therefore, function as a nucleation center for the T4SS (29, 77).  
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VirB10 subunits have a short N-terminal domain, a transmembrane region, a proline-rich 
region, and a C-terminal β-barrel domain (73, 78, 79).  VirB10 is an energy 
sensor/transducer that undergoes a conformational change in response to ATP hydrolysis 
from VirB11 and VirD4 to activate substrate transfer through the distal portion of the 
secretion channel (58). 
 Recent studies have shown for the related pKM101 T4SS that VirB7-like TraN, 
VirB9-like TraO, and VirB10-like TraF assemble as a stable ‘core’ complex (67, 68). This 
core complex was visualized as a large (185 Å wide and long) ring-shaped channel by 
cryoelectron microscopy (CryoEM) and X-ray crystallography.  The complex, composed of 
14 copies of each subunit, consists of two stacked layers (I- and O-layers) linked by a thin 
density stretch. The I- and O-layers are double-walled, ring structures that create a hollow 
chamber that is thought to span the cell envelope. The I-layer is anchored at the inner 
membrane while the O-layer is stacked on top and inserted into the outer membrane. The I-
layer is composed of the N-terminal domains of TraO and TraF; the O-layer is formed by 
TraN and C-terminal domains of TraO and TraF.  
Outer Membrane Core Complex Structure 
 The structure of the distal portion of the core complex, presumptively located near 
the outer membrane, was resolved by X-ray crystallography (68). This complex 
corresponds to the O-layer visualized by CryoEM and contains 14 copies of the C-terminal 
domains of TraO and TraF and the full-length TraN (Fig. 1.3A and B). Alpha helical 
projections extending from the top the TraF β-barrel create a halo which forms the outer 
membrane ‘pore’. The remainder of the C-terminal domain of TraF shapes the inner 
chamber of the O-layer surrounded by the TraN-TraO complex (Fig. 1.3 A and B).  The C-
terminal domains of TraO and TraF interact directly, while full-length TraN interacts with the 
C-terminal domain of TraO but not with TraF [Fig. 1.3A and refer to (68)].  Given the 
sequence conservation between these pKM101 Tra proteins and the VirB as well as other 
T4SS core subunits, the Tra core structure is postulated to represent a structural paradigm 
for core complexes of all Gram-negative bacterial T4SSs.  Notably, no other proteins were 
found associated with this outer membrane core complex (67, 68) and the T-DNA substrate 
was never shown to form a close contact with VirB10 (58).  VirB2, which is required for 
substrate transfer and T-pilus formation, forms the distal portion of the secretion channel 
and may, therefore, form a secretion conduit inside the VirB10 pore.  The core  complex  
may  in  addition  serve  as  a  base for assembly of the extracellular T-pilus; however, 
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Figure 1.3 Structure of the ‘core’ type IV secretion system 
A) Crystal structure of the outer membrane complex, comprising the O-layer. TraN, TraO, 
TraF are colored blue, yellow, and red respectively. VirB7, VirB9, VirB10 homologues 
encoded by pKM101. VirB7, VirB9CTD, VirB10CTD heterotrimer, side view with periplasmic 
side facing downwards B) Crystal structure of complete pKM101 outer membrane core 
complex Top: Tilt-view from outer-membrane Bottom: Side view with periplasmic side 
facing downwards.  Modeled with coordinates from pKM101 core outer membrane complex 
X-ray structure (DOI:10.2210/pdb3jqo/pdb) (68) using the PyMOL (http://pymol.org/) to 
construct the figure.  
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at this point,no studies have outlined the functional relationship between the VirB2 pilin and 
core component VirB10.  
 
Structure of the Inner Membrane Complex 
 The I-layer was resolved at ~15 Å by cryoelectron microscopy (67).  The I-layer is 
composed of the N-terminal domains of TraO and TraF. TraF inserts into the inner 
membrane forming a portion of the base of the core structure (67, 68). In the A. 
tumefaciens system, we propose that the VirB7/VirB9/VirB10 complex represents a scaffold 
for the T4SS, and that the other channel subunits assemble within the core chamber to 
form the translocation channel.  Correspondingly, the ring formed by 14 copies of the 
VirB10 transmembrane (TM) sequence would encircle the translocase, comprised of 
polytopic VirB6, bitopic protein VirB8 and, possibly, other subunits (3, 80, 81). VirB6 and 
VirB8 form close contacts with the T-DNA (58) (3, 80, 81). VirB6 has 5 transmembrane 
domains and a large periplasmic region that has been shown to be important for making 
T4SS interactions (65, 82). VirB8, as mentioned above, may play a key role in localization 
of the T4SSs (29, 77). VirB9 likely forms portion of the translocation channel extending 
through the periplasm to the outer membrane. Finally, VirB2 would assemble within the 
core chamber to comprise the distal-most portion of the transfer channel (Fig. 1.2) (58). 
 
Inner Membrane-Associated ATPases 
 Most T4SS have two to three dedicated ATPases that supply energy needed for 
assembly or function of the translocation channel and T-pilus (15). In A. tumefaciens, all 
three ATPases (VirB4, VirB11, and VirD4) are required for substrate transfer, whereas 
VirB4 and VirB11 but not VirD4 are required for T-pilus biogenesis. These ATPases interact 
with each other, likely forming an ATPase complex at the cytoplasmic entrance to the T4SS 
channel (45). This ATPase complex probably interacts with VirB6, VirB8 and/or VirB10 at 
the inner membrane in order to energize the T4SS (83).  Yet, the exact architecture of this 
complex and the specific role each ATPase plays during transfer and machine assembly of 
the secretion channel and the T-pilus remains unknown.  
 VirB11 and its homologs are widely distributed among Gram-negative and Gram-
positive bacteria and several species of Archaea (15). These ATPase are tightly-associated 
with the inner membrane but do not possess any known transmembrane regions. VirB11 
self-associates (84), and structural studies of VirB homologues e.g. TrbBRP4, TrwCR388, 
HP0525Cag, and Brucella suis VirB11 have supplied evidence that this family of ATPases 
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assemble as double-stacked, homohexameric rings (84, 85, 86). The crystal structure of 
ADP-bound HP0525 from H. pylori showed that the N termini and the C termini form two 
globular domains that are separated by the NTP-binding domain (85).  VirB11-like subunits 
are expected to share structural features, although a comparison of H. pylori HP0525 and 
B. suis VirB11 identified structural differences between inter-domain contacts within the 
respective homohexamers (86).  VirB11 and homologs contain Walker nucleoside 
triphospate (NTP) binding regions; where examined, mutation of the Walker A motif 
(GxxGxGKT/S) abolishes both channel activity and pilus biogenesis (87-92).  Studies from 
our lab also identified mutations that selectively abolish T-pilus production without affecting 
substrate transfer (87); how VirB11 regulates biogenesis of either terminal organelle has 
not been established. 
 VirD4 is a member of the family of ATPases termed coupling proteins or substrate 
receptors. Coupling proteins are present in all characterized conjugation systems to date 
(15). These subunits recruit substrates by serving as substrate receptors at the base of the 
T4SSs, thus linking the substrate processing and translocation reactions. The VirD4 
coupling protein and its homologs TraDF, TrwBR388, and TraGRP4 have been extensively 
characterized through biochemical and structural studies (93-96). They contain three 
domains: an NTP-binding region, an N-terminal transmembrane region, and an all-α-
domain.  A crystal structure was obtained for the coupling protein TrwBR388 deleted of its 
transmembrane region (97).  This structure presents as a homohexameric ring, and 
modeling of the N-terminal transmembrane stem yielded an overall F1F0 ATPase-like ball-
stem structure (97, 98). Mutagenesis of the conserved Walker NTP-binding motifs in VirD4 
and homologs abolishes protein function (99-101). Several coupling proteins have been 
shown to bind single and double stranded DNA (93, 94, 102). Biochemical studies have 
also supplied evidence that coupling proteins self-associate and also interact with other 
T4SS components, e.g. VirD2, VirB4, VirB10, and VirB11 (45, 83, 103, 104). 
 VirB4-like ATPases are ubiquitous across all T4SSs described (15). Studies from 
our laboratory have demonstrated that the VirB4 protein is a membrane-associated ATPase 
containing two periplasmically exposed domains (105), however,  soluble versions of VirB4 
homologs have also been identified in other systems. VirB4 self associates, and also 
interacts with VirD4, VirB11, VirB8, VirB10, and VirB11 (45, 83, 106, 107). Homology 
between the C terminus and the coupling proteins TrwBR388 suggests that C-terminal 
domain of VirB4 would form a homohexamer (108). Yet, studies have identified both 
dimeric and hexameric forms of VirB4 homologs (78, 106, 108-110).  Phenotypic studies 
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established the importance of the Walker NTP-binding motif and, by extension, VirB4 NTP-
binding and/or hydrolysis activities, for substrate translocation and pilus biogenesis  (87, 
104, 105, 111, 112). In addition, alleles encoding a VirB4 NTP-binding mutant exhibit 
transdominant effects over the wild-type virB4 gene, suggesting that VirB4 functions as a 
homo- or heteromultimer (105). Biochemical studies showed that a purified VirB4 homolog 
binds and hydrolyses ATP (113). Although the specific function of these activities is not 
known, the transmembrane topology of VirB4 and its likely interactions with components 
localized at the inner membrane, suggest that VirB4 can energize ATP-induced 
conformational changes necessary for biogenesis of the T4SS.  
 
VII)  VirB2 Pilin and the T-Pilus Biogenesis Pathway 
 The VirB proteins direct assembly of the extracellular T-pilus (25). The T-pilus is 
composed of VirB2 pilin and the VirB5 minor subunit (25, 31, 114). VirB2 homologs or 
orthologs, with low levels of similarity yet retaining key residues, are present in several 
other T4SSs (78). The VirB2-like proteins are typically small and hydrophobic, and they 
also contain a cleavable signal sequence (Fig. 1.4) (115, 116). Several novel processing 
reactions are known to be associated with pilin maturation (115). The VirB2 pro-pilin is 121 
amino acids, the first 47 comprising an unusually long signal sequence.  After cleavage, the 
74-residue peptide is further processed by joining of the N- and C-termini, forming a cyclic 
peptide.  The mature pilin is composed of two hydrophobic domains and two short 
hydrophilic domains (104, 117). When synthesized in E. coli, the signal sequence of VirB2 
is cleaved but the mature protein is not cyclized (118). In A. tumefaciens, the cyclized 
mature pilin is presumably shunted through the core channel complex and serves as the 
building block for assembly of a functional secretion channel and the extracellular T-pilus 
(58) (Fig. 1.5).  
 The T-pilus has been shown to localize at the A. tumefaciens cell poles (104, 119). 
Little is known about the function of the T-pilus. There is some evidence, using VirB2 in 
yeast two hybrid screening methods aimed at identifying plant host receptors, that T-pili are 
involved with sensing of the host cell surface (120). No structural information is available for 
VirB2 or the T-pilus; however, a structure was solved for a VirB5 homolog, TraCpKM101. 
 
 
 
 
15
  
 
 
 
 
 
Figure 1.4 Sequence alignment of VirB2 pro-pilin homologues  
The homologs of A. tumefaciens VirB2 pro-pilins (At VirB2) were aligned using CLUSTAL 
W program and edited manually. The homologous proteins shown here are LvhB2 in 
Legionella pneumophila (Lp LvhB2), VirB2 in Brucella suis (Bs VirB2), PtlA in Bordetella 
pertussis (Bp PtlA), VirB2 in Bartonella henselae (Bh VirB2), TraM of IncN plasmid 
pKM101, TrwM of IncW plasmid R388, TrbC of IncP plasmid RP4, and TraA of IncF 
plasmid F. The conserved domains and amino acid residues are highlighted in color. The 
signal peptidase I cleavage site is indicated; it was predicted by the conserved sequences 
of the cleavage sequences in all homologues and based on the known processed sites of F 
TraA, RP4 TrbC and At VirB2. The putative hydrophobic transmembrane (TM) helices and 
the core regions of all processed VirB2 homologues are indicated as single solid lines and 
double dashed lines, respectively. This figure was modified from from Figure3  in “The T-
pilus of Agrobacterium tumefaciens.” Trends Microbiol. 8, 361-69. (doi:10.1016/S0966-
842X(00)01802-3). 
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Figure 1.5 Schematic of the pilin processing and proposed T-pilus biogenesis 
pathway of the Agrobacterium tumefaciens VirB/D4 secretion system 
The VirB1-VirB11 and VirD4 type IV secretion system (T4SS) components are shown 
according to their proposed localization and interactions.  VirB2 is produced as a 121 amino 
acid pro-pilin that is inserted into the inner membrane. The 47 residue signal sequence is 
cleaved by a signal peptidase, resulting in a 74 amino acid product. The N- and C-termini 
are joined in a head-to-tail peptide bond, forming a cyclic peptide. The mature pilin is 
composed of two hydrophobic domains and two short hydrophilic domains. The cyclized 
mature pilin is then predicted to be shunted up the core complex where is can serve as the 
building block for assembly of a functional secretion channel and the extracellular T pilus. 
P: periplasm; IM: inner membrane; OM; outer membrane; S.S: Signal Sequence. 
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T-pili are long, 10nm wide filaments; when treated with sodium dodecyl-sulfate, a 2 nm 
channel was detected (104). In such a putative channel, it would be possible for the 
monomeric cyclic VirB2 peptides to be transported to the growing tip of the T-pili, in an 
assembly mechanism similar to that of flagella. Alternatively, new monomeric protein may 
be added at the base of the pilus. Immunogold labeling studies confirmed that VirB2 pilins 
comprise the entire length of the T pilus, and also supplied evidence that VirB5 is localized 
to the filament tip (121). A VirB4-VirB8-VirB5 interaction sequence was shown to be 
required for formation of a VirB2-VirB5 complex; assembly of this complex is thought to be 
a prerequisite for T-pilus assembly (122). Beyond this interaction network, little is known 
about the subunits involved or the specific steps necessary for T-pilus assembly. 
Uncoupling Mutations 
 Interestingly, various VirB mutations have been isolated that disengage or separate 
substrate transfer from T-pilus biogenesis. Mutations have been identified in VirB6, VirB9, 
and VirB11 that abolish formation of detectable T-pilus without disrupting secretion of 
substrates through the VirB channel (82, 87, 123). In addition, deletion of the VirB1 
transglycosylase was shown to abolish T-pilus production without blocking substrate 
transfer (124-126), whereas, conversely, deletion of the VirD4 coupling protein does not 
affect T-pilus biogenesis but blocks substrate transfer. On the basis of these findings, it has 
been proposed that the VirB proteins can alternatively assemble as the T-pilus or the 
secretion channel. Signals directing assembly of the VirB proteins as the secretion channel 
or the T-pilus are not known, but could include events occurring at the inner face of the 
inner membrane e.g. substrate docking, ATP hydrolysis, or the outer face of the outer 
membrane, e.g. target cell contact, pilus breakage.  
 
VIII)  The Importance of VirB2 and VirB10 Subunit Studies of the VirB/D4 T4SS 
 Both VirB2 and VirB10 are required for substrate transfer and T-pilus biogenesis 
(25, 127, 128). The movement of VirB2 from the inner membrane to a predicted periplasmic 
VirB2 polymer (secretion channel portion) (58, 123) and an elaborate extracellular 
organelle, suggests that VirB2 undergoes dynamic changes in structure and protein-protein 
contacts. Energy is predicted to play a key role in T-pilus biogenesis but the specific 
contributions of the VirB ATPases VirB4 and VirB11 have yet to be defined.  Biochemical 
assays have shown that VirB10 is an energy sensor that undergoes a conformation change 
in response to ATP hydrolysis by VirB11 and VirD4 at the inner membrane (58). Structural 
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information on the ‘core’ channel complex of the T4SS encoded by pKM101 showed that a 
VirB10 homolog forms the outer membrane pore and spans the entire cell envelope (67, 
68). Nevertheless, the structural and functional role of VirB10 domains with respect to T-
pilus biogenesis and substrate transfer remain undefined. The location of VirB10 and its 
energy sensing capability suggest that VirB10 could gate the outer membrane channel and 
VirB10 domains may play specific roles in both secretion and T-pilus assembly. Thus, 
studies aimed at characterizing the contributions of the VirB2 pilin and VirB10 energy 
sensor during formation of the T4SS will help develop a more detailed mechanistic 
understanding of T4SS biogenesis and function, and will also contribute to a broader 
comprehension of the energetics and molecular events underlying assembly of complex 
surface organelles.  
 
IX) Dissertation Focus and Specific Aims 
 In this thesis, I sought to define key reactions required for the integration of the 
VirB2 pilin into the secretion channel and T-pilus. My work focused primarily on VirB2, 
VirB4, and VirB10,  and the 4 aims were: i) define the VirB2 inner membrane topology and 
packing architecture in the T-pilus (Chapter 3), ii) characterize the contributions of the VirB4 
and VirB11 ATPases to the structural state of membrane-integrated VirB2 pilin during 
machine biogenesis (Chapter 4), iii) Characterize how VirB10 domains contribute to T-pilus 
biogenesis and channel activity (Chapter 5), and iv) explore the mechanism by which a 
VirB10 gating mutant mediates release of secretion substrate while selectively blocking T- 
pilus biogenesis (Chapter 6). 
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Strains, plasmids, and induction conditions 
  Agrobacterium tumefaciens and Escherichia coli strains and plasmids used in this 
study are listed in Table 2.1 and 2.2.   Conditions for growth of A. tumefaciens and E. coli 
and for vir gene induction with 100 µM acetosyringone (AS) in induction media (ABIM) have 
been described previously (128). Plasmids were maintained in A. tumefaciens and E. coli 
by addition of gentamycin sulfate (100 & 20 µg/ml, respectively), carbenicillin (100 µg/ml), 
tetracycline (5 µg/ml), spectinomycinn (600 µg/ml) and kanamycin (100 µg/ml). 
 
VirE2-FLAG tag construction 
 Cristina Alvarez-Martinez, a postdoctoral fellow in the Christie laboratory 
constructed a plasmid expressing PvirB-virE1-FLAG-virE2 by site-directed mutagenesis 
using two-step PCR (129). Primers used to construct this plasmid are listed in Table 2.3.  
Primers virE1_for_Nde and virE1_rev_FLAG were used to amplify the region upstream of 
the FLAG epitope tag (the FLAG sequence was introduced in the virE1_rev_FLAG primer). 
Primers virE2_for_FLAG and E2Down were used to amplify the region downstream of the 
FLAG tag (primer virE2_for_ FLAG contained the desired tag). The 5’ and 3’ fragments 
obtained after PCR amplification were used as templates in another PCR reaction using 
primers virE1_for_Nde and E2Down, generating the full-length gene containing the desired 
FLAG tag in frame with VirE2. The fragment was cloned in the pGEMT-Easy vector 
(Promega) and sequenced.  
 
VirB2-FlAsH tag construction 
 Plasmids in pJKFlAsHxx series were constructed by cloning a FlAsH Kanr cassette 
into the SphI site created by the Cys substitutions in VirB2 (See (130)). FlAsH Kanr cassette 
was constructed by PCR amplification of the Kanr cassette from pXZ151 and flanked by an 
SphI site, half of the FlAsH tag, and a SmaI site, resulting in: SphI – Cys – Cys – Pro – 
SmaI -- Kanr cassette – SmaI – Gly – Cys –Cys -- SphI. Primers used for amplification are 
listed in Table 2.3, Following cloning into the SphI site created by the Cys substitutions in 
VirB2 (130), the Kanr cassette was removed by SmaI digestion. Imran Shah, a postdoctoral 
fellow in the Christie laboratory, constructed plasmids pISFlAsH63 and pISFlAsH114 using 
oligonucleotde-directed mutagenesis.  Plasmid pBB8 served as the template (128) and the 
FlAsH tag was inserted using the primers listed in Table 2.3. Insertions were confirmed by 
sequencing.  
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 TABLE 2.1: Bacterial strains used in these studies. 
Bacterial Strain  Relevant characteristics  Source 
E. coli     
GIBCO-BRL DH5α    λΦ80d/lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rK - mK+)supE44 thi-1 gyrA relA1 
S17-1   Tra genes from pRP4 integrated into chromosome  BIO-RAD 
A. tumefaciens    
A348   A136 containing pTiA6NC  (131) 
A348Spcr  A348 with Spcr by spontaneous mutagenesis  (87) 
PC1000  A348 deleted of entire virB operon from pTiA6NC  (132) 
PC1001 A348 deleted of virB1 and from pTiA6NC   (128) 
PC1002  A348 deleted of virB2 from pTIA6NC; polar on virB3  (128) 
PC1003  A348 deleted of virB3 from pTIA6NC  (128) 
PC1004  A348 deleted of virB4 from pTIA6NC  (133) 
PC1005 A348 deleted of virB5 from pTiA6NC   (128) 
PC1006  A348 deleted of virB6 from pTIA6NC  (128) 
PC1007  A348 deleted of virB7 from pTIA6NC  (128) 
PC1008  A348 deleted of virB8 from pTIA6NC  (128) 
PC1009  A348 deleted of virB9 from pTIA6NC  (128) 
PC1010  A348 deleted of virB10 from pTIA6NC  (128) 
PC1011  A348 deleted of virB11 from pTIA6NC   (128) 
PC1211  A348 deleted of virB2 and virB11 from pTIA6NC   (123) 
JK1002  A348 deleted of virB2 from pTiA6NC    (130) 
JK1204  A348 deleted of virB2 and virB4 from pTiA6NC   (130) 
C58-fliR C58 deleted of fliR- Aflagellate, non-motile Dr. Clay 
Fuqua 
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TABLE 2.2: Plasmids vectors used in these studies 
 
Plasmid or 
Vector 
Relevant characteristics Source 
pGEMT-Easy  Crbr; cloning vector  Promega 
pBSIIKS+ NdeI   Crbr; cloning vector containing NdeI restriction  (128) 
pXZ151  Kanr; broad-host-range IncP plasmid containing Plac (134) 
with downstream polylinker sequence 
pSW172  Tetr; broad-host-range IncP plasmid  Plac with (128) 
downstream polylinker sequence 
pBBR1MCS2Kr
  
Kanr; broad-host-range cloning vector  (135) 
pBBR1MCS2Gr  Genr; broad-host-range cloning vector  (106) 
Genr; IncQ RSF1010 derivative pML122ΔKr   (60) 
Kanr; ~3-kb BamHI fragment containing nptII pBB50 (128) 
virB  expression 
plasmids 
   
Crbr; pBIIKS+NdeI expressing PvirB-virB2C64S pJEK01 (130) 
Crbr; pBB8 with a virB2 internal deletion pJEK02 (130) 
Crbr Kanr; sacB-containing pBB50 (128) with the pJEK03 (130) ΔvirB2 mutation and flanking sequences from pJEK02 
Crbr; pBIIKS+NdeI expressing PvirB-virB1 pPC914  (128) 
Crbr; pBIIKS+ expressing PvirB-virB1, virB2 with NdeI at  
start site, and virB3 
pPC927  (128) 
Genr; pBBR1MCS2Gr expressing PvirB-virB4 pKA93   (45) 
Genr; pBBR1MCS2Gr expressing PvirB-virB4K439Q   pKA96   (130) 
pKA94   Genr; pBBR1MCS2Gr expressing PvirB-virB4 and PvirB- (130) 
virB11   
pJKxx series  pJEK01 with VirB2 Cys substitutions; xx denotes the (130) 
position of the codon replacement  
pJKBxx series  Crbr Kanr; pXZ151 ligated to pJKxx plasmids (130) 
pJKBBxx series  Crbr Kanr; pBBR1MCS2Kr ligated to pJKxx plasmids (130) 
pXZB100  Crbr Kanr; pXZ151 with PvirB-virB11 (136) 
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pPCB39  Crbr Kanr; pXZ151 with PvirB-virB11K175Q   (90) 
pXZB102  Crbr Kanr; pXZ151 with PvirB-virB11I265T (87) 
pKVD10  Crbr Tetr; pSW172 with Plac-VirB10 (69) 
pKVD116  pKVD10 with residues 2-18 deleted from VirB10 (69) 
pKVD136  pKVD10 with residues 2-46 deleted from VirB10  (69) 
pKVD117  pKVD10 with residues 70-114 deleted from VirB10  (69) 
pKVD145  pKVD10 with residues 72-92 deleted from VirB10  (69) 
pKVD146  pKVD10 with residues 92-114 deleted from VirB10 (69) 
pKVD126   pKVD10 with residues 268-287 deleted from VirB10 (69) 
pKVD129  pKVD10 with residues 308-337 deleted from VirB10 (69) 
pIG022  pKVD10 with VirB10 Cys substitution  at residue 356 in (69) 
the RDLDF motif 
pKVDΔ150   pKVD10 with residues 2-150 deleted from VirB10, (69) 
fused to the 5’ end of VirB5 signal sequence from 
pZD74 
pZD74   virB5 signal sequence   (69) 
pIGxx series  pKVD10 with VirB10 Ala-Cys codon insertions or cys (69) 
codon substitutions; xx denotes the codon immediately 
preceding the insertion or codon of substitution 
pCM48  PvirB VirE1-VirE2 FLAG in pGEM-Easy vector  (Dr. Cristinta 
Martinez, 
this study) 
(Dr. Cristinta 
Martinez, 
this study) 
pCM50   PvirB VirE1-VirE2 FLAG cloned as a NdeI/XhoI  
fragment from pCM48 into pPC914 Nde/Xho 
pCMB50  Crbr Kanr; pBBR1MCS2Kr ligated to  pCM50 PvirB (Dr. Cristinta 
Martinez, 
this study) 
VirE1-VirE2 FLAG  
pLB100  VirB10 with substitution G272R Dr. Lois 
Banta 
pJKFLAG85 pBB8 with VirB2 FLAG insertion following residue 85  This study 
pJKFlAsHxx series pVS10 with VirB2 Cys substitution and FlAsH tag This study 
insertion; xx denotes the Cys substitution FlAsh tag 
inserted at the SphI site 
pISFLAG62 pBB8 with VirB2 FLAG insertion following residue 62 (Dr. Imran 
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Shaw, this 
study 
pISFLAsH63 pBB8 with VirB2 FlAsH tag insertion following residue (Dr. Imran 
Shaw, this 
study) 
63 
pISFLAsH114 pBB8 with VirB2 FlAsH tag insertion following residue (Dr. Imran 
Shaw, this 
study) 
114 
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Table 2.3: Oligonucleotide primers used for epitope tag construction and insertion 
Name 5’Primer 
VirE1_for_Nde 5’ –  AAT ACA TAT GGC CAT CAT CAA G  – 3’ 
VirE1_rev_FLAG 5’ – TTT GTC GTC GTC GTC TTT GTA GTC CAT CGT CTC 
ACT CCT TCT GAC – 3’ 
VirE2_for_FLAG 5’ – ATG GAC TAC AAA GAC GAC GAC GAC AAA ATG 
GAT CTT TCT GGC AAT– 3’ 
E2Down 5’ – TTC TCG AGT CAA AAG CTG TTG ACG CTT TGG 
CTA CG – 3’ 
FlAsH Kan SphI SmaI-AS 5’ – AAT GCA TGC ACA ACA CCC GGG GTC GAC CTG 
CAG – 3’ 
FlAsH Kan SphI SmaI -S 5’ – AAT GCA TGC TGC CCC GGG TGA GGT CTG CCT C 
B2FlAsH 63/64-S 5’ – GCT GCC CAG GAT GCT GCA TAT GCA GCT TTA 
TCC TTG GTC C – 3’ 
B2FlAsH 114/115-AS 5 ’– GCA GCA TCC TGG GCA AGC AGC CGA GGA AGC 
TCG CCC C –  3’ 
B2FLAG 59/60-AS 5 ’– CGT GCA TAT ATT GTT AAC CTT GTC ATC GTC GTC 
B2FLAG62/63-S 5’- GAT TAT AAA GCG TTT GAT AAC CTG ATA TGC ACG 
TTT ATC CTT GGT CC – 3’ 
B2FLAG 64/65-AS 5’ –  CGG ACC AAG GAT AAA CGT CTT GTC ATC GTC 
GTC GTC CTT ATA ATC GCA TAT ATT GTT AAC CAT –  3’ 
B2FLAG 85/86-AS 5’- CCG CCC GAA CAT CCA GGA CTT GTC ATC GTC 
GTC CTT ATA ATC GAT CCC GAT AGC GAC AAT – 3’ 
B2FLAG 118/119-AS 5’- TCA ACT ACC GCC CTT GTC ATC GTC GTC CTT ATA 
ATC AGT GAG CGT TTG GCC GAG – 3’ 
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VirB2-FLAG tag construction 
 Plasmid pBB8 served as the template for construction of the FLAG tagged VirB2 
insertion mutations using oligonucleotde-directed mutagenesis (128) and the FLAG tag was 
inserted using the primer listed in Table 2.3. Imran Shah, a postdoctoral fellow in the 
Christie laboratory constructed plasmid pISFlag62. 
 
Virulence assays 
 Strains of A. tumefaciens were tested for virulence on wounded Kalanchoe 
daigremontiana leaves (128). Controls for the tumorigenesis assays included co-inoculating 
the same leaf with wild-type A348 and the corresponding vir gene deletion. Virulence was 
scored in terms of and time course of tumor appearance and tumor size. Tumors were 
scored on a scale of – avirulent to +++ wild-type virulence. Assays were performed in 
triplicate. 
 
Conjugation assays 
 Diparental mating with E. coli strain S17-1(pML122) was used to introduce the IncQ 
plasmid pML122 (Genr) into various A. tumefaciens donor strains (82, 87).  Conjugative 
transfer of the mobilizable IncQ plasmid pML122Genr from A. tumefaciens donor strains of 
interest to A348Spcr recipient cells was carried out as described previously (87).  Assays 
were performed in triplicate and transfer frequencies presented as the number of 
transconjugants per donor for a representative experiment. 
 
Protein analysis and immunobloting 
 Proteins were resolved by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) using 12.5% or 10% polyacrylamide gels, or Tricine sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (Tricine SDS-PAGE) using 16.5% 
polyacrylamide gels (84).  Gels were transferred to nitocellullose membranes, and 
visualized by immunoblot development with goat anti-rabbit conjugated to alkaline 
phosphatase (BioRad) or blots were developed with anti-rabbit antibodies conjugated to 
horseradish peroxidase and were visualized by chemiluminescence (Pierce, Thermo 
Scientific). Pre-stained SDS-PAGE Broad Range from BioRad served as the molecular size 
markers.  
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T-pilus isolation and extracellular blot assay 
 A. tumefaciens strains were grown to an OD600 of 0.5 in MG/L media at 28 °C, and 
then induced for expression of the vir genes with acetosyringone (AS) at 25 °C, as 
described previously (137). The induced culture (1 mL) was spread on ABIM agar plates 
and incubated for 4 d at 18 °C.  Cells were removed from the plates and placed in 1 ml 50 
mM KPO4 buffer (pH 5.5). The cell suspension was passed through a 25-gauge needle.  
The sheared material was centrifuged for 30 min at 14,000 x g at 4 °C and the supernatant 
was saved. The fraction was centrifuged for 1 h at 100,000 x g at 4 °C to recover T- pili or 
alternatively prepped for analytical gel filtration or viewing in the electron microscope (refer 
below). T-pili were suspended in 50 μL of Laemmli's buffer and boiled, or suspended in 
buffer A [100 mM Hepes (pH 7.5), 250 mM sucrose, 25 mM MgCl2, 0.1 mM KCl] and further 
fractionated through a 20-70% sucrose density gradient as described previously (138).  
Alternatively, resuspended T-pili were used in Cys labeling studies, as described below. 
Extracellular VirB2 and VirB5 were detected by colony surface immunoblotting as described 
previously (69). 
Analytical gel filtration  
 Recovered T-pili  samples were subjected to analytical gel filtration (AGF) by Dr. 
Hye-Young Yeo (University of Houston) using a Superdex 75 10/300GL column (Tricorn) 
(69). The column was equilibrated and run with buffer S [50mM Hepes pH 7.0, 2mM MgCl2, 
5% glycerol, 100mM NaCl, 0.1mM EDTA].  The AGF column was calibrated using 
molecular weight standard markers RNase A (14kDa), chymotrypsinogen A (25kDa), 
albumin (67kDa), and lactate dehydrogenase (140kDa) (Amercham Biosciences).  
Recovered gel filtration factions were analyzed using tricine SDS-PAGE as mentioned 
above.  
Chemical labeling of cysteine residues 
 Cysteine labeling experiments were performed as previously described (65) with 
some modifications. Briefly, A. tumefaciens strains producing VirB2 Cys derivatives were 
induced for vir gene expression and grown to an OD600 of 0.6. Cells from 30 ml cultures 
were harvested, resuspended in buffer A and distributed into two oakridge tubes to a final 
OD600 of 12 in 500 μl of buffer A. 4-acetamido-40-maleimidylstilbene-2,20-disulfonic acid 
(AMS; Molecular Probes) was  added (5 mM final) to one cell suspension, and cells were 
incubated at 25 °C for 30 min. Ten ml of buffer A was added to the cell suspension and 
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centrifuged to remove the AMS. The resulting cell pellet was resuspended in 500 μl of 
buffer A. 3-(N-maleimidylpropionyl) biocytin (MPB; Molecular Probes) was added to the 
AMS-pretreated cells and the second cell suspension at a final concentration of 100 μM (20 
mM stock in dimethyl sulfoxide). The cells were incubated at 25 °C for 5 min. The final 
concentration of dimethyl sulfoxide in the reaction did not exceed 0.5% (v/v).The 
biotinylation reaction was quenched by addition of β-Mercaptoethanol (β-ME; 20 mM final) 
and cells were washed two times in buffer A with 20 mM β-ME. As controls, sonicated cell 
extracts were treated with MPB. For labeling of the T-pilus, enriched T-pili were suspended 
in 500 μl of buffer A, treated with a final concentration of 100 μM MPB, and incubated at 25 
oC for 5 min.  The biotinylation was stopped by addition of β-ME (40 mM final).  T-pili were 
recovered by centrifuging at 100,000 x g, and MPB labeling of Cys-substituted pilin was 
assessed as described below.   
Detection of labeled cysteine residues 
 MPB-treated T-pili or whole cells were suspended in 200 μL TES buffer [10 mM Tris 
pH 7.5, 5 mM EDTA, 2% (w/v) SDS] and vortexed at 37 °C for 30 min. Samples were 
incubated on ice for 1 h with 250 μl of buffer B [150 mM Tris (pH 8.0), 0.5 M sucrose, 10 
mM EDTA] plus lysozyme (1mg/ml final).  Sample  were then vortexed at 37 °C for 15 min. 
Triton X-100 (20 μl), 13 μL of 1 M MgCl2 stock solution, and protease inhibitor cocktail 
EDTA-free (30 μl; Pierce Biochemicals) were added and the samples were vortexed at 25 
°C for 10 min followed by gentle rocking at 4 °C for 3 h.   Samples were diluted with 900 μl 
of buffer B and centrifuged at 14,000 × g for 15 min. The resulting supernatant was 
incubated with a 30 μl bed volume of Protein A-Sepharose CL4B (Pharmacia) at 25 oC and 
for 45 min and centrifuged at 5000 × g to remove protein A-Sepharose and non-specifically 
bound proteins. The recovered supernatant was incubated overnight at 4 °C with a 60 μl 
bed volume of Protein A-Sepharose coupled to anti-VirB2 antibodies. The beads were 
recovered by low-speed centrifugation at 400 x g and washed two times in buffer B plus 1% 
(w/v) Triton X-100 at 4 °C for 10 min, one time in buffer B plus 0.1% (w/v) Triton X-100 at 4 
°C for 10 min, and one time in buffer B at 25 °C for 5 min. Beads were recovered and 15 μL 
buffer B  plus 15 µl of 5X Laemmli’s buffer was added prior to boiling samples (5min). 
Boiled samples were centrifuged at 400 × g for 5 min and proteins were subjected to 
Tricine-SDS-PAGE and transferred to nitrocellulose as described above.  Membranes were 
blocked with buffer C [1X PBS, 0.1% Tween 20, 5% (w/v) bovine serum albumin (BSA)] 
overnight and then for 4 h in the presence of avidin-HRP (Pierce; 2:10,000 dilution from 2 
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mg/ml stock). Blots were washed 3 times in buffer D (1X PBS, 0.1% Tween 20, 0.5% BSA) 
and incubated for 10 min with buffer C prior to analysis by chemiluminescence according to 
the manufacturer’s instructions (Pierce, Thermo Scientific). 
Growth Curves 
 A. tumefaciens strains were grown to an OD600 of 0.5 in MG/L media at 28 °C, and 
then induced in ABIM at 25 °C for 4 h. Cells were normalized and diluted in ABIM (OD600= 
0.1). Greinier Bio-One flat-bottom, 24- well PS microplates (Sigma-Aldrich, Prague, Czech 
Republic) were filled with the cell suspension (1mL in each well). Plates were covered with 
a sealing membrane (Breathe-Easy; Sigma-Aldrich). Growth over time (18 h) was 
monitored using a SynergyTM Mx Multi-Mode Microplate Reader (Biotek Instrucments).  The 
absorbance in each well was measure at 600 nm at given intervals (30 min) with continuous 
shaking of the microplate. The absorbance data, with background absorbance subtracted, 
were exported to MS Excel for further processing. Data are shown for a representative 
experiment. 
FLAG-VirE2 Release Screen 
 Surface-exposed FLAG-VirE2 was detected by colony immunoblotting as described 
previously for VirB2 detection (69) with minor modification. Monoclonal FLAG antibody was 
used as the primary antibody followed by immunoblot development with goat anti-mouse 
conjugated to alkaline phosphatase (BioRad).   
Assays for vancomycin and SDS sensitivity 
 Growth of each strain in ABIM supplemented with 0.5% SDS or Vancomycin (50 
μg/ml and 100 μg/ml) was monitored over 18 h using Synergy™ Mx Multi-Mode Microplate 
Reader (BioTek Instruments) as described above.  
Assays for outer membrane integrity 
 RNase I release from intact cells was assayed according to Lazzaroni and Portalier 
(139).  Briefly, ABIM induced cells were normalized (OD 600  = 0.6) and 20 μl was spotted 
on ABIM RNase agar [standard ABIM agar supplemented with 0.1% yeast extract and 1% 
RNA type VI from Torula yeast (Sigma)]. After overnight growth at 28 oC, RNA was 
precipitated with cold 10 % trichloroacetic acid (TCA), and RNase I leakage was detected 
by identification of clear zones surrounding colonies.  Alternatively, after overnight 
incubation, colonies were scraped from the plates, resuspended in 50 μl ABIM, and 
sonicated. Lysed cells were spotted on fresh ABIM RNase agar for 1h prior to TCA 
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precipitation and monitored for clearing. ChvE release was monitored by colony 
immunobloting with anti-ChvE antibody (69). Alternatively, after incubation, colonies were 
scrapped from the plates, resuspended in 50 μl ABIM, and sonicated. Lysed cells were 
spotted on 0.45 mm nitrocellulose membrane, allowed to sit for 5 min, and developed by 
immunostaining as mentioned above (69). 
Co-immunoprecipitation 
 Coimmunoprecipitation was performed as described previously (82).  Briefly, 500 ml 
cultures induced by AS were harvested and cells were lysed by the French press. 
Ultracentrifugation was used to recover total membranes.  Membrane were cross-linked 
with dithiobissuccidimidyl propionate (DSP; 0.5 mg /ml final) and solubilized with RIPA 
buffer (50 mM Tris pH 7.6, 0.1% SDS, 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP-
40). The solubilized membranes were used in immunoprecipitation experiments probing 
with anti-VirB2, anti-VirB4, or anti-VirB11 antibodies coupled to Protein A-Sepharose CL-4B 
beads (Amersham Biosciences). 
Osmotic shock 
 Cells were subjected to osmotic shock treatment as previously described (140).  
Briefly, A. tumefaciens strains were induced and grown to an OD600 of 0.5.  Cells from 65 ml 
cultures were harvested and normalized to final OD600 of 18. Cells were pelleted by 
centrifugation at 10,000 x g, resuspended in 8 ml of ice-cold osmotic shock solution [20% 
(w/v) sucrose, 5 mM CaCl2, 33 mM Tris–HCl pH 8.0, 0.5 mM Na2 EDTA] and incubated 
while shaking at 4 °C for 15 min. Cells were pelleted by centrifugation at 10,000 × g for 10 
min and the supernatant was removed.  The pellet was resuspended in 1 ml ice-cold 
reverse osmosis water and incubated at 4 °C for 10 min while shaking.  The cell 
suspension was centrifuged at 8000 x g for 10 min, and the osmotic shockate 
(supernanant) was recovered and the cell pellet was reserved. The shockate was 
concentrated by precipitation with 5 % trichloroacetic acid or alternatively by 
ultracentrifugation at 100,000 x g at 4 °C for 1 h. the resulting pellet was resuspended in 20 
μl of 5X Laemmli’s buffer. The remaining cell pellet was resuspended in 400 μL 5X 
Laemmli’s buffer. Samples were boiled (5 min) and then analyzed using 12.5% SDS-PAGE 
and Tricine SDS-PAGE as described above.    
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Electron microscopy 
 T-pili in the saved supernatant from ABIM plates, mentioned above, were 
precipitated with 1M MgCl2 (0.1 M final) by incubation overnight at 4 °C. T-pili were 
collected  by centrifugation at 16,000 x g at 4 °C for 1.5 h. The resulting pellet was 
resuspended in 100μl of 10 mM Tris-Cl (pH 8.0) and further fractionated through a 20-70% 
sucrose density gradient at 99,000 x g at 4 °C for 4 h. Fractions (~400 μl) containing T-pili 
were pooled and centrifuged at 100,000 x g at 4 °C for 1 h. The pellet was resuspended in 
100μl 10 mM Tris-Cl (pH 8.0) and fractionated through a 1.1-1.5g/mL CsCl step-gradient for 
at 120,000 x g at 5 °C 18 h (115). Fractions (~250 μL)harboring T-pili were pooled and 
centrifuged at 100,000 x g at 4 °C for 1 h. The pellet was resuspended in 10 mM Tris-Cl 
(pH 8.0) and further diluted to 4 mL to remove excedd CsCl prior to centrifuging at 100,000 
x g at 4 °C for 1 h.  The final pellet was resuspended in 50 μL of 50 mM Hepes, a 5 μl 
sample was placed on a 300-mesh carbon-Formvar grid (Ted Pella, Inc.). Grids were 
stained with 1% uranyl acetate (Ted Pella, Inc.) and examined with a JOEL 1400 electron 
microscope.  
Disulfide crosslinking 
 Isolated T-pili (as described above) were resuspended in non-reducing Laemmli's 
buffer [125 mM Tris-HCl, pH 6.8, 20% (v/v) glycerol, and 4% (w/v) SDS) containing 50 mM 
EDTA and no reducing agent] or standard β-ME-containing Laemmli's buffer, boiled, and 
electrophoresed through a Tricine SDS-PAGE gel, as described above.  Alternatively, 
isolated T-pili were suspended in PBS (pH 7.4), and samples were cross-linked by 
incubation with 1 mM Cu2-(phenanthroline)3 as the oxidant at 37 °C for  5 min. The 
reactions were stopped by addition 5 mM EDTA followed by addition of non-reducing 
Laemmilis’ buffer. Samples were subjected to Tricine-SDS PAGE gels and proteins were 
detected as described above. 
Immunofluorescence microscopy 
 Cells induced with AS for synthesis of the Vir proteins were washed once in 1 X 
phosphate buffered saline (PBS; 150 mM NaCl, 15 mM KCl, 0.11% Na2HPO4, 0.03% 
NaH2PO4) and a 30 μl suspension (OD600=2) was applied onto a 0.1% poly-L-lysine-coated 
glass cover slip and briefly air dried. Cells were fixed by incubation overnight at 25 °C in 
fixation solution (37.5% methanol + 12.5% acetic acid), and unbound cells were removed 
by three  20 min washes in PBS containing 0.05% Tween-20 (PBS-T). Cells were treated 
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overnight at 4oC with primary antibodies (1:100 dilution in 2% BSA), followed by three PBS-
T washes.  Cells were then incubated in the dark with Alexa fluorR 488 goat-anti-rabbit IgG 
(1:100 dilution in 2% BSA)  (Molecular Probes) at 25 °C  for 1 h. Cells were washed one 
time with PBS-T and two times with PBS. Cover slips were treated with anti-fade solution 
(50% glycerol in PBS), sealed with base coat of nail polish (Revlon) on a microscopic slide, 
and visualized Nomarski microscopy. 
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Chapter 3: T-pilus Maturation as Monitored by Cysteine Accessibility  
 
 
 
 
 
 
 
 
NOTE: This chapter is derived from work that has been published in 2010: “Evidence for 
VirB4-Mediated Dislocation of Membrane-Integrated VirB2 Pilins during Biogensis of the 
Agrobacterium VirB/VirD4 Type IV Secretion System.” Journal of Bacteriology 192(19): 
4923-34. PMID: 20656905.  I am the primary author on this paper. I performed all 
experiments described in this chapter.  I have been given permission by the publisher of 
Journal of Bacteriology, the American Society for Microbiology, to reproduce any/all of my 
manuscript in print or electronically for the purposes of my dissertation (License Number 
2510961139325).  
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Introduction 
A fundamental question of interest for bacterial surface organelles is how the 
machine subunits are processed and delivered to their sites of assembly.  In A. 
tumefaciens, VirB2 is an essential component of the two organelles elaborated by the 
VirB/VirD4 type IV secretion system (T4SS), the membrane-spanning translocation channel 
and the extracellular T-pilus (25, 31, 141).   The assembly of VirB2 into the channel and T-
pilus is poorly understood, although a few early processing reactions have been 
biochemically defined.  Upon synthesis, VirB2 pro-pilin is first integrated into the inner 
membrane and then cleaved of its 47-residue signal sequence.  Next, the N- and C-termini 
are covalently joined by a novel head-to-tail cyclization reaction (115). The protein 
catalyzing cyclization has not been identified in A. tumefaciens, but in E. coli the VirB2 
homolog TrbC (24/51 % identity/similarity) of plasmid RP4 (115, 142, 143) is also cyclized 
and the cyclization reaction is carried out by the TraF protein (115).  Cyclization of VirB2 
and TrbC is required for functionality of these pilins, whereas another VirB2 homolog, TraA 
(19/47 % identity/similarity) of E. coli plasmid F (113), is not cyclized although its N terminus 
is N-acetylated (144).   
Despite differences in these early processing reactions, a common feature of T4SS-
encoded pilus biogenesis pathways is that the pilin subunits integrate into the inner 
membrane as a pool for subsequent use in building the pilus.  Topology models for VirB2, 
TraAF, and TrbCRP4 were developed from computer-derived hydropathy profiles and limited 
reporter fusion studies with periplasmically-active alkaline phosphatase (PhoA) (144, 145). 
These profiles generally predict that two hydrophobic domains of these pilins span the inner 
membrane, resulting in localization of hydrophilic terminal domains in the periplasm and 
small central hydrophilic loops in the cytoplasm.  However, these hydropathy predictions 
are often only 60-70% accurate in predicting topology organization (146), and computer 
algorithms also do not account for interactions between transmembrane (TM) helices, 
contacts with another subunit(s), and/or specific lipid - protein interaction(s) (146-148).  
Strategies used to verify membrane protein topologies often rely on general principles 
including: impermeability of the membrane bilayer to hydrophilic molecules, the difference 
in properties between the compartments separated by the membrane, or incorporation of 
reporter groups whose orientation is thought to reflect the topology of the protein (146, 
149). While there are other methods available to experimentally determine VirB2’s 
predicted protein topology, cysteine scanning remains one of the least invasive and is less 
likely than other methods to perturb function and overall structure (149). 
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If we consider the membrane-integrated pool of VirB2 as a starting-point in a pilin 
assembly pathway, the secretion channel and T-pilus represent the terminal organelles. 
VirB2 is required for substrate transfer, even in cells that do not elaborate T-pili (123). 
Moreover, on the basis of a demonstrated close contact with translocating T-DNA and 
associated genetic studies (58) we predict that the pilin subunit is delivered to and 
comprises part of the distal region of the secretion channel near the outer membrane. With 
regard to the T-pilus, nothing is known about the pilus structure or the packing geometry of 
pilin. However, studies of the related TraAF pilin have led to a proposal that the two α-
helices comprising the TM domains form anti-parallel helix-helix interactions in the F-pilus 
resulting in surface-exposed N- and C-termini and a charged central domain lining the pilus 
lumen (145).   
Here, I sought to exploit the power of the substituted cysteine accessibility method 
(SCAM) to define the inner membrane topology of VirB2, and then to identify differences in 
the structural states of the pilin when assembled as a component of the secretion channel 
vs. the T-pilus. This work represents the first detailed in vivo structural analysis of the VirB2 
pilin.   
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Results 
Phenotypes of VirB2 Cysteine Substitution Mutations  
Native VirB2 contains 3 Cys residues, two within the signal sequence and Cys64 in 
the mature protein. The Christie laboratory reported in an earlier study that a Ser 
substitution of Cys64 results in an attenuated virulence phenotype (87). In those studies, 
virulence assays were carried out at room (25 oC) temperature; however, more recent 
studies have shown that the VirB/D4 T4SS functions optimally at 18 – 20 oC (150). At this 
lower temperature, I determined that the C64S mutant exhibits near wild-type substrate 
transfer frequencies, as monitored by two assays, virulence on plants and conjugative 
transfer of an IncQ plasmid to agrobacterial recipient cells (Fig. 3.1B). T-pili produced by 
the C64S mutant at the lower temperature also were indistinguishable from pili from the wild 
type strain, as monitored by sucrose density gradient fractionation and electron microscopy 
(Fig. 3.1C and D). The wild-type properties of the C64S mutant enabled its use as a 
platform for construction of single Cys substitution mutations at 5-7 residue intervals along 
the length of VirB2. 
In initial phenotypic studies, I determined that all 16 Cys mutant proteins migrated at 
the same position and most accumulated at comparable steady-state levels as native VirB2 
with minimal to no effect on function, as monitored by pilus production and DNA transfer 
(Fig. 3.1). However, two mutant proteins (G51C and T54C) accumulated at diminished 
levels in whole cell extracts, although both proteins were detectable in membrane fractions 
(Fig. 3.1A).  These mutations, as well as T58C, L117C, and G119C which reside near N/C 
processing and cyclization sites, completely abolish substrate transfer (Fig. 3.1B).  Cys 
substitution of the aromatic residue F71 also abolished substrate transfer. Of these 
mutations, only G51C, F71C, and L117C also completely abolished T-pilus biogenesis (Fig. 
3.1B). Notably, the transfer minus (Tra-) strain producing the G119C mutant pilin assembled 
morphologically wild-type pili as monitored by sucrose fractionation and electron 
microscopy (Fig. 3.1C and D). This mutant therefore selectively blocks substrate transfer 
without detectable effects on pilus biogenesis.    
 
Inner Membrane Topology of VirB2 
 VirB2 contains two hydrophilic regions and two hydrophobic stretches. For the 
purposes of discussion, I will depict VirB2 as consisting of 4 domains (I-IV).  This domain 
architecture derives from in silico hydropathy analyses (Fig. 3.2A), and is consistent with 
that described for the VirB2 homolog, TraA pilin of the F plasmid T4SS (151, 152).   
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Figure 3.1 Phenotypes of VirB2 Cys substitution mutations.  
(A) Effects of mutations on total cellular and membrane levels of VirB2. Total cellular 
material and membrane fractions were subjected to SDS-PAGE, and immunoblots were 
developed with anti-VirB2 antibodies. Protein samples were loaded on a per-cell-equivalent 
basis. (B) Upper panel, effects of mutations on T-DNA transfer as monitored by virulence 
on wounded Kalanchoe leaves (black bars) (–, avirulent; +++, WT virulence) and transfer of 
the mobilizable IncQ plasmid pML122 to A. tumefaciens recipients (gray bars) (Tc's/Donor, 
number of transconjugants per donor cell). Lower panel, effects of mutations on T-pilus 
production, as monitored by VirB2 abundance recovered from the shear fraction by 
ultracentrifugation (top) and colony immunoblots developed with anti-VirB2 antibodies 
(bottom). (C and D) Pilin fractionation profiles and pilus morphologies produced 
by ΔvirB2 mutant strains synthesizing native VirB2 (Cys64; WT) or the Cys64Ser (C64S) or 
Gly119Cys (G119C) mutant protein. (C) Distribution profiles of extracellular pilins in 
identically prepared 20 to 70% sucrose density gradients, as monitored by immunoblot 
development with anti-VirB2 antibodies. (D) Morphologies of pili from peak sucrose gradient 
fractions, as detected by uranyl acetate staining and electron microscopy. 
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Figure 3.2 MPB accessibility of Cys substitutions.  
 (A) Predicted domain architecture of VirB2. Numbers correspond to the N and C termini of 
mature pilin and a compilation of hydrophobic domain (gray cylinders) boundaries as 
predicted by computer hydropathy programs: TMHMM (boundaries predicted: TM1 66 and 
88, TM2 92 and 114), Mobyle (70 and 90, 93 and 113), Phobius (65 and 87, 94 and 113), 
SOUSI (61 and 83, 91 and 113), and HMMTOP (63 and 85, 92 and 114). Domain 
numbering (I to IV) follows the nomenclature devised for the VirB2 homolog, TraA, of the F 
plasmid (117). (B) Δ virB operon strains producing pilins with Cys substitutions at the 
residues indicated were treated with thiol-reactive MPB without and with pretreatment with 
AMS. Cys-substituted pilins were isolated by immunoprecipitation and analyzed for MPB 
labeling. Immunoprecipitates also were analyzed for VirB2 protein abundance by blot 
development with anti-VirB2 antibodies (ΔB2). (C) MPB labeling profiles obtained by 
treatment of intact and lysed cells (by sonication) at neutral and alkaline pH. (D) A topology 
model for membrane-integrated VirB2 pilin. Thick black-outlined circles with gray centers, 
Cys substitution mutations at these positions were labeled by MPB treatment of intact cells; 
thick black-outlined circles with white centers, substitutions at these positions were not 
labeled under any condition; gray circles with gray outlines, substitutions labeled upon 
sonication (Cys94) or MPB treatment at alkaline pH (Cys64). Peri, periplasm; IM, inner 
membrane; Cyto, cytoplasm. Bar, N-C cyclization junction. 
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As shown in Fig. 3.2A, it has been proposed that hydrophobic domains II and IV 
form transmembrane α-helices and hydrophilic domains I and III reside in the periplasm 
and cytoplasm, respectively.  To examine the disposition of the pilin at the inner membrane 
(IM), I analyzed the accessibility of the substituted Cys residues to the biotinylated 
sulfhydryl-specific maleimide probe MPB.  MPB has a molecular size of 542 daltons and 
crosses the outer membrane (OM) through porins, but inefficiently traverses the inner 
membrane (153-155).  MPB therefore labels residues located in the periplasm but not 
residues located in the cytoplasm or those buried in transmembrane regions or structural 
folds. VirB2 has been shown to undergo processing, cyclization, and membrane insertion 
independently of other VirB proteins (156).   Thus to define the inner membrane topology of 
the cyclized pilin, I developed an MPB-labeling profile for Cys substitution mutants 
produced in the ΔvirB operon strain. 
As shown in Fig. 3.2B, upon treatment of whole cells, Cys residues throughout 
Domain I were MPB-labeled. To confirm the periplasmic location of hydrophilic Domain I, I 
pretreated cells with the highly hydrophilic, non-biotinylated sulfhydryl-specific maleimide 
probe AMS, which also crosses the OM but not the IM. Labeling of Domain I Cys residues 
was efficiently blocked by AMS pretreatment. Curiously, MPB did not label Cys64 in 
Domain I even though neighboring Cys substitutions were labeled (Fig 3.2 B).  To examine 
the possibility that Cys residue may be buried in a structural fold within the periplasmic loop, 
MPB-labeling was carried out at alkaline pH 9.5.  This alkaline reaction condition has been 
shown to render Cys residues in a structural fold - but not those embedded in the 
membrane - accessible to MPB labeling (155).  As shown in Fig. 3.2 C, Cys64 but not Cys 
residues in the TM helices were labeled, supporting the proposal that Cys64 is buried in a 
pH-sensitive structural fold.  
Cys substitutions present in the hydrophobic Domains II and IV or in the small 
hydrophilic loop III (Domain III) were not MPB-labeled in alkaline or neutral conditions (Fig. 
3.2C).  However, MPB treatment of sonicated cell extracts resulted in the labeling of Cys94 
(Fig. 3.2 C), suggesting that Domain III is cytoplasmically localized.   Cys residues in 
Domains II and IV were not detectably labeled in whole cells or sonicated cell extracts, 
supporting predictions that these correspond to membrane α−helices. 
Taken together, these MPB-labeling patterns favor a membrane topology model 
depicted in Fig. 3.2 D. This model is consistent with the positive-charge-inside rule for 
membrane proteins (157) since Domain III (GR+ASL) has an overall net positive charge.  
This model is also compatible with earlier predictions that the cleavage and cyclization 
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reactions (Domain I) for the related pilin TrbC of the RP4 T4SS are carried out in the 
periplasm (115).   
   
SCAM Reveals VirB2 Topology Changes in the Presence of Other Secretion Subunits 
In the above studies, the membrane topology of VirB2 was determined in a strain 
lacking other VirB proteins.  I predict that this topology model is also valid for pilin 
monomers that accumulate in the membrane as a pool early during T4SS biogenesis in 
wild-type cells. I next sought to identify differences in the VirB2 structural organization when 
produced together with the other T4SS subunits; any differences detected with the Cys-
labeling profile presented above might reflect the altered structural organization of VirB2 
when assembled as a component of the secretion channel.   I detected differences in MPB-
labeling patterns for 3 of the Cys substituted pilins when produced in ΔvirB2 (presence of 
VirB proteins) vs. ΔvirB operon (absence of VirB proteins) mutant strains (Fig. 3.3 A). 
Specifically, Cys51 in hydrophilic Domain I was not detectably labeled in the presence of 
VirB proteins but was strongly labeled in their absence.  Conversely, Cys64, also in Domain 
I, was strongly labeled in the presence of VirB proteins but was unlabeled in their absence. 
Finally, and most strikingly, Cys94, in the hydrophilic loop Domain III, was labeled in in the 
presence other VirB proteins even when intact cells were MPB-treated, whereas as shown 
above Cys94 was only labeled upon sonication of cells lacking other VirB proteins. We 
previously demonstrated, using the same experimental protocol, that Cys substitutions in 
the cytoplasmic regions of bitopic protein VirB10 (69) and polytopic protein VirB6 (65) were 
not MPB labeled during treatment of intact cells but were labeled in cell lysates.  These 
data suggest that Cys94 MPB-labeling, observed in a functionally wild-type strain, is 
unlikely attributable to cell rupture or permeation of MPB across the inner membrane.  
Remaining Cys mutant proteins exhibited the same labeling patterns in both the ΔvirB2 and 
ΔvirB operon mutant backgrounds (refer to figure 3.2).  
 Although the differences in MPB-labeling of Cys51, Cys64, and Cys94 observed in 
strains producing vs lacking VirB proteins could reflect differences in the membrane-
integrated vs secretion channel form of VirB2, the former strain also produces T-pili.  T-pili 
are rarely detected on the surfaces of intact cells but are instead readily sloughed into the 
extracellular milieu.  Nevertheless, I sought to characterize the structural organization of 
pilin in a strain that produces a functional secretion channel but lacks extracellular T-pili.  
Such strains have been isolated previously in the Christie laboratory as a result of 
mutations generated in various VirB subunits including VirB6, VirB9, VirB10, and VirB11  
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Figure 3.3 Disposition of VirB2 in VirB-producing cells and T-pili 
 (A) Comparison of MPB labeling patterns of Cys-substituted pilins synthesized in the 
absence (ΔvirB) or presence (ΔvirB2) of other VirB proteins and Pilins (B2*) carried Cys 
substitutions at the residues indicated at the tops of the blots. Intact cells and cell lysates 
were MPB treated and analyzed as described in the text. VirB2 protein abundance in 
immunoprecipitates was assessed by immunoblot analysis with anti-VirB2 antibodies (ΔB2). 
Schematic diagrams of MPB labeling patterns are presented below the blots for each strain. 
Thin lines, hydrophilic loops; gray cylinders, hydrophobic domains; bar, cyclization junction; 
black-filled circles, MPB labeled upon treatment of intact cells; gray-filled circles, no MPB 
labeling. IM, inner membrane. Data are presented only for Cys replacements displaying 
differences in labeling patterns between the two genetic backgrounds. (B) the patterns in an 
uncoupler mutant (B11-I265T) that does not produce T-pili but is substrate positive. (C) 
MPB labeling patterns of pilins incorporated into the T-pilus. Corresponding colony 
immunoblots developed with anti-VirB2 antibodies are shown for each mutant strain. The 
schematic at the right shows MPB accessibility of Cys residues in the isolated T-pilus. Black 
and gray circles, accessible and inaccessible residues, respectively. 
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(69, 82, 87, 123).  These Tra+, Pil- mutations are postulated to ‘uncouple’ pathways 
mediating assembly of the T-pilus and the secretion channel and therefore are termed 
‘uncoupling’ mutations.  Importantly, mutant strains with the Tra+, Pil- phenotype still require 
VirB2 for substrate translocation (123), indicating that the pilin is a component of the 
secretion channel.   
I introduced these three Cys-substituted pilin genes into a strain producing a VirB11 
mutant (I265T) that confers the Tra+, Pil- “uncoupling” phenotype (87).  Upon treatment of 
these strains, I found that the Cys-substituted pilins exhibited the same MPB-labeling 
patterns as observed for strains producing native VirB11 together with the other VirB 
proteins (Fig. 3.3 A and B). The differences in MPB-labeling of Cys51, Cys64, and Cys94 in 
strains lacking vs. producing other VirB proteins therefore likely reflect differences in 
structural organization of the pilin when integrated in the membrane vs assembled as a 
component of the secretion channel.   
The T-pilus is the alternative terminal organelle produced during T4SS biogenesis.  I 
sought to examine the pilin structural organization when polymerized as the T-pilus, and to 
this end I isolated T-pili from the Pil+ strains producing Cys-substituted pilins.  MPB 
treatment of the isolated T-pili yielded a labeling profile that was in stark contrast to that 
obtained for the cell-associated pilins.  In the T-pilus, Cys residues at positions 64 and 67 in 
hydrophilic Domain I and position 77 in hydrophobic domain II were labeled (Fig. 3.3 C).  
Other Cys residues in Domain I (at positions 54, 58, and 119) and Cys94 in Domain III did 
not MPB label upon treatment of isolated T-pili (Fig. 3.1 B & 3.3 C). These data suggest 
that hydrophilic and hydrophobic residues 64-77 in Domains I and II, respectively, are 
surface-displayed in the T-pilus.  Other residues in Domain II, and those in Domains III and 
IV, were MPB-inaccessible and therefore likely buried in packing interfaces or the lumen of 
the T-pilus. 
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Discussion  
Here, I developed a topology model for the membrane-integrated VirB2 pilin by 
SCAM.  I then used SCAM to identify differences in the structural organization of pilin when 
it is incorporated as part of the VirB/D4 T4SS machine. My data supplied the first evidence 
that VirB2 adopts distinct structural states when assembled as a component of the 
secretion channel vs. the T-pilus.   I discuss my findings below in the context of available 
data on other conjugative pili. 
The topology model derived from my MPB labeling studies was for VirB2 pilin 
produced in the absence of other VirB proteins.  The data confirmed and extended previous 
studies of VirB2 and the related pilins TraAF and TrbCRP4 based on in silico secondary 
structure analyses and PhoA fusion studies (152, 158, 159).  Essentially, I found that the 
two hydrophobic regions (domains II and IV) span the IM, the intervening hydrophilic loop 
(domain III) is located in the cytoplasm, and a large hydrophilic region comprised of N- and 
C-terminal hydrophilic residues joined by cyclization (domain I) is located in the periplasm 
(31, 143, 152). The general model for biogenesis of T4SS pili is that the pro-pilin subunit 
integrates into the inner membrane and is then processed into the mature pilin.  Pilin 
monomers then accumulate in the membrane until a signal that is currently unknown 
activates pilin dislocation and subsequent assembly reactions.  Although the formation of a 
pilin pool remains untested for the A. tumefaciens VirB/VirD4 T4SS, at this point it is 
reasonable to assume that the topological profile of pilin synthesized in the absence of 
other VirB proteins corresponds to that of the pilin pool in wild-type cells.  It is important to 
test the pilin pool model and studies presented in the Future Studies section (see Chapter 
7) are designed to evaluate this model. 
 
Contribution of Domains and Residues to VirB2 Function 
 Mutational studies of VirB2, as well as TraAF and TrbCRP4, have identified residues 
generally in the hydrophilic loops that are critical for pilin processing, stability, and function 
(Fig. 3.4) (160, 161).  VirB2 mutations within the signal sequence near the cleavage site 
disrupt processing of the pro-protein and cyclization (115) and similar results have been 
seen with TraAF and TrbCRP4 (Fig. 3.4).  Here, I found that Cys substitutions near the N-
terminus of the mature pilin (Cys51, Cys54) disrupted protein stability (Fig. 3.1) Mutations 
within both the N- and C-termini of VirB2 that do not appear to affect processing, also 
resulted in loss of substrate transfer (Cys51, Cys54, Cys58, Cys117, Cys119).  
Correspondingly, effects on pilin function as monitored by pilus production and transfer  
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Figure 3.4 Mutations in domains of related pilin subunits have similar effects on 
function  
Comparison of select mutant phenotypes of related pilin subunits: VirB2A.t., TraAF, and 
TrbCRP4. The core pilin sequence for each subunit is shown, including the predicted 
transmembrane regions (TM). Related pilin subunits show similarities in predicted structure 
with two hydrophobic regions, a long hydrophilic loop, and a shorter cytoplasmic loop. This 
summarizes the phenotypes of a subset of point mutations made along the length of VirB2 
(Fig.3.1), TraAF (161), and TrbCRP4 (160).  
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frequencies have been reported for mutations located near the N-termini of mature TraAF 
pilin (161) and N- and C-termini of TrbCRP4 pilin (160) (Fig. 3.4).  Together, these data 
suggest the hyrodrophilic domain is important for pilin processing but independently of 
processing also contributes in unspecified ways to protein function.   
 My finding that Cys51 and Cys64 residues showed differences in MPB-labeling in 
the absence and presence of other VirB proteins suggests the periplasmic domain is 
important for machine assembly, possibly by mediating a critical contact(s) with another 
VirB subunit(s). In the absence of other VirB proteins, native Cys64 was not labeled in 
reactions carried out at pH 7.5, but was labeled at pH 9.5 (Fig. 3.2 C).   These conditions 
are expected to favor alkylation of an extramembrane cysteine as well as expose Cys 
residues buried in secondary structure.  At this elevated pH, maleimides can nonspecifically 
label amine groups(162), but the controls showed that Cys-less VirB2 or derivatives with 
Cys residues located in the two hydrophobic TM domains did not label.  In the absence of 
other VirB proteins, therefore, Cys64 is probably buried in secondary structure as opposed 
to associating with or embedding into the membrane. In contrast to Cys64, Cys51 was 
labeled in a strain lacking other VirB proteins but was not labeled in a strain producing the 
other VirB proteins.  This mutant pilin might adopt a structure rendering Cys51 inaccessible 
only in the context of the assembled VirB machine.  Other T4SS subunits may be shielding 
MPB-labeling directly or they might indirectly induce a change in the secondary structure of 
the VirB2 periplasmic loop. However, because the Cys51-substituted pilin is both less 
stable and also confers a Tra-, Pil- phenotype, the observed labeling pattern could reflect an 
interaction(s) between the mutant pilin and other VirB subunits that perturbs machine 
assembly or function.  
The Cys94 substitution constitutes a topological marker for the cytoplasmic loop, as 
deduced from its accessibility only in treated cell lysates.  Although VirB2 tolerated a L94C 
substitution in the central hydrophilic loop, other mutations altering positively-charged 
residues in the central loop of TraAF disrupted function (160) (Fig. 3.4), consistent with the 
proposed general importance of a positive charge in this cytoplasmic domain for topological 
orientation at the IM (163, 164).  Interestingly, however, in other studies of VirB2 
summarized in Chapter 7, I introduced epitope tags at various sites in the pilin both to 
identify permissive regions and to facilitate pilin and pilus purification.  Although insertions 
at most sites abolished protein function, a mutant pilin with a FLAG tag (DYKDDDDK) 
inserted immediately after residue 85 fully supported both pilus biogenesis and substrate 
transfer.  This FLAG-tagged pilin will be the subject of further investigations, but at this 
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juncture it is intriguing to note that this tag is highly negatively-charged and therefore would 
change the overall net charge of the cytoplasmic domain from positive to negative.  The fact 
that this is a functional protein raises fundamental questions about the requirements for 
membrane insertion of this pilin and/or the validity of the model that this pilin integrates into 
the membrane during T4SS biogenesis.   
Finally, VirB2 generally tolerated Cys substitutions in both hydrophobic domains, as 
was also reported for TraAF (161).   However, for both VirB2 and TraAF, mutations of 
aromatic (VirB2 F71C; TraAF F50A, F54V, F60V) or charged (TraAF E34A) residues in the 
hydrophobic domains disrupt pilus assembly, DNA transfer, or phage attachment.  These 
mutations could affect membrane insertion of the pilin or packing of hydrophobic helices 
during assembly of the pilin into the secretion channel or pilus (161) (Fig. 3.4).  
 
Pilus vs. Secretion Channel 
 The pilin structural organization or the nature of its homo- or heteromeric contacts in 
the two terminal organelles, the secretion channel and T-pilus, are not defined. At least two 
lines of evidence suggest that VirB2 pilin assembles not only as the T-pilus but also as a 
component of the secretion channel. First, VirB2 was shown to form formaldehyde-
crosslinkable contacts with translocating T-DNA by use of the transfer DNA 
immunoprecipitation (TrIP) assay (58). Further TrIP studies with various virB mutant strains 
also suggested that VirB2 is positioned at the distal portion of the secretion channel, 
probably near the OM (58).  Second, several “uncoupling” mutations that selectively block 
pilus assembly without affecting substrate transfer have been isolated in VirB subunits, e.g., 
VirB6, VirB9, VirB10, and VirB11 (69, 87, 123).  The Tra+, Pil- strains harboring these 
mutations require synthesis of VirB2 for formation of a functional secretion channel, 
confirming the importance of pilin - not the T-pilus - for substrate transfer.  Here, I also 
isolated the opposite class of “uncoupling” mutation, VirB2 G119C, conferring a Tra-, Pil+ 
phenotype (Fig. 3.1).  This class of mutations also was isolated in the TrbCRP4 (e.g., 
G114A) (160) and TraAF (e.g., K49A, F50A, F54A, F60V) (161) pilins (Fig. 3.4).  The Tra-, 
Pil+ “uncoupling” mutation of VirB2 is located in the C-terminal hydrophilic domain (domain 
I). In my studies, I determined that Cys94 and Cys119, as well as other Cys substitutions in 
domain I, are accessible to MPB-labeling, raising the possibility that one or both of these 
hydrophilic domains are exposed within the lumen of the secretion channel.  In addition, I 
showed that the MPB-labeling patterns of Cys mutants produced in a Tra+, Pil- uncoupling 
mutant strain (VirB11. I265T) (87) matched the isogenic, phenotypically wild-type strain, but 
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differed appreciably from MPB-labeling patterns of pilins assembled into T-pili (Fig. 3.3). 
This is further evidence that VirB2 adopts distinct structural states when assembled as a 
component of the secretion channel vs. the T-pilus.   However, deciphering the quaternary 
structure of VirB2 in the secretion channel is technically challenging and will require further 
studies of VirB2 binding partner interactions and definition of residues or regions in close 
contact with translocating substrate.  
The T-pilus structure is not yet known, although a structure of the F-pilus has been 
presented at ~20 Å by cryoelectron microscopy.  This structure yielded dimensions for the 
pilus (8 nm) and interior lumen (30 Å) but was insufficient for definition of the pilin packing 
geometry (145).  The hydrophobic helices of VirB2 and TraAF likely pack against one 
another, resulting in exposure of hydrophilic residues on the surface and interior of the 
respective pili (165). To gain insight into the pilin packing geometry, I analyzed the 
accessibility of the engineered Cys residues in isolated pili.  My accessibility studies 
identified a surface patch, marked partly by MPB-labeling of Cys64 and Cys67 in 
hydrophilic domain I (Fig. 3.3 C).  Residues 64-69 of VirB2 correspond to residues 17-24 of 
TraAF, a region also exposed laterally on the pilus, as shown by bacteriophage binding and 
antibody labeling of immunodominant epitopes (161, 166) (Fig. 3.4).  For both VirB2 and 
TraAF, the surface patch extends into hydrophobic domain II, as shown by labeling of 
Cys77 and phage attachment data for a TraAF K28 substitution mutant (161). Cys 
substitutions at residues 51, 71 and 117 blocked pilus assembly, and therefore it is possible 
that additional residues in domain I of the native protein are also surface-displayed.  Cys 
substitutions of other hydrophobic residues in domains II and IV were inaccessible to MPB 
and are probably buried in pilin-pilin subunit interfaces.  
It is interesting to note that hydrophobic domain IV possesses a GG4 dimerization 
motif (167, 168) (Fig. 3.5). This motif has been shown to be important for stabilizing 
intermolecular helix-helix interactions (169, 170) as well as for stabilizing folding of certain 
protein monomers (171-173).  In addition, I. Garza in the Christie lab identified a glycine 
zipper motif (G-XXX-G-XXX-G) within domain IV (Fig. 3.5).  This motif has also been shown 
to mediate helix-helix interactions (174).    Conceivably, the GxxxG dimerization motif or the 
gylcine zipper mediates formation of domain IV helix – helix interactions among adjacent 
VirB2 pilins in the assembled T-pilus. 
 Cys94 in the hydrophilic central loop did not label and might reside in the interior of 
the T-pilus, as also proposed for TraAF in the F pilus (165, 175).  Interestingly, TraAF can  
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Figure 3.5 Helical wheel representations of VirB2 transmembrane helices, regions II  
and IV 
Helical wheel patterns shown for VirB2 regions II and IV defined by MPB-labeling shown in 
figure 3.1D. Red asterisks denote the predicted GG4  dimerization motif (Gly-X-X-X-Gly) in 
VirB2 domain IV. Blue asterisks denote the predicted glycine zipper motif (G-XXX-G-XXX-
G) identified by I. Garza. This figure is modified from a screen capture of the Java Applet 
written by Edward K. O'Neil and Charles M. Grisham (University of Virginia in 
Charlottesville, Virginia).  
The applet is available at: 
http://cti.itc.Virginia.EDU/~cmg/Demo/wheel/wheelApp.html. 
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accommodate epitope tags at its C terminus without loss of pilus assembly, and these 
epitopes are surface displayed (161, 166, 175).  By contrast, VirB2 G119C was 
inaccessible to MPB, suggesting that it is buried in pilus.  I have been unable to generate 
functional forms of VirB2 pilin with epitope tags inserted at the C terminus probably 
because these tags disrupt one or more of the cyclization, folding, or oligomerization 
reactions.   
 The absence of Cys77 labeling upon treatment of intact cells is consistent with 
previous findings for this T4SS and the RP4 conjugation system that few T-pili remain 
attached to cells (104, 115).  Additionally, at this time there are two general models 
describing the mechanism of pilus assembly: i) the T-pilus might assemble from an IM VirB-
platform such that the pilus extends across the periplasm and OM, or ii) the T-pilus might 
assemble from a VirB platform at the OM in which case no pilus polymer would project 
through the periplasm.  My inability to detect Cys77 labeling in intact cells, a diagnostic for 
T-pilus polymerization, is more consistent with the latter scenario.  This is of particular 
interest in view of properties that have been ascribed to T-pili and related conjugative pili.  
Unlike the F-pilus, which dynamically extends and retracts to mediate mating pair formation 
in liquid media, T-pili and related pili are sloughed or broken from the cell surface and 
readily form bundles in solution.  The released T-pili are thought to promote nonspecific 
cell-cell aggregation and formation of mating junctions with target cells(116).  I gained 
evidence that VirB2 assembles in the T-pilus in a way that exposes hydrophobic residues in 
domain II.  This patch of surface hydrophobicity along the length of the T-pilus could 
account for pilus bundling and pilus-mediated aggregation and mating pair formation.  
In conclusion, this work provided the first detailed analysis of the inner membrane 
topology of VirB2, showed that VirB2 forms distinct structural states as part the secretion 
channel and T-pilus, and presented new information about the potential packing 
arrangement of VirB2 in the T-pilus.  
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Chapter 4: VirB4 and VirB11 ATPases Modulate the Structural State of Membrane-
Integrated VirB2 Pilin During Biogenesis of the VirB/D4 Type IV Secretion System 
 
 
 
 
 
 
NOTE: This chapter is derived from work that has, for the most part, been published in 
2010: “Evidence for VirB4-mediated dislocation of membrane-integrated VirB2 pilins during 
biogenesis of the Agrobacterium VirB/VirD4 type IV secretion system.” Journal of 
Bacteriology 192(19): 4923-34 PMID: 2065690.  I am the primary author on this paper. I 
performed all experiments described in this chapter.  I have been given permission by the 
publisher of Journal of Bacteriology, the American Society for Microbiology, to reproduce 
any/all of my manuscript in print or electronically for the purposes of my dissertation 
(License Number 2501460079655).  
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Introduction 
VirB2 pilin is required for elaboration of the T4SS channel and the extracellular T-
pilus (25, 128). The VirB2 propilin is processed in two successive steps involving cleavage 
of its signal sequence and covalent linkage of the N- and C-terminal residues to form a 
cyclic polypeptide, and the mature pilin is inserted into the inner membrane by a sec-
independent mechanism presumptively as a pool for use in T4SS machine assembly (117).  
Little is known about the movement of VirB2 from its inner membrane location to its site of 
assembly in the secretion channel and the extracellular T-pilus. A proposed general feature 
of T4SS biogenesis is that ATP energy is used to drive pilin extraction and subsequent 
polymerization reactions.  Although three ATPases, VirB4, VirB11, and VirD4, are required 
for elaboration of a functional T4SS channel, only VirB4 and VirB11 are required for T-pilus 
assembly (104). 
Both VirB4 and VirB11 contain the conserved Walker A nucleoside triphospate 
(NTP) binding motif (GxxGxGKT/S) (90, 133). Mutations in the Walker A binding pocket of 
VirB4 and VirB11 do not produce T-pili (Pil-) and are unable to transfer substrate (Tra-), 
establishing the importance of NTP energy use for T4SS assembly (89, 106, 133). All 
T4SSs described to date contain a VirB4-like ATPase, while VirB11-like ATPases are 
widespread but not universal (15). Interestingly, conjugative pili, produced by the 
Escherichia coli F-like plasmids, actively extend and retract by a process that requires the 
VirB4 homolog TraC; yet, these T4SSs lack a VirB11 homolog (15). These observations 
prompted a hypothesis that VirB4-like subunits drive early steps associated with 
conjugative pilus biogenesis. However, the specific contributions of each of these ATPases 
in relation to pilin movement remain to be defined.  
The question of how pilin monomers of T4SSs as well as other pilus biogenesis 
systems are extracted from the inner membrane to build the pilus is not understood. To 
begin to address this question, we asked whether the VirB ATPases induce structural 
changes in membrane pilin as monitored with the scanning cysteine accessibility method 
(SCAM) (146). SCAM has been used not only to verify predicted membrane protein 
topologies but also to study structure–function relationships and the dynamics of protein 
function (153, 155, 176-179).  In this study, I further defined the requirements for assembly 
of the mature, membrane-integrated pilin into the VirB/D4 channel and T-pilus. My findings 
support a model that the VirB4 ATPase functions as a pilin dislocase to extract VirB2 from 
the inner membrane during machine biogenesis.  This function might be a universal feature 
of the broadly conserved VirB4 ATPase superfamily. 
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Results 
In the preceding chapter, I reported differences in MPB-labeling of Cys51, Cys64, 
and Cys94 substitution mutations in the presence versus absence of VirB proteins. I 
proposed that labeling of Cys94 in the presence of VirB proteins was due to a structural 
change in the pilin that exposed the cytoplasmic domain to the periplasm, a change 
consistent with membrane extraction. To examine the hypothesis that one or both of the 
VirB4 and VirB11 ATPases is responsible for Cys94 labeling, I carried out Cys accessibility 
studies with strains engineered to co-produce Cys-substituted pilins together with i) one or 
both ATPases or ii) Walker A motif mutants, both in the presence and absence of other VirB 
proteins. 
 
VirB4 ATPase Influences MPB-labeling Patterns of Membrane Pilin 
 I first assayed for MPB-labeling of Cys-substituted pilins in a ΔvirB4 mutant (Fig 
4.1A).  Interestingly, I found that Cys94 was labeled in a virB4 null mutant complemented 
with a plasmid expressing wild-type virB4, but was not labeled in the virB4 null mutant strain 
or the isogenic strain producing the VirB4 K439Q Walker A mutant. Previous studies have 
shown that the complemented virB4 mutant strains produce abundant levels of native VirB4 
or the K439Q mutant and exhibit the expected WT (Tra+, Pil+) and null (Tra-,Pil-) 
phenotypes, respectively (133). In addition, the Christie lab has shown that Cys 
replacements in cytoplasmic domains of VirB6 (65) and VirB10 (69) are not labeled upon 
MPB treatment of whole cells. Strains producing the Cys-substituted VirB6 and VirB10 
proteins synthesized native VirB4, excluding the possibility that this ATPase generally 
disrupts the inner membrane integrity or otherwise conveys MPB across the cytoplasmic 
membrane. I conclude that VirB4 with an intact Walker A motif is required for MPB-labeling 
of Cys94-substituted VirB2. 
 Cys64 also was labeled in a strain producing native VirB4 but not the isogenic 
virB4 null mutant strain (Fig. 4.1A).  However, in contrast to Cys94, Cys64 was labeled in a 
strain producing the VirB4 Walker A mutant, suggesting that accessibility was dependent on 
VirB4 production but not on ATP hydrolysis. Importantly, steady-state levels of the VirB2 
Cys mutants were unaffected by the absence of native or mutant forms of VirB4. 
 The above findings prompted a test of whether VirB4 similarly would affect MPB-
labeling in the absence of other VirB proteins.  As shown in Fig. 4.1B, Cys94 was labeled in 
a ΔvirB operon mutant producing only VirB4, but not in the isogenic strain lacking VirB4 or  
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Figure 4.1 Effects of VirB4 ATPase on MPB labeling patterns of pilins  
(A) Cys-substituted pilins synthesized in strain JK1204 deleted of 
native virB2 and virB4 (nonpolar ΔvirB2, ΔvirB4). (B) Cys-substituted pilins produced in 
strain PC1000 (ΔvirB operon mutant). JK1204 and PC1000 were engineered to synthesize 
mutant pilins (B2*) with Cys substitutions at the residues indicated at the tops of the blots 
alone or with native VirB4 (B4) or a Walker A mutant (KQ) derivative. Panels showing MPB 
labeling patterns, VirB2* abundance in the immunoprecipitates. Schematic diagrams of 
MPB labeling patterns are presented below the blots for each strain. Thin lines, hydrophilic 
loops; gray cylinders, hydrophobic domains; bar, cyclization junction; black-filled circles, 
MPB labeled upon treatment of intact cells; gray-filled circles, no MPB labeling. IM, inner 
membrane.  Data are presented only for Cys replacements displaying differences in 
labeling patterns among the strains analyzed.  
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producing the K439Q Walker A mutant.  By contrast, Cys64 was not labeled in the ΔvirB 
mutant background regardless of the presence of VirB4, showing that VirB4 promotes 
MPB-labeling of this periplasmic residue only in the presence of other VirB proteins (Fig. 
4.1A). Cys51 was labeled only in the absence of other VirB proteins, and labeling was not 
altered by the absence or presence of VirB4 alone (Fig. 4.1B).  
   Together, these findings indicate that VirB4 exerts an ATP-dependent change in 
the accessibility of the region of VirB2 marked by Cys94, and that VirB4 also exerts an 
ATP-independent structural change in the region marked by Cys64 but only in the presence 
of other VirB proteins.  
 
VirB11 ATPase Influences Membrane Pilin Disposition 
I next assayed for effects of the VirB11 ATPase on MPB-labeling of Cys-substituted 
pilins. I observed that Cys94 was MPB-labeled in a ΔvirB11 mutant, in agreement with the 
above proposal that VirB4 alone (among the T4SS ATPases) is responsible for catalyzing 
the structural change required for labeling of this cytoplasmic residue.   I did observe, 
however, that production of native VirB11 was required for labeling of Cys64.  Cys64 was 
not labeled in a ΔvirB11 mutant or an isogenic strain producing a VirB11 Walker A mutant 
(Fig. 4.2A).  These findings suggest that Cys64 accessibility is dependent on VirB11 ATP 
energy binding or hydrolysis activities.  
To determine whether the VirB11-dependent effect on MPB-labeling of Cys64 
requires the other T4SS proteins, I compared MPB-labeling patterns for VirB2 synthesized 
in a ΔvirB operon mutant or this strain engineered to co-produce only native VirB11 or the 
VirB11 K175Q Walker A derivative (Fig. 4.2 B). Cys64 was not labeled in any of these 
strains, suggesting that VirB11 requires at least one other VirB protein to catalyze a 
structural change necessary for Cys64 labeling.  
 
VirB4 and VirB11 Act Synergistically to Direct Structural Differences in Membrane-
Associated Pilin 
 In the above studies, I assayed for effects of each ATPase on pilin structure as 
monitored by SCAM.  Next, I sought to determine whether the two ATPases act together to 
induce structural changes in the cell-associated pilin.  To examine this possibility, a ΔvirB 
operon strain lacking other VirB proteins was engineered to coproduce the VirB2 Cys 
mutants with VirB4 and VirB11.   
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Figure 4.2 Effects of VirB11 ATPase on MPB labeling patterns 
Effects of VirB11 ATPase synthesis on MPB labeling patterns of pilins. (A) Cys-substituted 
pilins synthesized in strain PC1211 (nonpolar ΔvirB2, ΔvirB11). (B and C) Cys-substituted 
pilins produced in strain PC1000 (ΔvirB operon mutant). PC1211 and PC1000 were 
engineered to synthesize mutant pilins (B2*) with Cys substitutions at the residues indicated 
at the tops of the blots alone or together with VirB11 (B11), a VirB11 Walker A mutant (KQ) 
derivative, or both native VirB11 and VirB4. Panels showing MPB labeling patterns, VirB2* 
abundance in the immunoprecipitates, and schematic representations of the labeling 
patterns are as described in the Fig. 4.1 legend. Data are presented only for Cys 
replacements displaying differences in labeling patterns among the strains analyzed. 
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Interestingly, both Cys64 and Cys94 were MPB-labeled when the mutant pilins were co-
synthesized with VirB4 and VirB11 but no other VirB proteins (Fig. 4.2C). Labeling profiles 
of these residues were therefore identical in strains producing just the VirB ATPases or 
strains producing all of the VirB proteins (see Fig. 4.1A, 4.2A). These findings indicate that 
VirB4 and VirB11 together coordinate structural changes in pilin necessary for labeling of 
Cys64 and Cys94, even in the absence of other VirB subunits.  However, it is also 
noteworthy that Cys51 was labeled in the absence of VirB proteins, and synthesis of VirB4 
and VirB11 in this background did not alter the labeling pattern (Fig. 4.2C). Synthesis of 
other VirB proteins thus appears to be necessary for a structural change in the pilin to 
render Cys51 inaccessible to MPB-labeling.    
 
VirB2 and VirB4 Form a Precipitable Complex 
The above findings suggest that VirB2 interacts with one or both of the VirB 
ATPases at the inner membrane. I assayed for complex formation between VirB2 and both 
VirB ATPases by immunoprecipitation.  To stabilize possible interactions, I treated isolated 
membranes with the crosslinker dithiobis succidimidyl propionate (DSP) prior to 
solubilization with RIPA buffer (Containing detergents - 0.1% SDS, 0.5% sodium 
deoxycholate, 1% NP-40). As shown in Fig. 4.3, anti-VirB2 antibodies coprecipitated VirB2 
and VirB4 from membrane extracts of strains producing both proteins both in the presence 
and absence of other VirB proteins. VirB2 also formed a precipitable complex with the VirB4 
Walker A motif mutant, suggesting that ATP binding/hydrolysis is not required for this 
interaction.  In control experiments, anti-VirB2 antibodies did not precipitate VirB4 from 
extracts of a ΔvirB2 mutant, nor was an immunoreactive species the molecular size of VirB4 
(87-kDa) precipitated from a ΔvirB4 mutant. I attempted but was unable to detect VirB11 in 
immunoprecipitates recovered with anti-VirB2 antibodies from membrane extracts of 
VirB11-producing strains. VirB11 thus might exert an effect on VirB2 structure through 
transient or weak affinity interactions, either directly with the pilin or indirectly through a 
VirB4 contact. Together, these results suggest that VirB2 does interact in an energy 
independent fashion with VirB4.  Although other VirB proteins are not required for VirB2-
VirB4 complex formation, my present findings do not exclude the possibility that another 
non-VirB protein could mediate this interaction.  
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Figure 4.3 VirB protein complexes 
 VirB protein complexes isolated from detergent-solubilized membrane extracts by 
immunoprecipitation (IP) with anti-VirB2 or anti-VirB4 antiserum. Strains: ΔvirB4, 
PC1004; ΔvirB2, JK1002; ΔvirBoperon, PC1000; ΔvirB11, PC1011 (engineered to 
synthesize the VirB proteins indicated in addition to those produced from the Ti plasmid). 
B2, VirB2; B4, VirB4; B4KQ, VirB4K439Q; B11, VirB11. Anti-VirB2 (ΔB2) and anti-VirB4 
(ΔB4) antibodies were used for immunoprecipitation (IP) (left) and development of 
immunoblots (Blot Dev) (right). 
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VirB4 Domains Exposed in Periplasm  
 If VirB4 interacts directly with VirB2, it would need to interact with the inner 
membrane. In early studies, the Christie lab supplied evidence that VirB4 tightly associates 
with the membrane (180).  By PhoA fusion reporter and proteinase K digestion analyses, 
evidence was also presented for an extracytoplasmic domain(s) of VirB4 (105). Native 
VirB4 possesses 9 Cys residues, and one of these, Cys57, is predicted to reside in the 
periplasm on the basis of the earlier reporter fusion studies (105).   Interestingly, I found 
that VirB4 was MPB-labeled both in the presence and absence of other VirB proteins (Fig. 
4.4).  Moreover, a Walker A motif, mutant form of VirB4 was also MPB-labeled, suggesting 
that VirB4 spans the inner membrane independently of its catalytic activity. I also detected 
increased labeling in cells treated with MPB during sonication, consistent with labeling of 
additional Cys residues located in the cytoplasmic domain. In future studies, it should be 
feasible to localize the region of VirB4 that interacts with VirB2 through a combination of 
MPB labeling studies to refine the VirB4 topology model and disulfide crosslinking studies 
with Cys-substituted binding partners.   
VirB4-Mediated Release of Membrane Pilin  
To further evaluate a model that VirB4 interacts with VirB2 pilin to catalyze its 
dislocation from the inner membrane, I assayed for VirB4-dependent release of VirB2 
during osmotic shock. I detected appreciably more VirB2 in the shockate of strains  
producing native VirB4 than strains lacking this ATPase.  Additionally, VirB4 alone among 
the VirB proteins sufficed for release of VirB2 into the shockate fraction (Fig. 4.5A). A VirB4 
Walker A mutant did not mediate release of VirB2 into the shockate fraction, consistent with 
the notion that VirB4 catalyzes VirB2 dislocation by an ATP-dependent mechanism. 
Furthermore, VirB2 was barely detectable in the shockates of strains producing VirB11 and 
VirB2 alone, further demonstrating VirB11 does not liberate VirB2 from the membrane.  
To confirm that osmotic shock did not result in massive cell lysis or that VirB4 did 
not somehow disrupt the integrity of the inner membrane, shockates were analyzed for the 
presence of periplasmic (ChvE) and cytoplasmic (VirE2) markers (Fig. 4.5A), outer 
membrane markers (VirB7) and inner membrane markers (VirB10, VirB11) (Fig. 4.5B).  The 
VirE2 secretion substrate was present in low amounts in the shockate and levels were 
independent of the presence of the VirB T4SS as shown previously (47, 181).  ChvE was 
also present at low levels in the shockate fractions of strains producing or lacking VirB4. 
Inner membrane markers, VirB10 and VirB11 (69, 90), were readily detectable in the cell  
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Figure 4.4 MPB labeling of VirB4  
MPB labeling patterns of native cysteine residues in ATPase VirB4. VirB4 synthesized in 
strain PC1004 (nonpolar ΔvirB4). Wild type VirB2 pilin (B2) and VirB4 or VirB4 Walker A 
mutant (KQ) derivative produced in strain PC1000 (ΔvirB operon mutant). Panels showing 
MPB labeling patterns in whole cells and cell lysates following sonication and VirB4 
abundance in the immunoprecipitates. 
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Figure 4.5 VirB4-mediated release of VirB2 upon osmotic sock treatment 
 Osmotic shock treatment, showing the presence of proteins indicated at the right in 
material released by osmotic shock (OS) or in the cell pellet (CP) obtained from 
centrifugation of shocked cells. (A) Detection of VirB2, periplasmic ChvE, and cytoplasmic 
VirE2. (B) Detection of outer membrane protein VirB7 and inner membrane proteins VirB10 
and VirB11. Strains: ΔvirB2 ΔvirB4, JK1204; ΔvirB, PC1000; WT, A348 (engineered to 
synthesize the VirB proteins listed in addition to those produced from the Ti plasmid). B2, 
VirB2; B4, VirB4; B4KQ, VirB4K439Q; B11, VirB11; B11KQ, VirB11K175 
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pellets, but not in the shockate fractions.  Finally, VirB7 levels were comparable in 
shockates from all strains.  The shockate fractions thus are comprised predominantly of 
periplasmic material and OM fragments. These findings further support the proposal that 
VirB4 catalyzes release of VirB2 pilin from the inner membrane. 
 
VirB/D4 Type IV Secretion System Assembly Pathway 
Together, results of my studies indicate that VirB4 catalyzes dislocation of the VirB2 
pilin early during biogenesis of this T4SS. VirB11 also coordinates with VirB4 to coordinate 
a structural change(s) in the pilin (Fig. 4.6). Summarizing the proposed steps of pilin 
maturation: i) VirB11 functions in concert with VirB4 to induce a structural change in 
membrane-integrated pilin (as shown by labeling of Cys64), ii) VirB4 then liberates VirB2 
from the membrane (as shown by Cys94 labeling), and iii) the pilin makes further contacts 
with remaining VirB proteins to form the secretion channel or T-pilus (resulting in blocking of 
Cys51 labeling). 
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Fig 4.6 Schematic summarizing effects of VirB4, VirB11, and other VirB subunits on 
MPB labeling patterns 
MPB labeling patterns are presented. Thin lines, hydrophilic loops; gray cylinders, 
hydrophobic domains; bar, cyclization junction; black-filled circles, MPB labeled upon 
treatment of intact cells; gray-filled circles, no MPB labeling. IM, inner membrane. 
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Discussion 
Biogenesis of the VirB/D4 T4SS requires maturation of VirB2 pilin in several steps.  
The early reactions (signal recognition and cleavage, head-to-tail cyclization, membrane 
insertion) occur independently of other VirB subunits, whereas subsequent reactions 
(membrane extraction, incorporation into a functional secretion channel, T-pilus 
polymerization) require the remaining 10 VirB subunits.  To begin defining the mechanistic 
details underlying these latter virB-dependent reactions, I used SCAM to monitor changes 
in VirB2 pilin. Here, SCAM studies identified effects of the VirB4 and VirB11 ATPases on 
the pilin structural state.  Complementary coimmunoprecipitation and osmotic shock data 
further supported a model that VirB4 catalyzes dislocation of mature pilin from the IM 
through direct protein-protein contact and by a mechanism requiring an intact Walker A 
motif. VirB11 ATPase also contributes to the pilin structural organization, although probably 
indirectly through a functional interaction with VirB4.   
Early studies established the importance of the VirB4 and VirB11 ATPases for 
assembly of both the secretion channel and T pilus (87, 89, 112, 133, 180), but how these 
subunits convert chemical energy derived from ATP hydrolysis into mechanical energy for 
machine biogenesis has remained poorly understood.  Here, I showed that VirB4 induces a 
structural change in VirB2 resulting in MPB accessibility of a Cys substitution located in a 
cytoplasmic loop (fig 4.1). Importantly, Cys residues located in other cytoplasmic protein 
domains did not label in any VirB4 producing strains, implying that MPB inner membrane 
permeability was unaffected by the presence of this ATPase. Thus, I suggest that exposure 
of Cys94 is the result of VirB4 catalyzing extraction of pilin subunits from the inner 
membrane into the periplasm. VirB4-mediated Cys94 accessibility and VirB2 release into 
the shockate fraction required an intact Walker A motif and occurred independently of other 
VirB proteins, indicating that VirB4 alone catalyzes the observed structural changes by a 
reaction dependent on ATP binding or hydrolysis.  In this study, I examined the Walker A 
box mutation at K439Q, which has previously been shown to be defective for pilus 
biogenesis and substrate transfer (106, 133), with similar mutations in VirB4 homologs 
(TrbERP4 and TrwKR388) blocking protein function.  Interestingly, however, a previous study 
reported that a different Walker A variant of VirB4At (K439R) from that used here blocked 
substrate transfer but still elaborated T-pili albeit at low levels (122).   The K439R Walker A 
mutation, which has not been biochemically characterized, is less disruptive structurally 
than the K439Q mutation and maintains the charge of the binding pocket. Thus, the mutant 
protein might hydrolyze ATP at levels sufficient for some pilus production.  Coupled with 
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evidence that VirB4 forms a precipitable complex with VirB2 (Fig 4.3) presumably through 
contacts with VirB4 in the transmembrane region and/or periplasm (Fig 4.4 and (105)), our 
findings support a working model that VirB4 functions as a dislocation motor to catalyze 
extraction of pilin subunits from the IM during T4SS biogenesis.   
As noted earlier, VirB4-like subunits are signatures for all bacterial and archaeal 
T4SS (15), and for the F-like T4SS’s VirB4-like subunits are the only ATPases required for 
extracellular elaboration of pilin (182-185).   Earlier studies have shown that there are 
ATPases capable of membrane protein extraction/dislocation (186, 187). The VirB4 
ATPases possess physical properties consistent with another well-characterized dislocase, 
E. coli FtsH (186).  A. tumefaciens VirB4 associates integrally with the IM via one or two 
membrane-spanning domains (Fig 4.4 and (105)).    Other VirB4-like ATPases such as 
TraCF, TraBpKM101 and TrwKR388 also associate with the membrane, although soluble forms 
of native or mutant forms of these proteins also exist (110, 182, 188).  A C-terminal domain 
of VirB4 also was shown to possess limited sequence homology with the TrwB R388 
substrate receptor (108), and on this basis the VirB4 C-terminal domain was predicted to 
assemble as homohexameric rings. In agreement, VirB4 was found to form oilgomers under 
native conditions consistent with the size of a hexamer (122).  Moreover, hexameric forms 
of both TraBpKM101 and TrwKR388 were detected upon size fractionation of purified forms of 
these proteins (109, 110).  Hexameric but not other oligomeric forms of these ATPases, 
e.g., dimers, were shown to hydrolyze ATP (110).  Lastly, VirB4-like subunits have been 
found to play a critical role in key protein interactions of the T4SSs (110, 122, 189). 
Specifically, VirB4At has been shown to interact with ATPases VirB11 and VirD4 (45), 
bitopic proteins VirB8 (122, 190) and VirB10 (190), and the inner membrane protein VirB3 
(66, 189). Taken together, these attributes are consistent with known protein 
dislocase/protease FtsH and the GspE ATPases predicted to function as pilin dislocases in 
type IV pilus systems (186, 187, 191, 192).  GspE ATPases undergo dynamic changes in 
structure following ATP hydrolysis (191).  While VirB11 is related in sequence to the GspE 
ATPases, I supplied evidence that VirB4 functions as a VirB2 dislocase. Yet, I also showed 
that VirB11 coordinates with VirB4 to effect a change in pilin structural organization, as 
monitored by labeling of Cys64 (Fig. 4.2). Previous work has shown that these two 
ATPases interact (45) and therefore it is possible that VirB11 acts through VirB4 to induce a 
structural modification in the pilin periplasmic domain required for subsequent contacts with 
other assembly factors in the periplasm or at the outer membrane (see below). 
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Interactions between the VirB2 pilin and the VirB ATPases have not been previously 
reported.  Here, I supplied evidence for complex formation between VirB2 and VirB4 by 
coimmunoprecipitation (Fig. 4.3).  Furthermore, I showed that VirB4 is MPB-labeled upon 
treatment of whole cells (Fig 4.4) indicating that at least a portion of the protein is exposed 
to the periplasm, in agreement with previous studies (105). Presumably, the membrane-
spanning or periplasmic domains of VirB4 interact with the membrane-integrated pilin, and 
further studies in the Christie lab are evaluating this possibility. Small integral membrane 
proteins, often homologs/orthologs of VirB2At pilin, are commonly found upstream of virB4 
loci (15). Thus, complex formation and/or interaction between VirB4-like ATPases and 
associated pilin-like subunits may represent a general characteristic of T4SSs. 
I propose that a VirB4 dislocase directs an early step in T4SS machine biogenesis. 
VirB4 forms stabilizing interactions with other inner membrane subunits including VirB3 and 
VirB8 (66, 122, 189, 190).  Furthermore, in agreement with our findings, VirB4 was shown 
to be required for assembly of a cell-associated complex of VirB2 and the pilus-associated 
protein VirB5 (122).  Although no other VirB2 binding partners have been identified besides 
VirB4 (this study, Fig. 4.4) and VirB5 (122), a VirB5 interaction with the periplasmic domain 
of VirB8 was identified (122).  In view of this emerging protein-protein interaction network, a 
model can be proposed wherein VirB11 modulates VirB4 which then functions in the 
context of a VirB3/VirB4/VirB8 ternary complex to dislocate VirB2.  The membrane-
extracted VirB2 then interacts with VirB5 to mediate binding with VirB8 (77), which has 
been postulated to function as an assembly center for building of the VirB/D4 T4SS at 
specific sites on the cell envelope. Presumably this network of interactions involving VirB2, 
VirB3, VirB4, VirB5, and VirB8 occurs within the VirB7/VirB9/VirB10 core complex allowing 
for further protein interactions necessary for pilin subunits to form the distal portion of the 
secretion channel (58, 87) and polymerize into the T-pilus (Fig 4.7).   
 My findings add new mechanistic detail to the VirB/VirD4 T4SS biogenesis pathway, 
and raise the possibility that VirB4 family members function generally as T4SS-specific 
membrane protein dislocases.  Overall, a mechanistic understanding of the T-pilus 
assembly pathway will provide targets for development of inhibitory compounds that 
specifically block individual steps of pilus biogenesis.   Information about this system also 
may guide studies exploring the assembly pathways of phylogenetically distinct pilus 
systems. 
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Fig 4.7 Model of T-pilus biogenesis pathway 
The VirB1-VirB11 and VirD4 type IV secretion system (T4SS) components are shown 
according to their proposed localization and interactions.  Black arrows indicate the path of 
the pilin. Biogenesis pathway: i) VirB2 inserts into the inner membrane where it is cleaved 
and cyclized, ii) it then interacts directly with VirB4, iii) VirB11 interacts with VirB4 leading to 
a change in pilin structure, iv) VirB4 extracts VirB2 from the inner membrane, and, finally, v) 
pilin subunits are shunted through the T4SS core complex and incorporated in the secretion 
channel and T-pilus.  P: periplasm; IM: inner membrane; OM: outer membrane. 
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Chapter 5: The Role of VirB10 Domains in T-pilus Biogenesis and Type IV Substrate 
Secretion 
 
 
 
 
 
 
NOTE: This chapter is derived from work that has been published in 2009: “Agrobacterium 
VirB10 domain requirements for type IV secretion and T pilus biogenesis.” Molecular 
Microbiology 71(3): 779-794 (doi: 0.1111/j.1365-2958.2008.06565.x).  I am one of the co- 
primary authors on this paper. Experiments performed by the other authors, Dr. Simon 
Jakubowski, Vidhya Krishnamoorthy,  or Isaac Garza, are indicated in the figure legend or 
text.  I have been given permission by the publisher of Molecular Microbiology, John Wiley 
and Sons, to reproduce any/all of my manuscript in print or electronically for the purposes of 
my dissertation (License Number 2501460079655). Crystal structure images were modeled 
in PyMOL. An educational-use program copy of PyMOL was obtained from 
http://pymol.org/ep, which states that images may be used for thesis/dissertation projects. 
All structural coordinates were obtained from the RCSB protein data base 
http://www.rcsb.org/pdb and individual identification numbers and specific references are 
included in the figure legends.  
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Introduction 
Homologs of the Agrobacterium tumefaciens VirB7, VirB8, VirB9, and VirB10 
subunits are present in nearly all Type IV secretion systems (T4SSs) of Gram-negative 
bacteria (39, 70).  A number of biochemical and ultrastructural lines of evidence indicate 
that these subunits assemble as ‘core’ subcomplexes required for building functional 
translocation systems (67, 68, 71-73). These ‘core’ subunits are required for both substrate 
transfer and T–pilus biogenesis in A. tumefaciens (104, 128). Studies of the VirB10At 
subunit have shown that it forms stabilizing interactions with the VirB7 lipoprotein and the 
outer-membrane-associated VirB9 (71, 72, 193).  Additionally, VirB10 was shown to 
undergo a structural transition in response to ATP utilization by the VirD4 and VirB11 ATP-
binding subunits, as monitored by protease susceptibility (83). This structural change is 
important for productive complex formation with VirB7 and VirB9, and it allows for transfer 
of DNA substrates through the distal portion of the secretion channel (58, 123).  
A core channel complex composesd of homologs of VirB7, VirB9 and VirB10 from 
the pKM101 T4SS was recently solved by cryo-EM and X-ray crystal structure analysis (67, 
68). This 1.05 MDa hollow complex spans both the inner and outer membranes, forming a 
cylindrical structure composed of 14 copies of each subunit.  A striking feature of the 
structure is that the VirB10-like TraF subunit appears to span the entire cell envelope. An 
N-terminal transmembrane (TM) domain anchors the protein to the inner membrane.  The 
protein then extends across the periplasm, in part via a Pro-rich domain termed the PRR 
(69).  Part of VirB10-like TraF then extends across the outer membrane pore and may be 
able to function as a gate or regulator of secretion and/or T-pilus elaboration. This proposed 
transenvelope topology is unique among bacterial proteins and warrants experimental 
confirmation as well as further characterization of functional significance.   That VirB10-like 
subunits function as transenvelope bridging proteins is supported by evidence for 
interactions between VirB10-like proteins from A. tumefaciens and plasmids R27 and R388 
with at least one ATPase subunit at the inner membrane (45, 107, 194, 195). A. 
tumefaciens VirB10 was shown to form complexes with the three ATPases -VirB4, VirB11, 
and VirD4 of the VirB/VirD4 system (45, 83, 107, 196).  As noted above, at or near the 
outer membrane, VirB10 also interacts with lipoprotein VirB7 and VirB9 (45, 71, 72, 74, 
137, 193, 197, 198).   
 In light of these findings, VirB10 is thought to function as both a ‘structural scaffold’ 
for the core channel, as well as an energy sensor/transducer, possibly gating the outer 
membrane channel complex during substrate translocation and T-pillus assembly. Similar 
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to VirB10, TonB from Escherichia coli senses energy via the proton motive force  through 
complex formation with the inner membrane proteins ExbB and ExbD (199-202). VirB10 
and TonB share similar structural features containing a short N-terminal cytoplasmic 
domain, a transmembrane region (69), a proline rich region, and a C-terminal periplasmic 
domain.  In one model, TonB was proposed to facilitate active transport by ‘shuttling’ from 
the inner membrane to the outer membrane in response to energy (203).  More recent 
findings suggest that TonB is stably anchored to the inner membrane (200), as we have 
shown is the case for VirB10 (69).  How the VirB10 and TonB energy sensors transduce 
inner membrane energy to mediate outer membrane translocation remains to be 
determined.  
 The C-terminal domains of two VirB10 homologs, Helicobacter pylori ComB10 and 
pKM101 TraF, have been solved by X-ray crystallography (68, 73).  These structures both 
present as modified β-barrels with inherent flexible regions. One main feature is the 
antennae projection (AP), composed of alpha helical regions designated α2,α3, which 
extends out from the top of the β-barrel.  In the TraF structure, solved as a large complex of 
14 copies of VirB10-like TraF, VirB7-like TraN and VirB9-like TraO, the AP domains form a 
pore that was postulated to span the outer membrane (68).    A second region that I have 
named the ‘bridging’ domain (BD) connects the AP via a flexible section to the core barrel 
structure. A third region, designated α1 for ComB10 (73) and αn1 for TraF (68), extends out 
to the side of the β-barrel region.  In the TraN/O/F structure, the αn1 helix of one TraF 
monomer forms contacts with β-barrel domains of neighboring TraF monomers to stabilize 
the core complex (68).   The β-barrel contains a large grooved ‘pocket’ along its side 
together with a flexible flap domain and a conserved XDLDF motif at its base (73). The 
ComB and TraF structures likely represent structural paradigms for VirB10-like proteins, as 
deduced from the overall extensive primary and secondary structural conservation of the 
family members (30). 
In the previous chapters of this thesis, I presented results of my studies defining 
early steps in the assembly of the VirB2 pilin into the T4SS channel and T-pilus.  Following 
integration and processing of the pro-pilin, VirB4 and VirB11 work together to mediate pilin 
structural changes resulting in membrane dislocation and formation of subsequent 
interactions in the assembly pathway.  In view of my model that upon dislocation from the 
membrane the pilin enters the VirB7/VirB9/VirB10 core chamber, and the current structural 
information indicating that VirB10 might span both cell membranes (67), I hypothesized that 
VirB10 contributes to the movement of pilin monomers to their final destinations in the 
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terminal organelles. The polymerization of pilin monomers into T-pili is easily monitored by 
assaying for surface-exposed VirB2 and assembly of high-molecular-weight VirB2 
complexes.  By contrast, at this time little is known about the disposition of VirB2 in the 
secretion channel and no specific assays are available to monitor pilin incorporation into the 
channel.  Consequently, here I focused my mutational studies on defining the contributions 
of VirB10 motifs or domains to T-pilus assembly.  
I characterized a number of VirB10 mutations generated by V. Krishnamoorthy and 
I. Garza with the goal of defining the importance of conserved motifs and domains to T-pilus 
assembly.  I collaborated with these lab members and S. Jakubowski, who together 
analyzed effects of the mutations on protein stability and substrate transfer.  A principal 
finding of interest reported in the publication of this collaborative effort was the discovery of 
mutations that permit substrate transfer while blocking assembly of T-pili.  These so-called 
‘uncoupling’ mutations were isolated in the two regions of VirB10 implicated in spanning the 
membranes – the N-terminal TM domain and the AP.  Our findings support a model in 
which VirB10 can selectively regulate formation of the extracellular T-pilus or the secretion 
channel. In the next section, I highlight my contributions to this larger study. 
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Results 
The mutations (see Fig. 5,1)  I. Garza and V. Krishnamoorthy created along the 
length of VirB10 included: i) two residue (Ala-Cys) insertions at 5-residue intervals along the 
N-terminal region, ii) Cys substitutions within the proline-rich region (PRR), α1 lever arm, 
and β-barrel, and iii) deletion of the N-terminus, TM, and/or PRR regions. V. 
Krishnamoorthy also constructed several deletion mutations within the conserved C-
terminal domain based on structural information for the VirB10 homologs crystallography 
(68, 73).  Two regions predicted to be important for function were the antennae projection 
(AP) which extends from the top of the β-barrel and the ‘bridging domain’ that connects the 
AP to the barrel structure (based on the TraF structure) (68). I characterized these 
mutations, looking for defects in T-pilus production, whereas other lab members assayed 
for effects on protein stability and substrate transfer.   
 
Mutations Within the N-Terminus of VirB10 Selectively Disrupt T-pilus Biogenesis 
 VirB10 has been shown to directly or indirectly interact with all of the ATPases in the 
VirB/VirD4 T4SS (45, 83, 107, 196). These ATPases are primarily located at the 
cytoplasmic face of the inner membrane (90, 105, 159). Both the N-terminal cytoplasmic 
and TM region of VirB10 are predicted to play a critical role in mediating those interactions. 
The Christie lab predicted that the insertion mutations in these regions should impact 
substrate transfer as a result of disrupted contacts with one or more of the ATPases. In 
order to test this hypothesis, I assayed strains producing the N-terminal deletion and 2-
residue insertion (i2) mutant proteins for effects on T-DNA transfer and T-pilus production.   
 The i2 mutations along the cytoplasmic domain did not affect protein function, as 
monitored by substrate transfer and T-pilus biogenesis (Fig. 5.2) (69).  However, a partial 
deletion (Δ2-18) completely blocked pilus production but still allowed for a low level of T-
DNA transfer, showing the importance of the extreme N terminus of VirB10 particularly for 
pilus production (Fig. 5.2). A longer deletion of the cytoplasmic and TM domains (Δ2-46) 
was nonfunctional (Fig. 5.2) (69). This mutant protein was delivered to the periplasm by 
fusion to the VirB5 signal sequence and although it accumulated at abundant levels, it was 
nonfunctional possibly because it failed to form a complex with the VirD4 ATPase 
[experiment performed by Vidyha Krishnamoothy, (69)].  Besides the importance of the 
extreme N terminus for pilus production, I determined that i2 mutations at positions 35, 40, 
and 45 in the TM domain significantly reduced or abolished pilus production without  
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Figure 5.1 Schematic of VirB10 domains and mutations  
A) Cartoon of VirB10 domains with C-terminal β-barrel domain depicted by crystal structure 
from VirB10 homologue TraFpKM101 (68) and associated structural features (67, 204). B) 
Top: The various domains of VirB10 and their locations with residue numbers above are 
depicted. Domain abbreviations: Cyto, cytoplasmic domain; TM, transmembrane helix, 
PRR, proline-rich region. Ala, Cys (i2, AC; black dots) insertion mutations were engineered 
at five-residue intervals in the N-terminal 50 residues. Cys substitution mutations in the 
remainder of the protein are listed at top; Ser substitutions for the two endogenous Cys 
residues, Cys190 and Cys206 (underlined), also were characterized. Bottom: Deletion 
mutations of various domains with deleted residues indicated; alternative designations used 
in the text for some deletion mutations are listed above the corresponding line. The ∆N46 
and ∆N150 fragments were exported to the periplasm by fusion to the signal sequence of 
VirB5 (B5ss). ∆AP, deletion of the antennae projection (see (67, 68, 73)). Deletion 
mutations were constructed by V. Krishnamoorthy. Cysteine substitutions and two residue 
insertions were constructed by I. Garza. Shown is the TraF β-barrel modeled with co-
ordinates from pKM101 core outer membrane complex X-ray structure 
(DOI:10.2210/pdb3jqo/pdb) (67, 68) using   PyMOL (http://pymol.org/) to construct the 
figure. 
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Figure 5.2 Phenotypes of N-terminal insertion and deletion mutations  
Effects of mutations on T-DNA transfer as monitored by virulence on 
wounded Kalanchoe leaves (− avirulent, +++ WT virulence) and effects of mutations on T-
pilus production. Top-to-bottom: colony immunoblots developed with anti-VirB2 antibodies 
showing presence of surface-exposed pilin protein (B2 surface); extracellular shear fraction 
subjected to ultracentrifugation, gel electrophoresis and immunoblot development with anti-
VirB2 antibodies revealing presence of high-molecular-weight T-pilus (B2 shear); total 
cellular material subjected to gel electrophoresis and blot development with anti-VirB2 
antibodies revealing total cellular levels of the protein. Strains: WT, wild-type A348; ∆B10, 
non-polar virB10 strain PC1010; ∆18, PC1010 producing VirB10∆1–18; ∆46, PC1010 
producing VirB10∆1–46 fused to the VirB5 signal sequence for export of the C-terminal 
fragment to the periplasm; 5–50, PC1010 producing i2 (Ala–Cys) insertion mutations at the 
residue indicated. DNA transfer experiments were performed by I. Garza for i2 insertions 
and Cys substitution mutations and V. Krishnamoorthy for deletion mutations. 
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influencing DNA substrate transfer (Fig. 5.2). None of the deletions or insertions impacted 
the stability of cell-associated VirB2.  
 
Contributions of the Proline Rich Region and β-barrel domain to VirB10 Function  
 Deletion and Cys-substitution mutations were introduced along the PRR and β-
barrel domains of VirB10.  These were extensively characterized and the results published 
(69).  Here, I will summarize my contributions to this larger study focusing on testing the 
effects of the various mutations on pilus biogenesis.    
First, with respect to mutations in the VirB10 PRR domain, the most informative 
mutations were partial or full deletions of this domain.  These abolished all protein function, 
including pilus biogenesis (Fig. 5-3), and they also abolished the capacity of VirB10 to form 
a precipitable complex with the outer membrane-associated VirB7 and VirB9 proteins 
(experiments performed by S. Jakubowski, (69)).  In earlier studies, it was shown that 
Proline-rich regions (PRRs) of proteins adopt extended structures and also mediate protein-
protein interactions (205). The VirB10 PRR might, therefore, adopt an extended structure 
necessary for a productive and stable interaction with the outer membrane core subunits 
(67, 68). In support of this idea, an N-terminal fragment of VirB10 composed of the 
cytoplasmic domain, TM domain and PRR (Δ150-377) also was nonfunctional with respect 
to transfer substrate and T-pilus production (Fig. 5.3).  This mutant protein failed to interact 
with VirB7 or VirB9 (S. Jakubowski, (69)). Conversely, a C-terminal β-barrel fragment (Δ1-
150) delivered to the periplasm by fusion to the VirB5 signal sequence was defective for 
both substrate transfer and T-pilus production (Fig. 5.3); however, it did show complex 
formation with VirB7 and VirB9 [S. Jakubowski; (69)]. Together, these results establish the 
importance of the PRR most likely for enabling VirB10 to extend across the periplasm.   
 With respect to the β-barrel domain, mutations that abolished substrate transfer also 
abolished pilus biogenesis (Fig. 5.4).  In general, these were Cys substitutions of residues 
that are conserved among VirB10 homologs.  These mutations might affect contacts 
between adjacent β-barrel domains, or β-barrel domain contacts with other VirB channel 
subunits, but further studies are needed to examine these possibilities.    
 
The Antennae Projection Selectively Contributes to T-pilus Assembly 
 The TraF β-barrel domain possesses two extensions, the α1 lever arm and the 
antennae projection (AP).  The AP is a helix-loop-helix that potentially spans the outer 
membrane (68) (Fig. 1.3B). In VirB10, the corresponding AP is predicted to span residues  
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Figure 5.3 Phenotypes of PRR deletions and substitution mutations.  
Effects of mutations on T-DNA transfer as monitored by virulence on wounded 
Kalanchoe leaves (− avirulent, +++ WT virulence) and effects of mutations on T-pilus 
production. Extracellular pilin and T pilus, and total cellular pilin and VirB10 derivatives were 
detected as described in Fig. 5.1 legend. Strains: WT, wild-type A348; ∆B10, non-
polar virB10 strain PC1010; isogenic PC1010 producing the following PRR mutants –∆70–
92, ∆93–114, ∆70–114, PRR internal deletion mutants; ∆N150, residues 150–377 
containing the β-barrel domain exported to the periplasm by fusion to the VirB5 signal 
sequence; ∆181–377, residues 1–180 containing the cytoplasmic, TM, PRR and linker 
domains; Cys substitution mutants as listed. DNA transfer level experiments were 
performed by I. Garza, V. Krishnamoorthy and S. Jakubowski. 
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282-335. Strikingly, partial deletions of the AP (here ΔAP denotes deletion of TraF based 
alpha 3 and linker region; Δ308-320, Δ323-337, Δ303-337) and a couple of Cys-
substitutions in the AP did not affect DNA transfer (Fig. 5.5A and see (69)), suggesting that 
the AP region is dispensable for DNA transfer.  Additionally, TraF also has a predicted 
flexible section I have denoted as the ‘bridging’ domain (BD).  The BD connects the AP to 
the β-barrel. Interestingly, a BD deletion mutation (Δ268-287) diminished but did not abolish 
substrate transfer (Fig. 5.4A), suggesting that the BD contributes to but is not essential for 
substrate transfer. 
 Although the mutational analyses established that both the AP and BD were found 
to be dispensable for substrate transfer, my further studies showed that both regions are 
vital for T-pilus biogenesis (Fig. 5.4).  Strains synthesizing the ΔAP and ΔBD mutant 
proteins possessed low levels of extracellular VirB2, as monitored by the colony blot and T-
pilus shear assays (Fig. 5.4A). I also analyzed the extracellular fractions by sucrose density 
gradient centrifugation. Interestingly, whereas pili isolated from the wild-type strain 
distribute across the gradient as a broad peak, VirB2 from the ΔAP and ΔBD mutant strains 
distributed predominantly in the low and high density sucrose fractions (Fig. 5.5A). These 
findings suggest that the mutant strains released VirB2 to the cell surface, but as 
monomers or short polymers or aggregates as opposed to intact pilus fibers.  
To determine if this observed phenotype is restricted to the AP and BD deletion 
mutations, I subjected extracellular fractions from other mutant strains (e.g., i2.35, i2.45, 
N218C) whose phenotypes resembled those of the ΔAP and ΔBD mutants, namely, 
reduced accumulation of extracellular VirB2 but Tra+ (see Figs. 5.2 and 5.4)  to sucrose 
density fractionation. All three mutants demonstrated a disperse profile of VirB2 consistent 
with wild-type pilus assembly; representative data are shown for pili obtained from the 
N218C mutant strain (Fig. 5.5A). 
 I further analyzed the extracellular material from AP deletion using an analytical gel 
filtration (AGF) column.  Due to the low production of VirB2 in the AP deletion mutant, ten 
times the amount of extracellular material relative to wild type was subjected to AGF. VirB2 
from wild-type cells partitioned in a size range consistent with high molecular weight T-pili 
(>100kDa) (fig. 5.5B).  By contrast, the majority of extracellular VirB2 from the ΔAP mutant 
was present in the lower molecular weight species (<10kDa) (Fig. 5.5B). Taken together, 
these results indicate that the AP and the BD are critical for T-pilus polymerization.  
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Figure 5.4 Phenotypes of β-barrel deletions and substitution mutations. 
A) Effects of mutations on T-DNA transfer as monitored by virulence on 
wounded Kalanchoe leaves (− avirulent, +++ WT virulence). Effects of mutations on T pilus 
production. Extracellular pilin and T pilus, and total cellular pilin were detected as described 
in Fig. 5.2 legend. Strains: WT, wild-type A348; ∆B10, non-polar virB10 strain PC1010; 
isogenic PC1010 producing Cys substitution mutants as listed. Here, ΔAP denotes deletion 
of TraF based alpha 3 and linker region (see (69)). B) β-barrel ribbon structure modeled 
with coordinates from pKM101 core outer membrane complex X-ray structure 
(DOI:10.2210/pdb3jqo/pdb) (67, 68) using the PyMOL (http://pymol.org/) to construct the 
figure. This C-terminal domain (residues 173–377) presents as a non-canonical β-barrel 
with a groove marked by the V243C substitution mutation, a flexible base marked by the 
S173C and N218C mutations and a conserved RDLDF motif,  the α2,α3 antennae 
projection (AP) marked by Q295C and G306C and the flexible bridging domain marked by 
D278C.  Cys substitution mutations are in blue.  Residue numbers labeled in red indicate 
pilus defect. Red boxes indicate deletion of region results in pilus defect. Deletion mutations 
were constructed by V. Krishnamoorthy. Cysteine substitutions were constructed by I. 
Garza. DNA transfer experiments were performed by V. Krishnamoorthy and S. 
Jakubowski. 
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Figure 5.5 Effects of VirB10 helix projection mutations on T-pilus assembly 
 Effects of VirB10 helix projection mutations on T pilus assembly. A. Sucrose density 
gradient distribution profiles of extracellular VirB2 pilin/T pili produced by WT cells and the 
∆AP and ∆BD helix mutants. Here, ΔAP denotes deletion of TraF based alpha 3 and linker 
region (see (69)).  For comparison, extracellular material from the N218C mutant strain, 
which also produces low amounts of surface pilin (Fig. 5.4), was similarly analyzed. 
Immunoblots developed with anti-VirB2 antibodies show the distribution profiles of 
extracellular pilin in identically prepared 20–70% sucrose density gradients. B. Extracellular 
material from WT cells and the ∆AP mutant was fractionated through a Superdex 75 
10/300 GL gel filtration column and fractions (listed at top) were analysed for the presence 
of VirB2 pilin by immunostaining. Molecular masses of reference proteins are shown below 
(in kDa). 
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Discussion 
VirB10 is predicted to assemble as a structural scaffold as well as a ‘communication’ 
bridge between the inner and outer membranes. In this study, I collaborated with other 
members of the Christie laboratory to characterize the contributions of specific VirB10 
domains to DNA transfer and/or T-pilus biogenesis.   The most interesting outcome from 
this work was the demonstration that two transmembrane domains, one spanning the inner 
membrane and the second spanning the outer membrane, contribute selectively to the 
biogenesis of T-pili.   
VirB10: a ‘Communication’ Bridge for IM and OM Machine Subassemblies 
VirB10 forms close contacts with inner membrane associated T4SS ATPases (45, 
107). VirB10 senses ATP binding or hydrolysis activities by the VirB11 and VirD4 ATPases 
and, in turn, undergoes a conformational change that is necessary for T-DNA transfer 
through the translocation pathway (58, 123). VirD4 spans the inner membrane (159), while 
VirB11 associates peripherally at the cytoplasmic face of the membrane (90). Therefore, 
the short N-terminal cytoplasmic domain and/or TM domain are predicted to interact with 
one or both of these ATPases.  Additionally, VirB10 might interact directly with the VirB4 
ATPase, which stimulates dislocation of membrane-integrated VirB2 (see Chapter 4 and 
(130)).  Interestingly, i2 insertions throughout the N-terminal domain and a deletion (Δ2-18) 
mutation did not abolish substrate transfer, but did disrupt pilus biogenesis.  A longer 
deletion (Δ2-46) of both the cytoplasmic N-terminus and the TM domain abolished both 
activities confirming the importance of both domains for VirB10 function.  I suggest that the 
N-terminal region of VirB10, including the cytoplasmic and TM domains, could mediate 
productive interactions with the VirB or VirD4 ATPases that are required for protein 
function. In view of the selective disruption of TM domain mutations on pilus biogenesis and 
my finding that VirB4 mediates dislocation of the membrane-integrated VirB2 pilin, I favor 
the hypothesis that a VirB10 TM domain interaction with the VirB4 ATPase serves to 
coordinate delivery of the pilin into the core chamber.  Experimental tests of this hypothesis 
are proposed in Chapter 7. 
 
VirB10: A Regulator of T-pilus Biogenesis  
The isolation of ‘uncoupling’ mutations that selectively disrupt T-pilus production or 
substrate transfer suggests that VirB10 might differentially regulate assembly or function of 
the secretion channel or polymerization of the T-pilus. In collaboration with other laboratory 
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members, I identified three subclasses of ‘uncoupling’ mutations in VirB10: Class I 
mutations attenuate substrate transfer levels, but do not disrupt T-pilus production, Class II 
mutations abolish T-pilus production, but do not affect substrate transfer, and Class III 
mutations selectively disrupt T-pilus polymerization, allowing for release of VirB2 monomers 
into the extracellular milieu but without affecting substrate transfer to target cells. The latter 
two classes were of primary interest as they arose, respectively, through mutation of the N-
terminal region at or near the inner membrane and the AP presumptively spanning the 
outer membrane.   
The Class II mutations included N-terminal deletion (Δ2-18) and i2 insertions with 
the transmembrane region (i2.35, i2.40, i2.45).  As discovered and further characterized by 
I. Garza, the i2 mutations are located within a sequence (33-LIV*GGVVL*ALSLS*L-46) that 
resembles a leucine zipper motif (206).  The model I. Garza developed from his studies is 
that this Leu zipper motif participates in homo- or heteromeric interactions that are 
selectively important for pilus biogenesis.   Again, in view of my studies defining a VirB4 
dislocase activity, the most reasonable model is that the VirB10 N-terminal region forms a 
productive interaction with the VirB4 ATPase.  
The Class III mutations included the ΔAP and ΔBD mutations (fig. 5.4 and 5.5).   On 
the basis of sequence conservation within this region, most or all VirB10 family members 
likely contain an α-helical AP. In view of the Class III phenotype, it is enticing to think that 
the AP may play a direct role in facilitating sequential addition of VirB2 subunits during 
polymerization.  In such a model, the AP might coordinate the packing of pilin monomers to 
build the pilus polymer.  According to this model, the AP functions directly in the 
morphogenesis of the pilus and might serve as a platform upon which the pili are 
assembled.  However, an alternative possibility is that the AP functions as a gate that 
opens to allow T-pilus extrusion across the outer membrane.  According to this model, the 
AP functions more passively in the polymerization process, but is still required for extrusion.     
The bridging domain is composed of a short β-sheet and flexible sections (Fig. 5.4 
B). While the ΔBD mutation did phenocopy the AP deletion, it also showed a significant 
reduction in substrate transfer. As discussed in more detail in the next chapter, the bridging 
domain contains a number of conserved glycine residues that might regulate translocation 
of substrates and extrusion of the T-pilus through the AP pore.  
The structures of the pKM101 outer membrane core complex (67, 68) have provided 
us with a picture of a T4SS subassembly. It is still unclear if T4SSs use this subcomplex to 
build the secretion channel, T-pilus, both structures, or neither structure. The isolation of 
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‘uncoupling’ mutations, however, minimally establishes that biogenesis of the secretion 
channel and pilus can be genetically separated. Uncoupling mutations have been isolated 
in a number of T4SS subunits, including polytopic VirB6 (65), outer membrane core subunit 
VirB9 (123), ATPase VirB11(87, 136), ATPase VirD4 (104), VirB2 and  the VirB2-like TrbC 
pilin of the RP4 plasmid transfer system  (130, 160).  Future studies aimed at isolating and 
characterizing T4SS subassemblies in association with substrates or T-pili should help to 
define the requirements for assembly of these two terminal organelles. 
Taken together, results of my studies establish that both the TM and AP regions of 
VirB10 are critical for T-pilus assembly. Here, I present two models that could account for 
the mutant phenotypes (Fig, 5.6). 
Model I: The VirB10 TM domain interacts with the pilus assembly factor VirB4 to 
enable pilin dislocation directly into the core complex.  According to this model, the i2 
mutations disrupt the VirB10-VirB4 interaction and this in turn blocks entrance of the pilin 
monomers into the core chamber or alternatively may prevent a necessary structural 
transition for incorporation into the T-pilus versus the channel. In earlier studies, the Christie 
lab identified VirB subunits that form close contacts with the translocating T-DNA (58).  
While VirB4 was required for substrate translocation (45), it did not form close contacts with 
the T-DNA substrate.  Therefore, VirB4 appears to selectively regulate delivery of the pilin 
monomer into the channel without directly regulating passage of secretion substrates.  A 
disruption in the VirB10-VirB4 interaction mediated by the i2 mutations could thus account 
for the Tra+,Pil- ‘uncoupling’ phenotype.  This model is also compatible with unpublished 
data by S. Jakubowski in our lab that VirB10 interacts with VirB4.   
Model II:  The AP region serves as a gating domain or polymerization chaperone.  In 
wild-type cells, the AP regulates passage of the pilus polymer across the outer membrane, 
whereas in the ΔAP mutant pilin monomers or short oligomers are extruded. This deletion 
may induce a leakiness to the secretion channel that allows for nonspecific release of both 
substrate and pilin monomers. As noted above, an alternative possibility is that the AP is 
directly involved in T-pilus polymerization, perhaps similar to the mechanism used by the 
chaperone-usher pathway of pilus biogenesis, via donor-strand exchange (207).   
In conclusion, our findings support the notion that VirB10 functions as a 
‘communication’ bridge between the inner and outer membranes and possibly also serves 
as an outer membrane gated pore.  Moreover, on the basis of the “uncoupling” phenotypes 
identified in the TM and AP regions, I propose that VirB10 differentially regulates assembly 
of the T-pilus or the secretion channel.  
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Figure 5.6 Models of VirB10 TM and AP domain involvement during T4SS T-pilus 
assembly 
Left figure depicts the proposed function of the VirB10 TM domains in establishing 
productive contacts with VirB4. Two residue transmembrane insertions (i2-TM; depicted by 
yellow stars) were shown to specifically block T-pilus biogenesis without affecting substrate 
transfer. VirB2 may be blocked (red ‘X’) from entering the core channel complex or fail to 
make a structural transition (small red ‘x’) necessary for incorporation into the T-pilus due to 
loss of specific contacts between VirB10 and VirB4.  Right figure highlights a model in 
which the VirB10 AP serves as an outer membrane gate and/or polymerization chaperone 
for VirB2. Removal of the AP (ΔAP) allows both substrate and VirB2 monomers to be 
released into the extracellular milieu.  In the absence of the AP, VirB10 cannot mediate 
polymerization through an indirect (e.g. channel gating, promoting contact with another VirB 
subunit) or possibly direct mechanism (e.g. donor-strand exchange to promote pilus 
assembly, see (207)). Outer membrane complex was modeled with co-ordinates from 
pKM101 core outer membrane complex X-ray structure (DOI:10.2210/pdb3jqo/pdb) (67, 68) 
using the PyMOL (http://pymol.org/) and modified to construct this figure. OM: outer 
membrane; P: periplasm; IM: inner membrane. 
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Chapter 6: Characterization of a virB10 Mutant Conferring Release of VirE2 to the 
Extracellular Milieu While Selectively Blocking T-Pilus Biogenesis  
 
 
 
 
 
 
 
NOTE: This work was performed as part of a collaboration between the laboratories of   Dr. 
Peter Christie and Dr. Lois Banta (Williams College - Biology Department - Williamstown, 
Massachusetts). This work describes a mutation that was first isolated in an experimental 
screen designed and performed by Dr. Lois Banta. Further characterization of this mutation 
was performed by Dr. Eric Cascales and Jennifer E. Kerr under the supervision of Dr. Peter 
Christie.  Each person contributed to the development and design of the experiments. 
Members of the collaboration responsible for data discussed are indicated. 
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Introduction 
 Type IV secretion systems (T4SS) mediate the movement of DNA and/or protein 
substrates into a variety of recipient cells or into the milieu (2, 3, 15, 30). The 
Agrobacterium VirB/VirD4 T4SS is dedicated to the movement of both T-DNA and protein 
substrates into plant and other cell types based on a cell-contact dependent mechanism 
(33, 34, 60, 64, 208). These T4SSs span the entire bacterial cell envelope and comprise a 
conduit for substrates to pass en route to target cells (2, 3, 15, 30). Three VirB/VirD4 T4SS 
components, the cell-envelope-spanning subunit VirB10 together with the outer-membrane-
associated subunits VirB7 lipoprotein and VirB9, form a stable T4SS subassembly that is 
known as a ‘core’ complex (2, 30). These ‘core’ subunits are phylogenetically conserved 
among T4SSs of Gram-negative bacteria (15), and therefore structure-function studies of 
paradigmatic ‘core’ complexes likely will identify mechanistic features of broad biological 
importance.  
Recently, structural information was obtained for a ‘core’ complex of the Escherichia 
coli pKM101 conjugation system by cryoelectron microscopy (cryoEM) and X-ray 
crystallography (67, 68). In this ‘core’ complex, homologs of VirB7, VirB9 and VirB10 
assemble together as a 185 Å ring composed of 14 copies of each subunit.  On the basis of 
the cryoEM images, VirB10-like TraF was postulated to span the inner membrane and 
project through the periplasm to the outer membrane. In view of the more recent X-ray 
structure, it was further suggested that an α-helical domain of TraF termed the antennae 
projection (AP), spans the outer membrane, such that the 14 AP’s in the core complex form 
an α-helical outer membrane pore with an opening of ~20 Å in diameter.  At the inner 
membrane, an N-terminal transmembrane (TM) domain anchors TraF in the membrane, 
and the 14 copies of TM domains in the core complex form a ring of a 55 Å in diameter. 
As suggested for the pKM101 core structure, a presumptive VirB7/VirB9/VirB10 
core complex likely functions as a structural scaffold during machine biogenesis.  In support 
of such a function, the three VirB proteins mutually stabilize each other as well as other 
VirB subunits.  Moreover, S. Jakubowski in our laboratory recently succeeded in enriching a 
ring-shaped complex resembling that of the pKM101 core and composed minimally of these 
3 subunits (unplublished data). Another interesting feature identified for the VirB10 subunit 
is that it senses ATP binding or hydrolysis activities of the VirD4 and VirB11 ATPases.  In 
response, VirB10 undergoes a structural transition, identified as a change in susceptibility 
to an endoprotease. This structural change is important for stable complex formation 
between VirB10 and the VirB7/VirB9 complex (83).  
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  E. Cascales, a postdoctoral fellow in the Christie laboratory, developed a substrate 
trapping assay based on the chromatin immunoprecipitation assay (ChIP).  In this assay, 
cells are treated with formaldehyde to crosslink the translocating T-DNA to subunits of the 
T4SS channel.  Following solubilization, subunits are immunoprecipitated with the anti-VirB 
antibodies, and co-precipitated crosslinked T-DNA is assessed by PCR amplification. With 
this assay, E. Cascales supplied evidence that the energy-activated form of VirB10 
regulates substrate transfer through the distal portion of the channel composed of the VirB2 
pilin and VirB9 subunits (58, 83).  Accordingly, VirB10 is postulated to function as a ‘gate-
keeper’ that regulates substrate translocation across the outer membrane by a mechanism 
dependent on sensing of inner membrane ATPase activities. One pototential protein that 
undergoes gated release is VirE2, a single-stranded DNA-binding protein that interacts with 
the T-DNA, forming the T-complex.  VirE2 protects the T-DNA from cytoplasmic nucleases 
in the plant cell and mediates delivery of the T-DNA to the plant nuclear pore with the help 
of VirE3 (47-52).  
The proposed role of VirB10 as an energy-activated regulator of substrate transfer 
across the outer membrane remains to be experimentally tested.  In this investigation, I 
participated in a study with our collaborator Dr. Lois Banta (Department of Biology, Williams 
College, Williamstown, MA, USA) aimed at testing the model that VirB10 regulates 
substrate translocation across the outer membrane.   In a genetic screen, Dr. Banta’s lab 
isolated a substitution mutation in VirB10 that confers leakage of a secretion substrate 
across the outer membrane.  Here, I present results of my studies confirming both the 
‘substrate leaky’ phenotype and an observed disruption of T-pilus biogenesis.  I also report 
results of experiments indicating that the mutation, which is located near the AP region, 
does not confer nonspecific disruption of outer membrane integrity.  Our collective findings 
add to a body of evidence that VirB10 functions as an energy-activated, outer membrane 
‘gate-keeper’,  
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Results 
The VirB/D4 T4SS translocates substrates across the entire cell envelope by a 
mechanism requiring direct contact with target cells (33, 34, 209).  The Lois Banta lab 
designed and performed a screen to identify ‘leaky’ T4SS channels. Her lab screened 
~12,000 strains expressing virB10 mutant alleles for the release of functional, FLAG-
tagged VirE2 (FLAG-VirE2) derivative to the cell surface.  One mutant strain was isolated 
that showed a significant increase in release of FLAG-VirE2 in comparison with a wild type 
T4SS.  The virB10 allele was sequenced and found to harbor a single mutation that 
resulted in a substitution of an arginine for glycine at residue 272. Here, I present 
additional characterization data for this VirB10 G272R mutant. Modeling of the G272R 
mutation within the pKM101 core complex was performed by Dr. Gabriel Waksman. 
 
virB10 Mutant Confers Release of VirE2 to the Extracellular Milieu  
In agreement with the Banta lab finding, I found that the G272R mutation confers 
increased levels of surface exposed FLAG-VirE2 substrate in comparison to both the 
isogenic ΔvirB10 mutant or the ΔvirB10 mutant producing native VirB10 (Fig. 6.1A). FLAG-
VirE2 accumulated at comparable total cellular levels in each strain background. The 
G272R mutation also did not affect cell viability in virB induction medium (ABIM) (Fig. 6.1B).    
  The G272R mutation may directly affect secretion channel gating or it could non-
specifically disrupt outer membrane integrity. In order to test this, I measured growth of a 
ΔvirB mutant producing native VirB10 or the G272R mutant in the presence of the large 
antibiotic vancomycin or anionic detergent SDS.  I also assayed for the release of 
periplasmic-localized proteins RNase and ChvE. The outer membrane of Gram-negative 
bacteria normally provides a barrier to potentially harmful molecules.  Porins at the outer 
membrane allow only the transit of small molecules (<600 Da) (210-212).  Vancomycin is a 
large antibiotic (~1,500 Da) that targets the N-acetylmuramic acid and N-acetylglucosamine 
peptide subunits from incorporating into the peptidoglycan matrix and therefore 
predominantly affects Gram-positive bacteria cell wall synthesis (213, 214); however, an 
ungated channel or pore at the outer membrane could allow for transit of the drug into the 
periplasm of Gram-negative bacteria (215). Likewise, the outer membrane also protects 
from the effects of anionic detergents (216).  
 The G272R mutant showed increased sensitivity to both vancomycin and sodium 
dodecyl sulfate (SDS) (Fig. 6.2A and B). The G272R mutant strain grew slower in the  
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Figure 6.1 Effects of the G272R mutation on VirE2 release and growth 
A) N-terminally FLAG-tagged VirE2 (Flag-VirE2) was produced in a nonpolar ΔvirB10 
mutant strain (PC1010) and and the ΔvirB10 mutant synthesizing native VirB10 or the 
G272R mutant protein.  Upper, total cellular levels of FLAG-VirE2 assessed by 
immunostaining with anti-Flag antibodies.  MW, molecular weight markers with sizes in 
kilodaltons (kDa) listed at left.  Lower, FLAG-VirE2 surface display on the corresponding vir-
induced strains as monitored by colony immunoblotting with anti-FLAG antibodies. B)  
Growth curves of PC1010 producing native VirB10 or the G272R mutant upon 
resuspension of cells in vir-induction media, as described in Materials and Methods.   
  
Note: FLAG release phenotype first observed in the Lois Banta lab. Shown here is a repeat 
of that assay in A lower panel.  
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Figure 6.2 Effects of G272R on membrane integrity, as monitored by vancomycin and 
SDS sensitivity and release of preiplasmic proteins 
A & B) PC1010 (ΔB10) producing native VirB10 or the G272R mutant were suspended in 
vir-induction media containing vancomycin (50 or 100 μg/ml) or SDS (0.5 %) and 
growth/lysis was monitored for 18 h. C) PC1010 (ΔB10) cells lacking or producing native 
VirB10 (B10) or G272R were assayed for RNase release from intact cells on RNA-
containing plates as described in Materials and Methods.  Presence of cellular RNase was 
confirmed by addition of sonicated cell extracts to RNA-containing plates.  Strains were 
assayed similarly for release of periplasmic ChvE as monitored by development of colony 
blots with anti-ChvE antibodies. Production of cellular ChvE was assessed by spotted in 
sonicating cell extracts on nitrocellulose and development with anti-ChvE antibodies. 
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presence of 50 μg/ml vancomycin compared to an isogenic strain producing native VirB10 
and the difference was more evident with the addition of 100 μg/ml vancomycin (Fig. 6.2A).  
Growth was prevented and cells were presumably lysed in both the G272R mutant and the 
functionally wild-type strain by addition of 0.5% SDS; however, the G272R mutant showed 
a more pronounced sensitivity (Fig. 6.2B). In addition to inhibiting molecules from entering 
the cell, the outer membrane prevents periplasmic proteins and large molecules from 
exiting the bacterium. A. tumefaciens possesses RNase and the sugar-binding protein 
ChvE  in the periplasm (217).  If the G272R mutant disrupted outer membrane integrity, 
these proteins might be released to the cell surface.  However, the G272R mutant did not 
show increased release of the periplasmic proteins as monitored by surface colony blots for 
ChvE and an RNA degradation assay for RNase in comparison to a ΔvirB10 mutant or an 
isogenic strain producing native VirB10 (Fig. 6.2C) (139). Thus, G272R likely disrupts the 
gating of the secretion channel at the outer membrane pore, allowing for release of FLAG-
VirE2 substrate and increased uptake of molecules that are typically unable to cross the 
outer membrane. 
 
G272R is Locked in an Energy-Activated Conformation 
In wild type cells, VirB10 undergoes a conformational change in response to 
sensing ATP binding or hydrolysis by VirD4 and VirB11. This energy-activated structural 
transition results in exposure of a protease cleavage site that can be monitored by the 
presence of a ~40-kDa degradation product following protease treatment of spheroplasts 
(83).  In the absence of ATPases VirD4 and VirB11 or in cells depleted of cellular ATP 
levels with arsenate treatment, VirB10 maintains a protease-resistant conformation (48 
kDa) (83).   Interestingly, Dr. E. Cascales showed that the G272R mutant protein is 
degraded to the ~40kDa species even in the presence of arsenate (E. Cascales, personal 
communication).  The data suggest that the G272R mutant protein might ‘lock’ VirB10 into 
the energy-activated conformation. 
 
G272R is Permissive for Intercellular Substrate Transfer, but Blocks T-Pilus 
Biogenesis 
 Next, the G272R mutation was tested for its potential impact on substrate transfer to 
recipient cells or T-pilus biogenesis. Substrate transfer to target cells was monitored by a 
plant tumor assay and conjugative transfer of a mobilizable IncQ plasmid. Interestingly, 
despite the apparent ‘leaky’ phenotype, the G272R mutation did not disrupt substrate 
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transfer of oncogenic T-DNA and protein substrates to plant cells as shown by appearance 
of plant tumors, or the conjugative transfer of an Inc Q plasmid substrate to bacterial 
recipient cells (Fig, 6.3A). In contrast, neither the VirB2 pilin nor the pilus-associated protein 
VirB5 were detectable on the cell surfaces or in the high-molecular-weight shear fraction of 
the G272R mutant strain (Fig. 6.3B). These findings indicate that the G272R mutation 
completely blocked extracellular T-pilus production.  Cellular levels of VirB2 and VirB5 were 
unaffected by production of the G272R mutant protein. Therefore, the G272 mutation is 
another example of an ‘uncoupling’ mutation that renders cells Tra+ and Pil-. 
 
 An AP Deletion Mutation Confers a Partial Gating Defect 
VirB10 is postulated to form the outer membrane pore in the pKM101 core complex 
structure by creating a halo of interlocking alpha-helical projections extending from the top 
of the β-barrels. In Chapter 5 and our publication reporting the results of the VirB10 
mutational analysis (69), I reported that deletion of these antennae projections (AP) and the 
associated bridging domains also resulted in Tra+, Pil- phenotype. Unlike the G272R 
mutation that completely abolished release of extracellular VirB2, these deletion mutants 
mediated the release of pilin monomers into the milieu. I hypothesized that since these 
deletion mutants release nonpolymerized VirB2, they may also release VirE2 to the surface, 
even in the absence of a target cell. Interestingly, strains producing the ΔAP or ΔBD mutant 
proteins did not release FLAG-VirE2 to the milieu (representative data are shown for the 
ΔAP mutant strain in Fig. 6.4A).  Both deletion mutants were also evaluated for nonspecific 
effects on the outer membrane. As shown for the ΔAP mutant (Fig 6.4), the mutant strains 
did not show enhanced vancomycin sensitivity or release of periplasmic proteins RNase or 
ChvE.  The strains showed only a mild defect in the presence of 0.5% SDS relative to the 
isogenic strain complemented with native virB10 ( Fig. 6.4D-E). These results suggest that 
deletion of this region does not phenocopy the putative ‘open’ channel defect associated 
with the G272R mutation. Deletions in or around the AP region of VirB10 appear to 
selectively release VirB2 monomers without influencing secretion channel substrate gating 
or outer membrane integrity.  
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Figure 6.3 Effects of G272R mutation on DNA transfer, surface display of VirB2 pilin 
and the pi 
lus-associated protein virB5 
A) Levels of substrate transfer to plants, as monitored by virulence assays, and IncQ 
plasmid transfer to agrobacterial recipients.  B) PC1010 (ΔvirB10) lacking or producing 
native VirB10 or the G272R mutant were assayed for surface-accessible VirB2 and VirB5 
by colony immunoblotting, and for the presence of both proteins in material recovered in the 
shear fraction.  Corresponding analyses with PC1002 (nonpolar ΔvirB2 mutant) shows 
specificity of the anti-VirB2 antibodies, and also the G272R mutation also blocked delivery 
of VirB5 to the cell surface independently of VirB2 production.  Bottom panels show steady-
state cellular levels of VirB2 and VirB5 in the various strains.  
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Figure 6.4 Effects of the ΔAP (Δ302-337) mutation on VirE2 release, DNA transfer, cell 
growth, and outer membrane integrity 
A) Effect of the ΔAP mutation on release of FLAG-VirE2.  Samples were prepared and 
analyzed as described in Fig. 6.1A.  The ΔAP mutant strain displayed only slightly reduced 
levels of substrate transfer to plants, as monitored by virulence assays, and IncQ plasmid 
transfer to agrobacterial recipients.  B – E) as described in Fig. 6.2 legend, showing that the 
ΔAP mutation did not result in diminished cell growth, enhanced sensitivity to vancomycin 
or SDS, or release of periplasmic RNase or ChvE.  My earlier studies showed that the ΔAP 
mutation disrupts polymerization of VirB2 into the T-pilus (See Chapter 5). 
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Discussion 
Export of virulence factors is typically tightly regulated in response to environmental 
as well as host-derived signals, and in many cases requires physical contact with a 
recipient cell (33, 34, 60, 64, 208, 218).  The outer membrane location of a portion of 
VirB10 in the pKM101 core channel complex led to a hypothesis that VirB10 may directly 
serve as a gate for the T4SS substrate channel. To test this model, VirB10 mutant strains  
were screened for leakage of protein substrate to the surface in the absence of target cell 
contact.  The VirB10 G272R mutation conferring such a phenotype was mapped to a 
highly-conserved glycine residue in the bridging domain (BD), which links the antennae 
projection (AP) to the β-barrel of VirB10 homolog TraFpKM101. Previously, I showed that 
deletion of this BD resulted in attenuated levels of DNA transfer (see chapter 5). Here, I 
show that, unlike the G272R substitution mutation, deletion of this region as well as the 
associated AP that extends from the β-barrel forming the outer membrane cap of the core 
complex does not result in leakage of protein substrates to the milieu. This work 
emphasizes not only the importance of the bridging domain but also the general role of 
VirB10 in mediating translocation of substrates across the outer membrane. 
The features of VirB10 as a putative envelope spanning subunit (67, 68) and as a 
coupler of inner membrane energy to outer membrane translocation (83) suggests VirB10 
might regulate channel activity at the outer membrane. Here, I showed that the G272R 
mutation appears to specifically disrupt the T4SS channel gating versus non-specifically 
disrupting the outer membrane (Fig, 6.1). The data from E. Cascales that this mutation 
confers a constitutive ‘energy-activated’ conformation even in ATP-depleted cells is in line 
with the idea that the G272R mutation locks the channel into an ‘open’ configuration.  
It is important to note, however, that in wild-type cells the energy-activated form of 
native VirB10 is also proteolytically degraded.  Yet, wild-type cells do not release detectable 
levels of protein substrates (Fig. 6.1 A and data not shown). G. Waksman located the 
G272R mutation in the VirB7/VirB9/VirB10 core complex modeled from the pKM101 X-ray 
structure, showing its exposure on the interior surface of the core complex near the outer 
membrane (Fig. 6.5 A and B).  This mutation, which consists of the introduction of a positive 
charge, may cause a conformational change that disrupts gating of the outer membrane 
pore leading to substrate leakage. Thus, while the G272R mutation appears to lock the 
channel into an open conformation, in wild-type cells additional checkpoints must be  
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Figure 6.5 Modeling of G272R in pKM101 crystal structures 
A)  Space-filling model of the pKM101 core complex comprised of homologs of VirB7 
(TraN) in pink, VirB9 (TraO) in blue, and TraF (VirB10) in gray corresponding to the β-
barrel/linker domains and yellow/green to the AP α-helices and intervening loop.  VirB10 
Gly272, corresponding to TraF Gly294, is indicated in red. B)  Ribbon model of VirB10 
(TraF) showing β-barrel, an α-helical lever arm extension, and antennae projection (AP).  
The G272R mutation sits in an unstructured linker domain between the β-barrel and AP. 
Modeled by Dr. Gabriel Waksman. 
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present to prevent the ‘energy-activated’ channel from translocating substrate until 
productive contact with target cells is established. In view of these observations, it is 
interesting to suggest that transenvelope VirB10 may also function as a transducer of a cell-
contact-mediated signal(s) to activate substrate transfer through the T4SS.  Such a 
transducer function could be required for propagation of the ‘mating’ signal, an unspecified 
recipient-produced signal that was postulated to exist by early investigators of the F-
plasmid transfer system (219-221). The G272R mutation might bypass this signal rendering 
cells transfer competent even in the absence of a target cell.    
The proposed outer membrane gating mechanism likely requires energy; however, 
energy is not readily available at the outer membrane. The periplasm does not maintain a 
pool of ATP and the outer membrane is unable to sustain an electrochemical gradient. 
VirB10 sensing of ATP binding or hydrolysis by the inner membrane channel ATPases, 
likely results in structural changes necessary not only for productive complex formation but 
also dynamic opening and closing the outer membrane pore. A similar mechanism for 
energy transduction to the outer membrane is seen in the TonB system that uses the inner 
membrane proton motive force, as well as the aerolysin secretion system of Aeromonas 
hyrophila, which relies on ATPase ExeA and TonB-like protein ExeB (222, 223). VirB10 
might differ from TonB in that a target cell contact might also serve to regulate channel 
gating.  Another notable difference is that whereas TonB activates transport by inducing 
conformational changes in an outer membrane transporter, VirB10 likely regulates 
assembly or activity of its own outer membrane AP pore. 
Finally, it is of considerable interest that the G272R mutant, similar to the ΔAP and 
ΔBD (see chapter 5), was also defective in T-pilus biogenesis (Fig. 6.3). The G272R 
mutation completely blocked extracellular release of VirB2 and pilus-associated protein 
VirB5, whereas the deletion mutants showed disrupted pilus production but still allowed for 
release of monomers or short oligomers of VirB2. The G272R mutation appears to block 
delivery of VirB2 and VirB5 across the outer membrane, either as monomers or polymers, 
while the deletion mutants specifically disrupt T-pilus polymerization.  It is still unknown if 
the T-pilus initiates polymerization from the inner membrane, extending through the core 
complex, or at the outer membrane using, perhaps, VirB10 as a platform. Cysteine 
accessibility labeling of the VirB2 cellular-associated and T-pilus forms supports the latter 
model (see Chapter 1 and (130)). Together the predicted flexible nature of the VirB10 
AP/BD region, its position at the outer membrane pore, and the genetic evidence from 
mutations provide support for a model in which VirB10 actively participate during T-pilus 
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polymerization. Although details of the T-pilus polymerization reaction(s) remain unknown, 
a possible mechanism of action of the AP is offered through studies of the chaperone-usher 
pathway of Pap pilus biogenesis.  For these pili, which are phylogenetically unrelated to 
T4SS-encoded pili, subunit polymerization takes place by a ‘donor-strand exchange’ 
mechanism, wherein a chaperone provides a temporary β-strand for folding of the pilin 
subunit; the next incoming pilin subunit displaces the chaperone β-strand with one of its 
own, resulting in polymerization at the outer-membrane (207). Conceivably, the VirB10 AP 
functions as a donor strand to promote folding of VirB2 pilin monomers; during the 
polymerization process, a hydrophobic helix of one pilin subunit might replace the VirB10 
AP.  Further studies will test this model vs. an alternative in which the AP serves more 
passively as a gating domain to regulate pilus/pilin passage across the outer membrane.  
In conclusion, the G272R mutation as well as the bridging domain and antennae 
projection deletions highlights the role of VirB10 in substrate trafficking across the outer 
membrane and assembly of T-pilus. It is curious to think how a single machine 
subassembly can remain ‘open’ for protein substrates but ‘closed’ for VirB2 release. VirB10 
might differentially regulate assembly/function of the secretion channel and T-pilus by 
distinct mechanisms and possibly as a component of different VirB subassemblies. 
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Chapter 7: Summary, Future Studies, and Perspectives 
 
 
 
 
 
 
 
 
 
 
 
NOTE: Electron microscope images presented in this chapter were taken by Dr. Angel 
Paredes (University of Texas Health Science Center – Medical School – Pathology 
Department – Houston, TX) and denoted in the figure legend. I performed all sample 
preparations for electron microscope experiments. 
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Summary 
The focus of this work has been to further characterize A. tumefaciens VirB2 pilin 
with respect to assembly of the secretion channel and T-pilus. My work focused primarily on 
VirB2, VirB4, and VirB10 which are all essential components of the VirB/D4 type IV 
secretion system (T4SS) (25, 104, 128, 133). A primary goal of the research presented 
here was to gain a broader understanding of the energetic, structural, and molecular events 
underlying the contributions of VirB2 pilin in assembly of the T4SS. Currently, there is little 
structural information for the VirB2 pilin subunit except for basic in silico analysis (115, 116, 
224).   There is some biochemical data describing early processing of pro-pilin to mature 
pilin (25) and contributions of certain VirB subunits to T-pilus biogenesis (122).  However, 
prior to my studies, the specific roles of the VirB ATPases or of VirB10 in promoting 
incorporation of the pilin into the secretion channel or T-pilus was fundamentally unknown. 
Studies summarized below bring to light new findings regarding intermediate steps in the T-
pilus pathway and assign specific roles for ATPases VirB4 and VirB11 along with domain 
contributions of VirB10.   
Studies presented in chapter 3 examine the detailed structure of VirB2 at the inner 
membrane, as part of the secretion channel, and within the T-pilus by use of scanning 
cysteine accessibility method. Past studies using sequence hydropathy had established 
that VirB2 possessed two hydrophobic stretches that likely created two transmembrane 
domains at the inner membrane.  VirB2 was predicted to move from the inner membrane 
allowing for T-pilus polymerization in the presence of the remaining T4SS VirB subunits. I 
predicted that VirB2 would likely undergo a structural transition in response to T4SS 
activation.  I tested this hypothesis by inserting unique cysteine residues along the length of 
VirB2 and assessing for changes in Cys labeling in the presence and absence of the VirB 
proteins. Initial phenotypic studies showed i) Cys substitutions at the N and C termini 
disrupted protein stability or function and ii) a C-terminal mutation (G119C) selectively 
abolished secretion channel activity without affecting T-pilus production.   I then defined the 
inner membrane topology of VirB2 - comprised of two transmembrane regions, a small 
cytoplasmic loop, and a long periplasmic loop containing the covalently linked N and C 
termini.  Next, I showed the cellular-associated form of VirB2 demonstrated differences in 
labeling consistent with extraction of the pilin from the inner membrane when in the 
presence of the other VirB subunits. I also showed that the labeling patterns of Cys mutants 
produced in a Tra+, Pil- uncoupling mutant strain matched the isogenic, phenotypically wild-
type strain, but differed appreciably from labeling patterns of pilins assembled into T-pili. In 
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the isolated T-pilus, Cys residues at positions 64, 67, and 77 but not elsewhere in the pilin 
were labeled, indicating that only a short motif comprised of hydrophilic and hydrophobic 
residues is surface-exposed. These findings supplied the first information about the pilin 
structural organization when assembled as an inner membrane pilin pool, and when 
incorporated into the secretion channel and the T-pilus.   
 Chapter 4 focused on determining the role of energy during early steps in the T-pilus 
biogenesis pathway. I proposed that the extraction of VirB2 from the inner membrane for 
further machine assembly requires one or more of the VirB ATPases. I again used my 
collection of Cys-substituted pilins to monitor differences in the VirB2 structural state in 
different genetic contexts. I determined that Cys-substituted pilins produced in strains 
lacking or producing the VirB4 or VirB11 ATPases exhibited differences in MPB-labeling 
patterns.  I further showed that VirB4 synthesis, but not the Walker A box binding motif 
mutant, was correlated with labeling of a VirB2 cytoplasmic residue Cys94 regardless of the 
presence of other VirB proteins. Additionally, co-synthesis of VirB4 and VirB11 was 
correlated with labeling of periplasmic Cys64. I also showed that VirB2 and VirB4 formed an 
immunoprecipitable complex.  Finally, I determined that VirB2 was released from the inner 
membrane in cells producing VirB4, but not in a ΔvirB4 mutant strain or a ΔvirB4 strain 
producing a VirB4 Walker A motif mutant proteins but no other VirB proteins. Overall, my 
findings support a model in which the VirB4 ATPase catalyzes extraction of VirB2 pilin from 
the inner membrane. Although the VirB11 ATPase is not required for pilin dislocation, it 
does seem to participate in modulating the VirB2 structural state during or after dislocation.   
 In chapter 5, I presented work characterizing the contribution of individual VirB10 
domains to T-pilus biogenesis and substrate transfer. VirB10 was previously shown by the 
Christie lab to sense ATP energy at the inner membrane resulting in a conformational 
change within VirB10 leading to complex formation (83). A series of mutations were 
generated, by V. Krishnamoorthy and I. Garza, to determine the function of specific regions 
within VirB10. Phenotypic studies identified Tra+, Pil- “uncoupling”: mutations that mapped 
to the N-terminal cytoplasmic region and transmembrane domain and the C-terminal α2,α3 
helix (AP) extending from the β-barrel domain.  On the basis of the “uncoupling” 
phenotypes, I propose that the extreme N-terminus, TM α-helical registry, and β-barrel 
antennae projection, assisted by the bridging domain, form specific intermolecular 
interactions that are critical for biogenesis of the T-pilus but not for a functional secretion 
channel. Together the data imply that VirB proteins can alternatively assemble as a 
secretion channel or a platform for the T-pilus.   
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 In chapter 6, I focused on further characterizing a mutant from the laboratory of Dr. 
Lois Banta, identified during a screen for ‘leaky’ substrate channels. VirB7, VirB9, and 
VirB10 subunits form a stabilizing core complex early during activation of the T4SS (2, 3, 
30). A detailed crystal structure of the pKM101 outer membrane core complex, from the 
Waksman lab, has revealed that VirB10 forms the external most part of the outer 
membrane pore. These findings have led to our hypothesis that VirB10 regulates substrate 
passage through the distal portion of the translocation channel. The Banta lab screened for 
mutations that would confer release of a tagged protein substrate (FLAG-VirE2) to the 
surface in the absence of a target cell. The screen identified one mutation G272R that 
mediated VirE2 release and also rendered the mutant insensitive to cellular ATP depletion. 
Notably, G272R was blocked for T-pilus biogenesis but unaffected in substrate delivery to 
plant and bacterial recipient cells. Modeling of the mutation by Dr. Gabriel Waksman 
showed that the G272R mutant is located near the antennae projection (AP) within the 
bridging domain (BD) of VirB10 homologue TraFpKM101. The AP and BD form the outer 
membrane pore and deletion of these regions phenotypically resembled the G272R 
mutation by allowing substrate transfer but blocking T-pilus assembly; however, these 
deletions did not permit leaking of FLAG-VirE2.  I propose that i) the G272R mutation 
disrupts regulation of substrate trafficking by locking the secretion channel in an ‘open’ 
position resulting in substrate leakage, and ii) the G272R mutation as well as the partial AP 
and BD deletion mutations selectively disrupt pilus polymerization by preventing formation 
of an outer membrane assembly platform.  How the G272R mutation can confer substrate 
leakage without affecting intercellular substrate transfer, while also blocking pilus 
biogenesis, are intriguing questions for further studies. A working model is that the VirB10 
contributes to substrate transfer or pilus biogenesis by modulating the structural 
organization of its AP and BD as a function of energy transduction from the inner 
membrane ATPases and sensory recognition of an extracellular signal(s) derived from a 
productive target cell interaction.  
 This works highlights the intriguing yet complex nature of type IV secretion systems. 
My studies contributed novel information pertaining to i) the structural organization of the 
VirB2 pilin in the inner membrane, secretion channel, and T-pilus ii) the role of an ATPase 
in driving pilin dislocation, and iii) contributions of VirB10 domains to T-pilus biogenesis and 
substrate transfer across the outer membrane.  While these findings significantly advance 
our understanding of the structural, energetic and molecular events underlying type IV 
secretion system assembly and function, clearly there are still many unanswered questions.  
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Future Studies 
The following experiments are meant to extend the analyses of the studies presented here. 
 Test the model that VirB2 accumulates in the inner membrane as a prerequisite to its 
polymerization into the T-pilus and secretion channel  
 Although early processing of the VirB2 propilin involving cleavage of the signal 
sequence and cyclization proceed via integration into the inner membrane, there is little 
experimental support for the notion that the mature pilin accumulates a pool in the 
membrane (delayed incorporation) (175, 225).  An alternative model is that upon 
processing the pilin is immediately dislocated for polymerization into the secretion channel 
or pilus. In chapter 3, I presented evidence that the VirB2 Cys51 mutant protein is labeled in 
the absence but not the presence of other VirB proteins. This labeling pattern is not 
consistent with the accumulation of a pilin pool, as it is unlikely that the synthesis of other 
VirB proteins would result in extraction of all pilin monomers.  Thus, at least a subset of the 
Cys51-substituted pilins should still label even in wild-type cells.  The one caveat to this line 
of reasoning, however, is that the Cys51 substitution is a loss-of-function mutation. This 
phenotype prevents firm conclusions about findings relating to the structural organization of 
this mutant.   
Further studies evaluating the pilin ‘pool’ model would involve screening other Cys-
substitutions that do not block protein function, but display the same MPB labeling pattern 
as the Cys51 mutant protein.  Such a mutation would constitute compelling genetic 
evidence against the pilin pool model.  Another line of study would involve use of different 
promoters to modulate the timing of VirB2 synthesis relative to the other VirB proteins. For 
example, virB2 expression by a tightly-controlled promoter could be used to synthesize a 
pool of membrane-integrated pilin prior to synthesis of the remaining VirB proteins from the 
acetosyringone-inducible virB promoter.  Two such promoters that function in A. 
tumefaciens include the salicylic acid inducible nah promoter (Pseudomonas) and 
arabinose-inducible BAD promoter (Escherichia coli) (226, 227). In addition, a new set of 
LacI-based expression vectors was created for E. coli that are inducible by addition of 
isopropyl β-D-1-thiogalactopyranoside (IPTG) (228). Temporal expression of virB2 would 
be monitored by transcript and protein accumulation via RT-PCR and Western blot 
analyses, respectively. Cells would be induced for synthesis of VirB2, then the inducing 
signal would be removed by centrifugation of cells and resuspension in fresh media. The 
remaining virB genes would be induced from the native promoter and assayed over time for 
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accumulation of pilin at the cell surface, pilus production, protein stability, and substrate 
transfer.  Variations on this temporal gene expression assay could include reversing the 
time course of virB2 vs. other virB gene expression, and differential synthesis of VirB4 with 
other VirB proteins to monitor the kinetics of pilin dislocation from the membrane.    These 
kinds of studies should allow for a rigorous test of the pilin ‘pool’ model. 
 It is also of central interest to define the kinetics of pilus assembly and where on the 
cell surface the pilus polymerizes. Other studies have used immunogold labeling and phage 
fluorescence (175, 225, 229, 230) to observe the movement of pilin subunits from a pre-
formed pool and monitor pilus extension. A similar technique could be used in A. 
tumefaciens; however, this application is more difficult in Agrobacterium because of its 
smaller size and lack of T-pilus-binding phage.  A potential fluorescence recognition site 
that could be used is Fluorescein Arsenical Hairpin binder (FlAsH) which is a tetra cysteine 
motif that strongly interacts with fluorophores.  This application might allow for real-time 
monitoring of pilus biogenesis and perhaps movement of pilin monomers across the cell 
envelope (231).  However, tagged versions of VirB2 have proven difficult to produce.  I 
engineered seven FLAG and tetra-cysteine motifs in different locations along the length of 
VirB2 using mutagenic PCR or cloning. I designed an SphI flanked FlAsH tag Kanamycin 
resistance cassette to place the FlAsH tag into the SphI site created by some of the Cys 
substitution mutants within VirB2 (Fig. 7.1A).   Two tags could be accommodated without 
loss of protein function: a FLAG tag placed directly after residue 85 and a tetra-cysteine 
motif (FlAsH) placed in the SphI site created by the Cys83 substitution resulting in Ala-Cys-
Cys-Pro-Gly-Cys-Cys-Cys (Fig. 7.1B). It is interesting that residues 83 and 85 are in the 
domain II hydrophobic patch within VirB2, near the cytoplasmic loop.  Even though the 
FLAG tag introduces a cluster of negative charges near this loop, the tagged protein is still 
functional. Since this would violate the ‘positive-inside’ rule of von Heijne (164), it is 
intrinsically interesting to explore the mechanism by which this FLAG-tagged variant inserts 
into the inner membrane.   However, for the pilus assembly kinetics and positioning studies, 
unfortunately, neither the FLAG- or FLAsH-tagged variants could be detected with anti-
FLAG or addition of the FLAsH reagent (J. Kerr, data not shown).  Because both tags might 
be buried in the pilus lumen, I suggest that additional FLAG tags be inserted within the 
region of VirB2 that I showed to be surface-displayed in the isolated T-pilus, e.g., between 
residues 67-77.  This collection of FLAG or FlAsH tagged variants could be used in 
fluorescence microscopy studies aimed at characterizing the timing and placement of pilus 
polymerization on the cell surface.  
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Figure 7.1 Schematic of FlAsH tag cassette and effects of tag introduction into VirB2 
on surface display of VirB2 and virulence 
A) Schematic of FlAsH tag cassette. Kanamycin resistance cassette (KanR) was PCR 
amplified from broad host range plasmid pXZ151 and flanked with a SmaI enzyme site and 
half of the FlAsH tag with an SphI site. Triangles represent enzyme sites.  B) Extracellular 
blot (surface) assay of Flag and FlAsH tagged versions of VirB2.  Negative controls ΔvirB 
operon and ΔvirB2, and positive control WT: wild type strain A348.  Mutagenic PCR was 
used for introduction of Flag 62, 85 and FlaSH 63, 114. FlAsH tag cassette in (A) was used 
for introduction of the tetra-cysteine motif at SphI sites created by Cys substitutions at 
residues 67, 83, and 111. Kanamycin cassette was removed following cloning by a SmaI 
digest. Virulence monitored by plants inoculation and scored on a scale of no virulence - to 
wild-type virulence +++.  
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Defining the Structure of the T-Pilus and Pilin Subunit Packing 
 Studies presented in chapter 3 showed that VirB2 adopts different structural states in 
the inner membrane, secretion channel, and T-pilus.  MPB-labeling further revealed that a 
patch of both hydrophilic and hydrophobic residues is exposed on the T-pilus surface. This 
presented the first structural information about the VirB2 pilin packing geometry within the 
T-pilus. Future studies aimed at defining the T-pilus structure are important because of 
another central, but unresolved question in the field of T4SSs: do substrates travel through 
the pilus?  Although the isolation of Tra+, Pil- ”uncoupling” mutations establishes that the T-
pili are not necessary for substrate transfer, other investigators suggest that T4SS-encoded 
pili function as conduits for substrate transfer (156, 232, 233).   High-resolution structural 
information about the T-pilus would establish whether the T-pili have a lumen and, if so, 
whether it is of sufficient diameter to accommodate passage of secretion substrates.   
  I invested a large amount of time and effort attempting to purify the T-pilus for 
structural analysis.  Purification proved challenging mainly due to contamination by the 
bacterial flagellum. I tested several purification protocols involving sequential density 
gradient centrifugation, e.g. sucrose and cesium chloride, and differential precipitation using 
excess magnesium chloride. These methods served to enrich the T-pilus, however, 
contaminating flagella were still present. We sent a highly enriched pilus sample to Dr. Joe 
Wall at Brookhaven National Labs for a mass per unit length measurement by scanning 
transmission electron microscope (STEM); this value was essential for use of iterative 
helical real-space reconstruction (IHRSR) software for generating a high resolution 
structure from pilus images collected by transmission electron microscopy. Results of the 
STEM analysis showed that the T-pilus filament appeared to vary in mass per unit length 
measurements. This may be due to an alternating structural arrangement along the length 
of the T-pilus, or to sample degradation or contamination with other fimbriae or flagella   
 I attempted to purify the T-pili from flagellar-minus mutant strains nt1reB (234) and 
fliR (235). However, the flagellar-minus mutant strains elaborate only very low levels of T-
pili (Fig. 7.2).  While exploring the underlying mechanism responsible for the apparent 
coordinated synthesis flagella and T-pili is of interest, the use of flagellar mutants 
complicates efforts to purify T-pili in sufficient amounts for image reconstructions. Future 
studies should explore the possibility of using other ‘bald’ strains or attempting to construct 
a tagged, functional VirB2 variant that could be used for pilus enrichment by affinity 
chromatography followed by other chromatography steps, e.g., gel filtration, to  
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Figure 7.2 Effects of flagella minus mutant on surface display of VirB2 and observed 
T-pili 
Upper panel: fliR mutant displays reduction in extracellular VirB2 release. Extracellular blot 
(surface) assay of flagella minus strain, fliR and negative controls ΔvirB2 and ΔvirB5. WT: 
wild type strain A348. Lower panel: Electron micrographs of T-pili. Isolated T pili from a 
flagella minus strain fliR were stained with 1% Uranyl acetate. Samples were viewed using 
a Joel 1200 microscope. Black bar represents 50nm. Electron micrographs pictures were 
taken by Dr. Angel Paredes PhD from samples I prepared.  
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the purification protocol. With a completely pure sample, images could be collected by 
electron microscopy for IHRSR.    
 Another way to gain structural information about the T-pilus is to refine our knowledge 
of the pilin subunit packing geometry with a combination of SCAM and disulfide crosslinking 
studies with or without oxidative catalysts, e.g., copper phenanthroline or thiol-reactive 
chemical crosslinkers (236, 237).  To date, I characterized a total of 16 Cys-substituted 
pilins.  In addition to the studies reported earlier in this thesis, I assayed for the capacity of 
Cys-substitutions to form disulfide crosslinks in isolated T-pili.  My initial findings support the 
idea that the hydrophobic residues in domain II of adjacent monomers form a packing 
interface.  Those in the hydrophilic domains do not appear to form close contacts with the 
corresponding region of adjacent monomers.  Those of hydrophobic domain IV also do not 
appear to pack against one another, but as noted in Chapter 3, this domain possesses a 
Gly zipper motif which could participate in packing of VirB2 monomers. Therefore, it is 
necessary to introduce additional Cys substitution mutations in this domain for a more 
complete analysis (Fig. 7 3). Ideally, all functional Cys-substituted pilins among the entire 
set of 74 replacements of native residues in the mature pilin would be subjected to the 
types of MPB labeling analyses I carried out thus far. Additionally, for the subunit-subunit 
packing studies by oxidative or chemical crosslinking, it would be necessary to 
combinatorially express pairs of Cys-substituted pilins. These studies would very accurately 
identify residues in the assembled T-pilus that are surface-exposed, exposed in the 
presumptive lumen, and buried in subunit – subunit interfaces.     
 
 Confirm the Dislocase Activity of VirB4 and Identify Regions Required for VirB2-
VirB4 Interaction and Dislocase Activity 
 Scanning cysteine accessibility, immunoprecipitation, and osmotic shock 
experiments all provided evidence that VirB4 functions as a pilin dislocase (chapter 4). 
Future studies should rigorously test this model  by i) assaying for dislocase activity in vitro, 
and  ii) identifying regions of VirB2 and VirB4 required for dislocase activity. VirB4 dislocase 
activity can be tested further by using an in vitro reconstitution assay. Membrane vesicle 
fusion experiments have previously been used to demonstrate and characterize the E. coli 
FtsH dislocase activity (186, 238). Akiyama and Ito (238) showed that fusion of membrane 
vesicles carrying ATPase FtsH with vesicles containing an FtsH substrate resulted in 
translocation and FtsH-mediated degradation of the substrate. We do not think VirB4  
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Figure 7.3 Disulfide crosslinking of Cys-substituted VirB2 in the T-pilus  
Immunoblots of isolated T-pili developed with anti-VirB2 antibodies showing migration of 
native VirB2 and mutant proteins in A) reducing B) non-reducing Tricine SDS-
polyacrylamide gels. Non-reducing conditions in the presence (+) or absence (-) of the 
oxidative crosslinker Copper phenanthroline (Cu-P). 
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functions as a protease, so the FtsH dislocase assay would need to be modified. Initial 
efforts could involve isolating membrane fractions from A. tumefaciens strains producing 
VirB2 alone or VirB4 alone and mixing them together in the presence of PEG to fuse the 
membranes. To assay for pilin release, one could attempt to use differential centrifugation 
to separate the membrane vesicles from the pilin. However, even when released the 
hydrophobic pilin might associate with or even re-integrate into the membrane. It could be 
possible to make use of cysteine labeling to define VirB4-mediated changes in the pilin 
structural state.  Following membrane fusion, addition of MPB might identify exposed Cys 
residues that in the absence of VirB4 are buried from this thiol-reactive reagent.  
VirB4-like ATPases have been found associated with all known T4SSs (15) and 
display similar physical properties such as size and the presence of conserved NTP-binding 
motifs. To examine whether dislocase activity is a common property of VirB4 homologs, 
approaches similar to the ones I used in my studies could be used. Interestingly, the lipid 
composition of the membrane appears to dramatically influence the functionality of several 
bacterial virulence systems (239, 240).  A. tumefaciens mutants lacking the lipid 
phosphatidylcholine were shown to be unable to cause the formation of tumors on plants 
(239). Recently, the ATPase TrwB, a coupling protein from the R388 system and homolog 
of VirD4, was successfully purified and reconstituted into liposome bilayers (241). This 
ATPase was shown to only express specific NTP binding activity when in the presence of a 
membrane environment. These studies indicate that care must be taken when using 
reconstituted liposomes systems in order to maintain proper protein function.  
Another line of study should focus on analyzing VirB2 and VirB4 mutants to define 
regions required for interaction and putative dislocase activity. Our lab has a large number 
of VirB4 truncation and substitution mutants and a growing collection of VirB2 mutants 
available to test for potential loss of interaction as monitored by immunoprecipitation and 
dislocation as monitored by osmotic shock.  I predict that a region of VirB4 that spans the 
inner membrane is required for pilin dislocation via a direct protein-protein interaction.  As 
shown in Chapter 4, I supplied evidence by MPB-labeling for the extramembranous 
location of at least one VirB4 Cys residues.   Further MPB-labeling studies of VirB4 Cys-
modified proteins (lacking some or all of the existing Cys residues, or carrying other Cys 
replacements in putative periplasmic domain(s) would further define the transmembrane 
domain(s) and potentially localize the pilin interaction domain.  Additional mutations in this 
domain could be characterized for effects on the VirB4 - pilin interaction and on pilin 
dislocation.  
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Confirm the Role of the VirB10 AP/BD in T-Pilus Polymerization  
 Results from Chapter 5 and 6 showed that VirB10 has a large influence on the pilus 
biogenesis pathway. Most interestingly, the TM domain, the antennae projection (AP), and 
bridging domain (BD) all appear to selectively contribute to T-pilus formation. Future studies 
should test a model that the VirB10 AP forms the pore through which VirB2 pilin subunits 
exit and actively promotes the polymerization of the T-pilus through direct contact. 
 My data suggest that deletion of the VirB10 AP confers release of VirB2 as 
monomers, aggregates or short polymers. Follow-up studies should analyze the oligomeric 
state of pilin on the surface of these cells by electron microscopy to further define the 
function of the AP in pilus polymerization. A complementary approach would be to 
characterize the structural organization of pilin released by the ΔAP mutant by MPB 
labeling, and compare the labeling profile with that of pilins produced in the functionally 
wild-type strain.  These studies would begin to test our hypothesis that the VirB10 AP 
participates in polymerization of the pilin subunits, perhaps by a strand-exchange method.  
 Further tests of this hypothesis would assay for a VirB2 interaction with VirB10, in 
particular, the AP/BD region. Such an interaction could be detected by 
coimmunoprecipitation (Co-IP) studies in the absence and presence of a protein 
crosslinker. If an interaction were observed, deletion constructs and point mutations would 
be tested in parallel to see if the interaction were disrupted and also, whether or not the 
interaction is dependent on the presence of other VirB proteins, e.g. other core 
components, ATPases, etc. Due to the potentially transient nature of the VirB2-VirB10 
interaction, disulfide crosslinking experiments pairing cysteine substitutions within VirB2 
(see chapter 3) and cysteine substitutions within VirB10 (69) may be more effective at 
trapping a VirB2-VirB10 interaction.  
 If the VirB10 AP region is found to interact with VirB2, future studies should focus on 
defining the requirements for this interaction. The AP region could be expressed as a 
tagged protein fragment and tested for potential interaction with VirB2 via Co-IP and 
protein-pull down assays. This fragment could then be overexpressed in the presence of 
native VirB10 and tested for negative dominance on T-pilus polymerization. Strains bearing 
mutations that permit substrate transfer but block pilus production (Tra+, Pil- ‘uncoupling 
mutations) could also be tested for a loss of VirB2-VirB10 interaction. 
   
 
 
 
138
Determine if Deletion of the AP Domain Changes the Extracellular Localization VirB2 
and VirB5 
The T-pilus form a long thin (~10nm) filament that probably extends from the cell 
pole (104, 121). Immunogold labeling has shown that VirB5 primarily localizes to the tip of 
the T-pilus, while VirB2 extends the entire length of the pilus (121). In future studies, it will 
be important to determine if the AP contributes to the spatial positioning of the pilin or pilus 
at the cell surface.  This could be achieved by analyzing the extracellular distribution of 
VirB2 and VirB5 at the cell surface of wild-type vs. AP mutant strains using a combination of 
immunofluorescence microscopy (IFM) and immunogold labeling paired with electron 
microscopy.  
In previous studies, it was shown that each VirB protein is required for elaboration of 
the T-pilus (104). However, I observed that deletion of virB1 reduces but does not 
completely abolish accumulation of extracellular VirB2, as monitored by the colony blot 
assay and T-pilus shear assay (Fig. 7.4). Interestingly, although in previous studies VirB5 
routinely displayed the same requirements as VirB2 for surface display, I was not able to 
detect VirB5 in a ΔvirB1 mutant with the colony blot assay. I also was able to detect VirB2 
but not VirB5 on the cell surface of the ΔvirB1 mutant by immunoflourescence microscopy, 
even though both VirB2 and VirB5 accumulated at abundant levels in these cells (Fig. 7.5). 
These findings raise the intriguing possibility that VirB1, a lytic transglycosylase (242), may 
participate in polymerization of the pilus. Since my studies highlighted the importance of 
VirB10 for pilus assembly, in future studies it will be interesting to determine whether VirB1 
coordinates with VirB10 for pilus production.  It is conceivable that the ΔAP mutant also 
selectively blocks surface localization of VirB5, or that the ΔvirB1 mutant also releases pilin 
monomers to the extracellular milieu.  I could envision a model in which VirB1 interacts with 
VirB10 to promote delivery of the pilus-tip-associated VirB5 subunit to the VirB10 AP.  This 
reaction would be required as a nucleation event for VirB2 recruitment and polymerization 
into the T-pilus.  In the absence of VirB5-VirB10 AP complex formation, VirB2 pilin would 
not nucleate properly but in certain mutant strains, e.g., channel gating mutants, could still 
be released to the cell surface as monomers, aggregates or short polymers.  In future 
studies, it will be intriguing to define the requirements at the outer membrane involving 
VirB1, VirB5, and the VirB10 AP for pilus polymerization.   
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Figure 7.4 Effects of virB deletion mutations on surface display of VirB2 and VirB5  
A) total cellular material subjected to gel electrophoresis and blot development with anti-
VirB2 or anti-VirB5 antibodies revealing total cellular levels of the protein (cellular); B) 
colony immunoblots developed with anti-VirB2 or anti-VirB5 antibodies showing presence of 
surface-exposed pilin protein (surface); C) extracellular shear fraction subjected to 
ultracentrifugation, gel electrophoresis and immunoblot development with anti-VirB2 or anti-
VirB5 antibodies revealing presence of high-molecular-weight T pilus (shear).  
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Figure 7.5 : Immunofluorsecence assays showing localization VirB2 and VirB5 in the  
 wild-type strain and nonpolar virB1, virB2, and virB5 deletion mutants 
VirB2 and VirB5 localization as monitored by immunofluorescence (IFM). AS-induced cells 
were examined by IFM for VirB2 or B5 localization with Alexa-488- goat anti-rabbit IgG 
probed with anti-VirB2 and anti-VirB5 antibodies. Corresponding DIC images by Nomarski 
microscopy shown below.  VirB2 and VirB5 both display peripheral fluorescence in wild type 
cells, while only VirB2 shows fluorescence in the absence of VirB1. 
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Screen for Effectors From other T4SSs Using ‘Leaky’ Channel Mutant 
The ‘leaky’ channel mutant identified during the screen by the Lois Banta’s lab presents a 
unique tool for identifying new, unknown substrates from related T4SSs. The G272R 
mutation could serve as the genetic context for the introduction of a DNA library containing 
tagged, unknown substrates that, like FLAG-VirE2, could be monitored for release to the 
cell surface using the colony blot assay.  In the limited studies of substrate recognition 
signals, there is evidence that substrates from phylogenitically diverse species carry similar 
secretion motifs (15).   If so, the A. tumefaciens VirB/VirD4 system might be a useful 
surrogate for identification of secretion substrates of T4SSs from bacterial species that are 
not genetically manipulable.  For many human pathogens genetic tools and manipulations 
are not available.  A simple translocation assay based on release of effectors to the A. 
tumefaciens cell surface could prove very useful for identification and characterization of 
T4SS effectors from medically-important pathogens  
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Perspectives 
 This is an exciting time for Type IV secretion systems (T4SS), as major structural 
breakthroughs are providing unprecedented detail about the architecture of these 
extraordinarily complex machines. The structures of the pKM101 outer membrane core 
complex provide excellent detail and allow our field the opportunity to rigorously test the 
structure/function relationship of these complexes and individual domains. Future advances 
in the field will need to continue to rely on a combination of in vivo biochemical analyses 
and in vitro isolation and structural resolution of larger machine subassemblies in order to 
answer difficult questions such as: i) Do T4SS assemble as one vs. two organelles, the 
secretion channel and T-pilus? ii) What is the physical relationship between the secretion 
channel and the T-pilus? iii) Does T-pilus polymerization initiate from the outer membrane 
or inner membrane? iv) What is the mechanism of action of VirB4 in dislocating pilin from 
the inner membrane, and v) What other steps in the biogenesis pathway direct the pilin to 
its final destination in the secretion channel or T-pilus? 
 T4SSs are intimately involved with a number of human and plant pathogens. A major, 
ongoing goal of T4SS research is to discover new ways of preventing these systems from 
contributing to disease progression (17). Many efforts have focused on identifying new 
effector proteins (243, 244), expanding vaccine development (245), and designing small 
molecule inhibitors (246).  Intriguingly, outer membrane-associated and surface-localized 
components of T4SSs have been tested for their ability to induce an immunogenic 
response. In Anaplasma, for example, both VirB10-like and VirB2-like proteins were shown 
to induce an immune response (18, 245, 247).  Determining the principal mechanisms 
responsible for T4SS biogenesis, channel gating, and intercellular translocation or release 
of these proteins to the cell surface or milieu is central to the development of prevention 
and treatment strategies for T4SS-associated diseases.  
 In recent years, significant progress has been made in deciphering underlying 
mechanisms and molecular architectures of paradigmatic T4SSs.  However, the 
identification of new uncharacterized T4SSs through genomic sequencing and in vivo 
screens for virulence factors continues to raise more questions about the broad biological 
functions of these machines in environmental or clinical settings.  Ultimately, structure – 
function studies of many different T4SS’s will be necessary to suppress their action or 
exploit them for novel therapeutic or biotechnological applications.   
 
 
 
145
REFERENCES 
1. Cascales, E., and P. J. Christie. 2003. The versatile bacterial type IV secretion 
systems. Nat. Rev. Microbiol. 1:137-150. 
2. Waksman, G., and R. Fronzes. 2010. Molecular architecture of bacterial type IV 
secretion systems. Trends Biochem. Sci. In press. 
3. Wallden, K., A. Rivera-Calzada, and G. Waksman. Type IV secretion systems: 
versatility and diversity in function. Cell. Microbiol. 12:1203-1212. 
4. Grohmann, E., Muth, G., Espinosa, M. 2003. Conjugative plasmid transfer in Gram-
positive bacteria. Microbiol. Mol. Biol. Rev. 67:277-301. 
5. Schroder, G., and E. Lanka. 2005. The mating pair formation system of conjugative 
plasmids - A versatile secretion machinery for transfer of proteins and DNA. Plasmid 
54:1-25. 
6. Ochman, H., J. G. Lawrence, and E. A. Groisman. 2000. Lateral gene transfer and 
the nature of bacterial innovation. Nature. 405:299-304. 
7. Karnholz, A., C. Hoefler, S. Odenbreit, W. Fischer, D. Hofreuter, and R. Haas. 2006. 
Functional and topological characterization of novel components of the comB DNA 
transformation competence system in Helicobacter pylori. J. Bacteriol. 188:882-893. 
8. Sexton, J. A., and J. P. Vogel. 2002. Type IVB secretion by intracellular pathogens. 
Traffic. 3:178-185. 
9. Hamilton, H. L., N. M. Dominguez, K. J. Schwartz, K. T. Hackett, and J. P. Dillard. 
2005. Neisseria gonorrhoeae secretes chromosomal DNA via a novel type IV 
secretion system. Mol. Microbiol. 55:1704-1721. 
10. Bates, S., A. M. Cashmore, and B. M. Wilkins. 1998. IncP plasmids are unusually 
effective in mediating conjugation of Escherichia coli and Saccharomyces 
cerevisiae. J. Bacteriol. 180:6538-6543. 
11. Bundock, P., D. R. A. den, A. Beijersbergen, and P. J. Hooykaas. 1995. Trans-
kingdom T-DNA transfer from Agrobacterium tumefaciens. EMBO J. 14:3206-3214. 
12. Schrammeijer, B., A. Dulk-Ras Ad, A. C. Vergunst, E. Jurado Jacome, and P. J. 
Hooykaas. 2003. Analysis of Vir protein translocation from Agrobacterium 
tumefaciens using Saccharomyces cerevisiae as a model: evidence for transport of 
a novel effector protein VirE3. Nucl. Acids Res. 31:860-868. 
13. Waters, V. L. 2001. Conjugation between bacterial and mammalian cells. Nat. 
Genet. 29:375-376. 
 
 
146
14. Zhu, J., P. M. Oger, B. Schrammeijer, P. J. Hooykaas, S. K. Farrand, and S. C. 
Winans. 2000. The bases of crown gall tumorigenesis. J. Bacteriol.  182:3885-3895. 
15. Alvarez-Martinez, C. E., and P. J. Christie. 2009. Biological diversity of prokaryotic 
type IV secretion systems. Microbiol. Mol. Biol. Rev. 73:775-808. 
16. Backert, S., and T. F. Meyer. 2006. Type IV secretion systems and their effectors in 
bacterial pathogenesis. Curr. Opin. Microbiol. 9:207-217. 
17. Llosa, M., C. Roy, and C. Dehio. 2009. Bacterial type IV secretion systems in 
human disease. Mol. Microbiol. 73:141-151. 
18. Lopez, J. E., G. H. Palmer, K. A. Brayton, M. J. Dark, S. E. Leach, and W. C. Brown. 
2007. Immunogenicity of Anaplasma marginale type IV secretion system proteins in 
a protective outer membrane vaccine. Infect. Immun. 75:2333-2342. 
19. Saenz, H. L., P. Engel, M. C. Stoeckli, C. Lanz, G. Raddatz, M. Vayssier-Taussat, 
R. Birtles, S. C. Schuster, and C. Dehio. 2007. Genomic analysis of Bartonella 
identifies type IV secretion systems as host adaptability factors. Nat. Genet. 
39:1469-1476. 
20. Cheng, Z., X. Wang, and Y. Rikihisa. 2008. Regulation of type IV secretion 
apparatus genes during Ehrlichia chaffeensis intracellular development by a 
previously unidentified protein. J. Bacteriol. 190:2096-2105. 
21. Gillespie, J. J., N. C. Ammerman, S. M. Dreher-Lesnick, M. S. Rahman, M. J. 
Worley, J. C. Setubal, B. S. Sobral, and A. F. Azad. 2009. An anomalous type IV 
secretion system in Rickettsia is evolutionarily conserved. PLoS ONE. 4:e4833. 
22. Ninio, S., J. Celli, and C. R. Roy. 2009. A Legionella pneumophila effector protein 
encoded in a region of genomic plasticity binds to Dot/Icm-modified vacuoles. PLoS 
Pathog. 5:e1000278. 
23. Fischer, W., R. Haas, and S. Odenbreit. 2002. Type IV secretion systems in 
pathogenic bacteria. Int. J. Med. Microbiol. 292:159-168. 
24. Ding, Z., K. Atmakuri, and P. J. Christie. 2003. The outs and ins of bacterial type IV 
secretion substrates. Trends Microbiol. 11:527-535. 
25. Lai, E. M., and C. I. Kado. 1998. Processed VirB2 is the major subunit of the 
promiscuous pilus of Agrobacterium tumefaciens. J. Bacteriol. 180:2711-2717. 
26. Rohde, M., J. Puls, R. Buhrdorf, W. Fischer, and R. Haas. 2003. A novel sheathed 
surface organelle of the Helicobacter pylori cag type IV secretion system. Mol. 
Microbiol. 49:219-234. 
 
 
147
27. Tanaka, J., T. Suzuki, H. Mimuro, and C. Sasakawa. 2003. Structural definition on 
the surface of Helicobacter pylori type IV secretion apparatus. Cell. Microbiol. 5:395-
404. 
28. Watarai, M., I. Derre, J. Kirby, J. D. Growney, W. F. Dietrich, and R. R. Isberg. 2001. 
Legionella pneumophila is internalized by a macropinocytotic uptake pathway 
controlled by the Dot/Icm system and the mouse Lgn1 locus. J. Exp. Med, 
194:1081-1096. 
29. Judd, P. K., R. B. Kumar, and A. Das. 2005. Spatial location and requirements for 
the assembly of the Agrobacterium tumefaciens type IV secretion apparatus. Proc. 
Natl. Acad. Sci. U.S.A. 102:11498-11503. 
30. Fronzes, R., P. J. Christie, and G. Waksman. 2009. The structural biology of type IV 
secretion systems. Nat. Rev. Microbiol.  7:703-714. 
31. Kalkum, M., R. Eisenbrandt, and E. Lanka. 2004. Protein circlets as sex pilus 
subunits. Curr. Protein Pept. Sci. 5:417-424. 
32. Christie, P. J. 2004. Bacterial type IV secretion: The Agrobacterium VirB/D4 and 
related conjugation systems. Biochem. Biophys. Acta. 1694:219-234. 
33. Douglas, C. J., W. Halperin, and E. W. Nester. 1982. Agrobacterium tumefaciens 
mutants affected in attachment to plant cells. J. Bacteriol. 152:1265-1275. 
34. Lippincott, B. B., and J. A. Lippincott. 1969. Bacterial attachment to a specific wound 
site as an essential stage in tumor initiation by Agrobacterium tumefaciens. J. 
Bacteriol. 97:620-628. 
35. Lai, E. M., H. W. Shih, S. R. Wen, M. W. Cheng, H. H. Hwang, and S. H. Chiu. 
2006. Proteomic analysis of Agrobacterium tumefaciens response to the Vir gene 
inducer acetosyringone. Proteomics. 6:4130-4136. 
36. Dehio, C. 2008. Infection-associated type IV secretion systems of Bartonella and 
their diverse roles in host cell interaction. Cell. Microbiol. 10:1591-1598. 
37. Ninio, S., and C. R. Roy. 2007. Effector proteins translocated by Legionella 
pneumophila: strength in numbers. Trends Microbiol. 15:372-380. 
38. Gao, R., A. Mukhopadhyay, F. Fang, and D. G. Lynn. 2006. Constitutive activation 
of two-component response regulators: characterization of VirG activation in 
Agrobacterium tumefaciens. J.  Bacteriol. 188:5204-5211. 
39. Christie, P. J., K. Atmakuri, V. Krishnamoorthy, S. Jakubowski, and E. Cascales. 
2005. Biogenesis, architecture, and function of bacterial type IV secretion systems. 
Annu. Rev. Microbiol. 59:451-485. 
 
 
148
40. Zhu, J., P. M. Oger, B. Schrammeijer, P. J. Hooykaas, S. K. Farrand, and S. C. 
Winans. 2000. The bases of crown gall tumorigenesis. J. Bacteriol. 182:3885-3895. 
41. Christie, P. J. 2000. Agrobacterium  and plant cell transformation. In Encyclopedia 
of Microbiology, Second ed. J. Lederberg, ed. Academic Press, San Diego, CA. 86-
103. 
42. Tzfira, T. 2006. On tracks and locomotives: the long route of DNA to the nucleus. 
Trends Microbiol. 14:61-63. 
43. Tzfira, T., and V. Citovsky. 2006. Agrobacterium-mediated genetic transformation of 
plants: biology and biotechnology. Curr. Opin. Biotech. 17:147-154. 
44. Tzfira, T., J. Li, B. Lacroix, and V. Citovsky. 2004. Agrobacterium T-DNA integration: 
molecules and models. Trends Genet. 20:375-383. 
45. Atmakuri, K., E. Cascales, and P. J. Christie. 2004. Energetic components VirD4, 
VirB11 and VirB4 mediate early DNA transfer reactions required for bacterial type IV 
secretion. Mol. Microbiol. 54:1199-1211. 
46. de Vos, G., and P. Zambryski. 1989. Expression of Agrobacterium nopaline-specific 
VirD1, VirD2, and VirC1 proteins and their requirement for T-strand production in E. 
coli. Mol. Plant Microbe Inter. 2:43-52. 
47. Christie, P. J., J. E. Ward, S. C. Winans, and E. W. Nester. 1988. The 
Agrobacterium tumefaciens virE2  gene product is a single-stranded-DNA-binding 
protein that associates with T-DNA. J Bacteriol. 170:2659-2667. 
48. Das, A. 1988. Agrobacterium tumefaciens virE operon encodes a single-stranded 
DNA-binding protein. Proc. Natl. Acad. Sci. U.S.A. 85:2909-2913. 
49. Citovsky, V., D. Warnick, and P. Zambryski. 1994. Nuclear import of Agrobacterium  
VirD2 and VirE2 proteins in maize and tobacco. Proc. Natl. Acad. Sci. U.S.A. 
91:3210-3214. 
50. Citovsky, V., M. L. Wong, and P. Zambryski. 1989. Cooperative interaction of 
Agrobacterium  VirE2 protein with single-stranded DNA: implications for the T-DNA 
transfer process. Proc. Natl. Acad. Sci. U.S.A. 86:1193-1197. 
51. Citovsky, V., J. Zupan, D. Warnick, and P. Zambryski. 1992. Nuclear localization of 
Agrobacterium  VirE2 protein in plant cells. Science. 256:1802-1805. 
52. Lacroix, B., M. Vaidya, T. Tzfira, and V. Citovsky. 2004. The VirE3 protein of 
Agrobacterium mimics a host cell function required for plant genetic transformation. 
EMBO J. 24: 428-37. 
 
 
149
53. Tzfira, T., M. Vaidya, and V. Citovsky. 2004. Involvement of targeted proteolysis in 
plant genetic transformation by Agrobacterium. Nature. 431:87-92. 
54. McCullen, C. A., and A. N. Binns. 2006. Agrobacterium tumefaciens plant cell 
Interactions and activities required for interkingdom macromolecular transfer. Annu 
Rev. Cell. Dev. Biol. 22:101-127. 
55. Sundberg, C., L. Meek, K. Carroll, A. Das, and W. Ream. 1996. VirE1 protein 
mediates export of the single-stranded DNA-binding protein VirE2 from 
Agrobacterium tumefaciens into plant cells. J. Bacteriol. 178:1207-1212. 
56. Regensburg, T. A., and P. J. Hooykaas. 1993. Transgenic N. glauca plants 
expressing bacterial virulence gene virF are converted into hosts for nopaline strains 
of A. tumefaciens. Nature. 363:69-71. 
57. Vergunst, A. C., M. C. van Lier, A. den Dulk-Ras, T. A. Grosse Stuve, A. Ouwehand, 
and P. J. Hooykaas. 2005. Positive charge is an important feature of the C-terminal 
transport signal of the VirB/D4-translocated proteins of Agrobacterium. Proc. Natl. 
Acad. Sci. U.S.A. 102:832-837. 
58. Cascales, E., and P. J. Christie. 2004. Definition of a bacterial type IV secretion 
pathway for a DNA substrate. Science. 304:1170-1173. 
59. Atmakuri, K., Z. Ding, and P. J. Christie. 2003. VirE2, a type IV secretion substrate, 
interacts with the VirD4 transfer protein at cell poles of Agrobacterium tumefaciens. 
Mol. Microbiol. 49:1699-1713. 
60. Fullner, K. J. 1998. Role of Agrobacterium virB genes in transfer of T complexes 
and RSF1010. J. Bacteriol. 180:430-434. 
61. Beijersbergen, A., A. D. Dulk-Ras, R. A. Schilperoort, and P. J. J. Hooykas. 1992. 
Conjugative transfer by the virulence system of Agrobacterium tumefaciens. 
Science. 256:1324-1327. 
62. Cascales, E., K. Atmakuri, Z. Liu, A. N. Binns, and P. J. Christie. 2005. 
Agrobacterium tumefaciens oncogenic suppressors inhibit T-DNA and VirE2 protein 
substrate binding to the VirD4 coupling protein. Mol. Microbiol. 58:565-579. 
63. Binns, A. N., C. E. Beaupre, and E. M. Dale. 1995. Inhibition of VirB-mediated 
transfer of diverse substrates from Agrobacterium tumefaciens by the IncQ plasmid 
RSF1010. J.  Bacteriol. 177:4890-4899. 
64. Buchanan-Wollaston, V., J. E. Passiatore, and F. Cannon. 1987. The mob and oriT 
mobilization functions of a bacterial plasmid promote its transfer to plants. Nature. 
328:172-175. 
 
 
150
65. Jakubowski, S. J., V. Krishnamoorthy, E. Cascales, and P. J. Christie. 2004. 
Agrobacterium tumefaciens VirB6 domains direct the ordered export of a DNA 
substrate through a type IV secretion system. J. Molec. Biol. 341:961-977. 
66. Mossey, P., A. Hudacek, and A. Das. Agrobacterium tumefaciens type IV secretion 
protein VirB3 is an inner membrane protein and requires VirB4, VirB7, and VirB8 for 
stabilization. J. Bacteriol. 192:2830-2838. 
67. Fronzes, R., E. Schafer, L. Wang, H. R. Saibil, E. V. Orlova, and G. Waksman. 
2009. Structure of a type IV secretion system core complex. Science. 323:266-268. 
68. Chandran, V., R. Fronzes, S. Duquerroy, N. Cronin, J. Navaza, and G. Waksman. 
2009. Structure of the outer membrane complex of a type IV secretion system. 
Nature. 462:1011-1015. 
69. Jakubowski, S. J., J. E. Kerr, I. Garza, V. Krishnamoorthy, R. Bayliss, G. Waksman, 
and P. J. Christie. 2009. Agrobacterium VirB10 domain requirements for type IV 
secretion and T pilus biogenesis. Mol. Microbiol. 71:779-794. 
70. Saier, M. H., Jr. 2003. Tracing pathways of transport protein evolution. Mol. 
Microbiol. 48:1145-1156. 
71. Das, A., and Y.-H. Xie. 2000. The Agrobacterium T-DNA transport pore proteins 
VirB8, VirB9, and VirB10 interact with one another. J. Bacteriol. 182:758-763. 
72. Sivanesan, D., M. A. Hancock, A. M. Villamil Giraldo, and C. Baron. Quantitative 
analysis of VirB8-VirB9-VirB10 interactions provides a dynamic model of type IV 
secretion system core complex assembly. Biochemistry. 49:4483-4493. 
73. Terradot, L., R. Bayliss, C. Oomen, Leonard., C. Baron, and G. Waksman. 2005. 
Structures of two core subunits of the bacterial type IV secretion system, VirB8 from 
Brucella suis and ComB10 from Helicobacter pylori. Proc. Natl. Acad. Sci. U.S.A. 
102:4956-4961. 
74. Spudich, G. M., D. Fernandez, X. R. Zhou, and P. J. Christie. 1996. Intermolecular 
disulfide bonds stabilize VirB7 homodimers and VirB7/VirB9 heterodimers during 
biogenesis of the Agrobacterium tumefaciens T-complex transport apparatus. Proc. 
Natl. Acad. Sci. U. S. A. 93:7512-7517. 
75. Anderson, L. B., A. V. Hertzel, and A. Das. 1996. Agrobacterium tumefaciens  VirB7 
and VirB9 form a  disulfide-linked protein complex. Proc.  Natl. Acad. Sci. U.S.A. 
93:8889-8894. 
 
 
151
76. Bailey, S., D. Ward, R. Middleton, J. G. Grossmann, and P. C. Zambryski. 2006. 
Agrobacterium tumefaciens VirB8 structure reveals potential protein-protein 
interaction sites. Proc. Natl. Acad. Sci. U.S.A. 103:2582-2587. 
77. Kumar, R. B., Y. H. Xie, and A. Das. 2000. Subcellular localization of the 
Agrobacterium tumefaciens T-DNA transport pore proteins: VirB8 is essential for the 
assembly of the transport pore. Mol. Microbiol. 36:608-617. 
78. Cao, T. B., and M. H. Saier, Jr. 2001. Conjugal type IV macromolecular transfer 
systems of Gram-negative bacteria: organismal distribution, structural constraints 
and evolutionary conclusions. Microbiology (Reading, England) 147:3201-3214. 
79. Chu, B. C., R. S. Peacock, and H. J. Vogel. 2007. Bioinformatic analysis of the 
TonB protein family. Biometals 20:467-483. 
80. Fronzes, R., P. J. Christie, and G. Waksman. 2009. Structural biology of type IV 
secretion systems. Nature Rev. Microbiol. 7: 703-14. 
81. Waksman, G., and R. Fronzes. 2010 Molecular architecture of bacterial type IV 
secretion systems. Trends Biochem. Sci. In press. 
82. Jakubowski, S. J., V. Krishnamoorthy, and P. J. Christie. 2003. Agrobacterium 
tumefaciens VirB6 protein participates in formation of VirB7 and VirB9 complexes 
required for type IV secretion. J. Bacteriol. 185:2867-2878. 
83. Cascales, E., and P. J. Christie. 2004. Agrobacterium VirB10, an ATP energy 
sensor required for type IV secretion. Proc. Natl. Acad. Sci. U. S. A. 101:17228-
17233. 
84. Rashkova, S., Zhou, X.-R.,  Christie, P. J. 2000. Self-assembly of the Agrobacterium 
tumefaciens VirB11 traffic ATPase. J. Bacteriol. 182:4137-4145. 
85. Yeo, H. J., S. N. Savvides, A. B. Herr, E. Lanka, and G. Waksman. 2000. Crystal 
structure of the hexameric traffic ATPase of the Helicobacter pylori type IV secretion 
system. Mol. Cell. 6:1461-1472. 
86. Hare, S., R. Bayliss, C. Baron, and G. Waksman. 2006. A large domain swap in the 
VirB11 ATPase of Brucella suis leaves the hexameric assembly intact. J. Mol. Biol. 
360:56-66. 
87. Sagulenko, Y., V. Sagulenko, J. Chen, and P. J. Christie. 2001. Role of 
Agrobacterium VirB11 ATPase in T-pilus assembly and substrate selection. J. 
Bacteriol. 183:5813-5825. 
 
 
152
88. Sexton, J. A., J. S. Pinkner, R. Roth, J. E. Heuser, S. J. Hultgren, and J. P. Vogel. 
2004. The Legionella pneumophila PilT homologue DotB exhibits ATPase activity 
that is critical for intracellular growth. J. Bacteriol. 186:1658-1666. 
89. Stephens, K. M., C. Roush, and E. Nester. 1995. Agrobacterium tumefaciens VirB11 
protein reqiures a consensus nucleotide-binding site for function in virulence. J. 
Bacteriol. 177:27-36. 
90. Rashkova, S., G. M. Spudich, and P. J. Christie. 1997. Characterization of 
membrane and protein interaction determinants of the Agrobacterium tumefaciens 
VirB11 ATPase. J. Bacteriol. 179:583-591. 
91. Turner, L. R., J. C. Lara, D. N. Nunn, and S. Lory. 1993. Mutations in the consensus 
ATP-binding sites of XcpR and PilB eliminate extracellular protein secretion and 
pilus biogenesis in Pseudomonas aeruginosa. J. Bacteriol. 175:4962-4969. 
92. Rivas, S., S. Bolland, E. Cabezon, F. M. Goni, and F. de la Cruz. 1997. TrwD, a 
protein encoded by the IncW plasmid R388, displays an ATP hydrolase activity 
essential for bacterial conjugation. J. Biol. Chem. 272:25583-25590. 
93. Schroder, G., S. Krause, E. L. Zechner, B. Traxler, H. J. Yeo, R. Lurz, G. Waksman, 
and E. Lanka. 2002. TraG-like proteins of DNA transfer systems and of the 
Helicobacter pylori type IV secretion system: inner membrane gate for exported 
substrates? J. Bacteriol. 184:2767-2779. 
94. Schroder, G., and E. Lanka. 2003. TraG-like proteins of type IV secretion systems: 
functional dissection of the multiple activities of TraG (RP4) and TrwB (R388). J. 
Bacteriol. 185:4371-4381. 
95. Gomis-Ruth, F. X., F. de la Cruz, and M. Coll. 2002. Structure and role of coupling 
proteins in conjugal DNA transfer. Res. Microbiol. 153:199-204. 
96. Gomis-Ruth, F. X., M. Sola, F. de la Cruz, and M. Coll. 2004. Coupling factors in 
macromolecular type-IV secretion machineries. Curr. Pharm. Des. 10:1551-1565. 
97. Gomis-Ruth, F. X., G. Moncalian, R. Perez-Luque, A. Gonzalez, E. Cabezon, F. de 
la Cruz, and M. Coll. 2001. The bacterial conjugation protein TrwB resembles ring 
helicases and F1- ATPase. Nature. 409:637-641. 
98. Gomis-Ruth, F. X., G. Moncalian, F. de la Cruz, and M. Coll. 2002. Conjugative 
plasmid protein TrwB, an integral membrane type IV secretion system coupling 
protein. Detailed structural features and mapping of the active site cleft. J. Biol. 
Chem. 277:7556-7566. 
 
 
153
99. Balzer, D., W. Pansegrau, and E. Lanka. 1994. Essential motifs of relaxase (TraI) 
and TraG proteins involved in conjugative transfer of plasmid RP4. J. Bacteriol. 
176:4285-4295. 
100. Lin, T. S., and C. I. Kado. 1993. The virD4 gene is required for virulence while virD3 
and orf5 are not required for virulence of Agrobacterium tumefaciens. Mol. Microbiol. 
9:803-812. 
101. Gunton, J. E., M. W. Gilmour, G. Alonso, and D. E. Taylor. 2005. Subcellular 
localization and functional domains of the coupling protein, TraG, from IncHI1 
plasmid R27. Microbiology. 151:3549-3561. 
102. Matilla, I., C. Alfonso, G. Rivas, E. L. Bolt, F. de la Cruz, and E. Cabezon. The 
conjugative DNA translocase TrwB is a structure-specific DNA-binding protein. The 
J. Biol Chem. 285:17537-17544. 
103. Atmakuri, K., E. Cascales, O. T. Burton, L. M. Banta, and P. J. Christie. 2007. 
Agrobacterium ParA/MinD-like VirC1 spatially coordinates early conjugative DNA 
transfer reactions. EMBO J. 26:2540-2551. 
104. Lai, E. M., O. Chesnokova, L. M. Banta, and C. I. Kado. 2000. Genetic and 
environmental factors affecting T-pilin export and T-pilus biogenesis in relation to 
flagellation of Agrobacterium tumefaciens. J. Bacteriol. 182:3705-3716. 
105. Dang, T. A., and P. J. Christie. 1997. The VirB4 ATPase of Agrobacterium 
tumefaciens is a cytoplasmic membrane protein exposed at the periplasmic surface. 
J. Bacteriol. 179:453-462. 
106. Dang, T. A., X. R. Zhou, B. Graf, and P. J. Christie. 1999. Dimerization of the 
Agrobacterium tumefaciens VirB4 ATPase and the effect of ATP-binding cassette 
mutations on the assembly and function of the T-DNA transporter. Mol. Microbiol. 
32:1239-1253. 
107. Draper, O., R. Middleton, M. Doucleff, and P. C. Zambryski. 2006. Topology of the 
VirB4 C-terminus in the agrobacterium tumefaciens VirB/D4 type IV secretion 
system. J. Biol. Chem. 281:37628-37635. 
108. Middleton, R., K. Sjolander, N. Krishamurthy, J. Foley, and P. Zambryski. 2005. 
Predicted hexameric structure of the Agrobacterium VirB4 C-terminus suggests 
VirB4 acts as a docking site during type IV secretion. Proc. Natl. Acad. Sci U. S. A. 
102:1685-1690. 
109. Arechaga, I., A. Pena, S. Zunzunegui, M. del Carmen Fernandez-Alonso, G. Rivas, 
and F. de la Cruz. 2008. ATPase activity and oligomeric state of TrwK, the VirB4 
 
 
154
homologue of the plasmid R388 type IV secretion system. J. Bacteriol. 190:5472-
5479. 
110. Durand, E., C. Oomen, and G. Waksman. Biochemical dissection of the ATPase 
TraB, the VirB4 homologue of the Escherichia coli pKM101 conjugation machinery. 
J. Bacteriol.192:2315-2323. 
111. Rabel, C., A. M. Grahn, R. Lurz, and E. Lanka. 2003. The VirB4 family of proposed 
traffic nucleoside triphosphatases: common motifs in plasmid RP4 TrbE are 
essential for conjugation and phage adsorption. J. Bacteriol. 185:1045-1058. 
112. Fullner, K. J., K. M. Stephens, and E. W. Nester. 1994. An essential virulence 
protein of Agrobacterium tumefaciens, VirB4, requires an intact mononucleotide 
binding domain to function in transfer of T-DNA. Molec. Gen. Genetics. 245:704-
715. 
113. Shirasu, K., N. Z. Koukolikova, B. Hohn, and C. I. Kado. 1994. An inner-membrane-
associated virulence protein essential for T-DNA transfer from Agrobacterium 
tumefaciens to plants exhibits ATPase activity and similarities to conjugative transfer 
genes. Mol. Microbiol. 11:581-588. 
114. Schmidt-Eisenlohr, H., D. N., A. C., G. Wanner, P. C. Zambryski, and C. Baron. 
1999. Vir proteins stabilize VirB5 and mediate its association with the T pilus of 
Agrobacterium tumefaciens. J. Bacteriol. 181:7485-7492. 
115. Eisenbrandt, R., M. Kalkum, E. M. Lai, R. Lurz, C. I. Kado, and E. Lanka. 1999. 
Conjugative pili of IncP plasmids, and the Ti plasmid T pilus are composed of cyclic 
subunits. J. Biol. Chem. 274:22548-22555. 
116. Lai, E. M., and C. I. Kado. 2000. The T-pilus of Agrobacterium tumefaciens. Trends 
Microbiol. 8:361-369. 
117. Lai, E. M., R. Eisenbrandt, M. Kalkum, E. Lanka, and C. I. Kado. 2002. Biogenesis 
of T pili in Agrobacterium tumefaciens requires precise VirB2 propilin cleavage and 
cyclization. J. Bacteriol. 184:327-330. 
118. Jones, A. L., E.-M. Lai, K. Shirasu, and C. I. Kado. 1996. VirB2 is a processed pilin-
like protein encoded by the Agrobacterium tumefaciens Ti plasmid. J. Bacteriol. 
178:5706-5711. 
119. Matthysse, A. G. 1987. Characterization of nonattaching mutants of Agrobacterium. 
J. Bacteriol. 169:313-323. 
 
 
155
120. Hwang, H. H., and S. B. Gelvin. 2004. Plant proteins that interact with VirB2, the 
Agrobacterium tumefaciens pilin protein, mediate plant transformation. Plant Cell. 
16:3148-3167. 
121. Aly, K. A., and C. Baron. 2007. The VirB5 protein localizes to the T-pilus tips in 
Agrobacterium tumefaciens. Microbiology. 153:3766-3775. 
122. Yuan, Q., A. Carle, C. Gao, D. Sivanesan, K. A. Aly, C. Hoppner, L. Krall, N. 
Domke, and C. Baron. 2005. Identification of the VirB4-VirB8-VirB5-VirB2 pilus 
assembly sequence of type IV secretion systems. J. Biol. chem. 280:26349-26359. 
123. Jakubowski, S. J., E. Cascales, V. Krishnamoorthy, and P. J. Christie. 2005. 
Agrobacterium tumefaciens VirB9, an outer-membrane-associated component of a 
type IV secretion system, regulates substrate selection and T-pilus biogenesis. J. 
Bacteriol. 187:3486-3495. 
124. Baron, C., M. Llosa, S. Zhou, and Patricia C. Zambrysk. 1997. VirB1, a component 
of the T-complex transfer machinery of Agrobacterium tumefaciens, is processed to 
a C-terminal secreted product, VirB1*. J. Bacteriol. 179: 1203-1210. 
125. Hoppner, C., Z. Liu, N. Domke, A. N. Binns, and C. Baron. 2004. VirB1 orthologs 
from Brucella suis and pKM101 complement defects of the lytic transglycosylase 
required for efficient type IV secretion from Agrobacterium tumefaciens. J. Bacteriol. 
186:1415-1422. 
126. Zupan, J., C. A. Hackworth, J. Aguilar, D. Ward, and P. Zambryski. 2007. VirB1* 
promotes T-pilus formation in the vir-Type IV secretion system of Agrobacterium 
tumefaciens. J. Bacteriol. 189:6551-6563. 
127. Fullner, K. J., J. C. Lara, and E. W. Nester. 1996. Pilus assembly by Agrobacterium 
T-DNA transfer genes. Science. 273:1107-1109. 
128. Berger, B. R., and P. J. Christie. 1994. Genetic complementation analysis of the 
Agrobacterium tumefaciens virB operon: virB2 through virB11 are essential 
virulence genes. J. Bacteriol. 176:3646-3660. 
129. Jayaraman, K., S. A. Fingar, J. Shah, and J. Fyles. 1991. Polymerase chain 
reaction-mediated gene synthesis: synthesis of a gene coding for isozyme c of 
horseradish peroxidase. Proc. Natl. Acad. Sci. U.S.A. 88:4084-4088. 
130. Kerr, J. E., and P. J. Christie. 2010. Evidence for VirB4-mediated dislocation of 
membrane-integrated VirB2 pilin during biogenesis of the Agrobacterium VirB/VirD4 
type IV secretion system. J. Bacteriol. 192:4923-4934. 
 
 
156
131. Garfinkel, D. J., R. B. Simpson, L. W. Ream, F. F. White, M. P. Gordon, and E. W. 
Nester. 1981. Genetic analysis of crown gall: fine structure map of the T-DNA by 
site-directed mutagenesis. Cell. 27:143-153. 
132. Fernandez, D., G. M. Spudich, X. R. Zhou, and P. J. Christie. 1996. The 
Agrobacterium tumefaciens VirB7 lipoprotein is required for stabilization of VirB 
proteins during assembly of the T-complex transport apparatus. J. Bacteriol. 
178:3168-3176. 
133. Berger, B. R., and P. J. Christie. 1993. The Agrobacterium tumefaciens virB4 gene 
product is an essential virulence protein requiring an intact nucleoside triphosphate-
binding domain. J. Bacteriol. 175:1723-1734. 
134. Zhou, X.-R., and P. J. Christie. 1999. Mutagenesis of Agrobacterium VirE2 single-
stranded DNA-binding protein identifies regions required for self-association and 
interaction with VirE1 and a permissive site for hybrid protein construction. J. 
Bacteriol. 181:4342-4352. 
135. Kovach, M. E., R. W. Phillips, P. H. Elzer, R. M. Roop, 2nd, and K. M. Peterson. 
1994. pBBR1MCS: a broad-host-range cloning vector. Biotechniques. 16:800-802. 
136. Zhou, X.-R., and P. J. Christie. 1997. Suppression of mutant phenotypes of the 
Agrobacterium tumefaciens VirB11 ATPase by overproduction of VirB proteins. J. 
Bacteriol. 179:5835-5842. 
137. Fernandez, D., T. A. Dang, G. M. Spudich, X. R. Zhou, B. R. Berger, and P. J. 
Christie. 1996. The Agrobacterium tumefaciens virB7 gene product, a proposed 
component of the T-complex transport apparatus, is a membrane-associated 
lipoprotein exposed at the periplasmic surface. J. Bacteriol. 178:3156-3167. 
138. Sagulenko, V., E. Sagulenko, S. Jakubowski, E. Spudich, and P. J. Christie. 2001. 
VirB7 lipoprotein is exocellular and associates with the Agrobacterium tumefaciens 
T pilus. J. Bacteriol. 183:3642-3651. 
139. Lazzaroni, J. C., and R. C. Portalier. 1981. Genetic and biochemical 
characterization of periplasmic-leaky mutants of Escherichia coli K-12. J. Bacteriol. 
145:1351-1358. 
140. Chen, J., K. S. de Felipe, M. Clarke, H. Lu, O. R. Anderson, G. Segal, and H. A. 
Shuman. 2004. Legionella effectors that promote nonlytic release from protozoa. 
Science. 303:1358-1361. 
 
 
157
141. Schmidt-Eisenlohr, H., N. Domke, and C. Baron. 1999. TraC of IncN plasmid 
pKM101 associates with membranes and extracellular high-molecular-weight 
structures in Escherichia coli. J. Bacteriol. 181:5563-5571. 
142. Haase, J., and E. Lanka. 1997. A specific protease encoded by the conjugative DNA 
transfer systems of IncP and Ti plasmids is essential for pilus synthesis. J. Bacteriol. 
179:5728-5735. 
143. Kalkum, M., R. Eisenbrandt, R. Lurz, and E. Lanka. 2002. Tying rings for sex. 
Trends Microbiol. 10:382-387. 
144. Moore, D., C. M. Hamilton, K. Maneewannakul, Y. Mintz, L. S. Frost, and K. Ippen-
Ihler. 1993. The Escherichia coli K-12 F plasmid gene traX is required for acetylation 
of F pilin. J. Bacteriol. 175:1375-1383. 
145. Wang, Y. A., X. Yu, P. M. Silverman, R. L. Harris, and E. H. Egelman. 2009. The 
structure of F-pili. J. Molec Biol. 385:22-29. 
146. Bogdanov, M., W. Zhang, J. Xie, and W. Dowhan. 2005. Transmembrane protein 
topology mapping by the substituted cysteine accessibility method (SCAM(TM)): 
application to lipid-specific membrane protein topogenesis. Methods. 36:148-171. 
147. Ott, C. M., and V. R. Lingappa. 2002. Integral membrane protein biosynthesis: why 
topology is hard to predict. J. Cell Sci. 115:2003-2009. 
148. Persson, B., and P. Argos. 1997. Prediction of membrane protein topology utilizing 
multiple sequence alignments. J. Prot. Chem. 16:453-457. 
149. van Geest, M., and J. S. Lolkema. 2000. Membrane topology and insertion of 
membrane proteins: search for topogenic signals. Microbiol. Mol. Biol. Rev. 64:13-
33. 
150. Baron, C., N. Domke, M. Beinhofer, and S. Hapfelmeier. 2001. Elevated 
Temperature Differentially Affects Virulence, VirB Protein Accumulation, and T-Pilus 
Formation in Different Agrobacterium tumefaciens and Agrobacterium vitis Strains. 
J. Bacteriol. 183:6852-6861. 
151. Kado, C. I. 1994. Promiscuous DNA transfer system of Agrobacterium tumefaciens : 
role of the virB operon in sex pilus assembly and synthesis. Mol. Microbiol. 12:17-
22. 
152. Paiva, W. D., T. Grossman, and P. M. Silverman. 1992. Characterization of F-pilin 
as an inner membrane component of Escherichia coli K12. J. Biol. Chem.  
267:26191-26197. 
 
 
158
153. Long, J. C., S. Wang, and S. B. Vik. 1998. Membrane topology of subunit a of the 
F1F0 ATP synthase as determined by labeling of unique cysteine residues. J. Biol. 
Chem. 273:16235-16240. 
154. Loo, T. W., and D. M. Clarke. 1995. Membrane topology of a cysteine-less mutant of 
human P-glycoprotein. J. Biol. Chem. 270:843-848. 
155. Bogdanov, M., J. Xie, P. Heacock, and W. Dowhan. 2008. To flip or not to flip: lipid-
protein charge interactions are a determinant of final membrane protein topology. J. 
Cell Biol. 182:925-935. 
156. Lai, E. M., and C. I. Kado. 2002. The Agrobacterium tumefaciens T pilus composed 
of cyclic T pilin is highly resilient to extreme environments. FEMS Microbiol. Lett. 
210:111-114. 
157. von Heijne, G., and C. Manoil. 1990. Membrane proteins: from sequence to 
structure. Protein Eng. 4:109-112. 
158. Beijersbergen, A., S. J. Smith, and P. J. Hooykaas. 1994. Localization and topology 
of VirB proteins of Agrobacterium tumefaciens. Plasmid. 32:212-218. 
159. Das, A., and Y. H. Xie. 1998. Construction of transposon Tn3phoA: its application in 
defining the membrane topology of the Agrobacterium tumefaciens DNA transfer 
proteins. Mol. Microbiol. 27:405-414. 
160. Eisenbrandt, R., M. Kalkum, R. Lurz, and E. Lanka. 2000. Maturation of IncP pilin 
precursors resembles the catalytic Dyad-like mechanism of leader peptidases. J. 
Bacteriol. 182:6751-6761. 
161. Manchak, J., K. G. Anthony, and L. S. Frost. 2002. Mutational analysis of F-pilin 
reveals domains for pilus assembly, phage infection and DNA transfer. Mol. 
Microbiol.  43:195-205. 
162. Culham, D. E., A. Hillar, J. Henderson, A. Ly, Y. I. Vernikovska, K. I. Racher, J. M. 
Boggs, and J. M. Wood. 2003. Creation of a fully functional cysteine-less variant of 
osmosensor and proton-osmoprotectant symporter ProP from Escherichia coli and 
its application to assess the transporter's membrane orientation. Biochemistry. 
42:11815-11823. 
163. Bogdanov, M., J. Xie, and W. Dowhan. 2009. Lipid-protein interactions drive 
membrane protein topogenesis in accordance with the positive inside rule. J. Biol. 
Chem. 284:9637-9641. 
164. von Heijne, G., and Y. Gavel. 1988. Topogenic signals in integral membrane 
proteins. Eurp. J Biochem.  FEBS.  174:671-678. 
 
 
159
165. Rondot, S., K. G. Anthony, S. Dubel, N. Ida, S. Wiemann, K. Beyreuther, L. S. Frost, 
M. Little, and F. Breitling. 1998. Epitopes fused to F-pilin are incorporated into 
functional recombinant pili. J. Mol. Biol. 279:589-603. 
166. Frost, L. S., and W. Paranchych. 1988. DNA sequence analysis of point mutations 
in traA, the F pilin gene, reveal two domains involved in F-specific bacteriophage 
attachment. Mol. Gen. Genet. 213:134-139. 
167. Russ, W. P., and D. M. Engelman. 2000. The GxxxG motif: a framework for 
transmembrane helix-helix association. J. Mol. Biol. 296:911-919. 
168. Senes, A., M. Gerstein, and D. M. Engelman. 2000. Statistical analysis of amino 
acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in 
association with beta-branched residues at neighboring positions. J. Mol.Biol. 
296:921-936. 
169. Bass, R. B., P. Strop, M. Barclay, and D. C. Rees. 2002. Crystal structure of 
Escherichia coli MscS, a voltage-modulated and mechanosensitive channel. 
Science.  298:1582-1587. 
170. Chang, G., R. H. Spencer, A. T. Lee, M. T. Barclay, and D. C. Rees. 1998. Structure 
of the MscL homolog from Mycobacterium tuberculosis: a gated mechanosensitive 
ion channel. Science. 282:2220-2226. 
171. Fu, D., A. Libson, L. J. Miercke, C. Weitzman, P. Nollert, J. Krucinski, and R. M. 
Stroud. 2000. Structure of a glycerol-conducting channel and the basis for its 
selectivity. Science. 290:481-486. 
172. Fu, D., A. Libson, and R. Stroud. 2002. The structure of GlpF, a glycerol conducting 
channel. Novartis Foundation symposium 245:51-61; discussion 61-55, 165-168. 
173. Kleiger, G., R. Grothe, P. Mallick, and D. Eisenberg. 2002. GXXXG and AXXXA: 
common alpha-helical interaction motifs in proteins, particularly in extremophiles. 
Biochemistry. 41:5990-5997. 
174. Kim, S., T. J. Jeon, A. Oberai, D. Yang, J. J. Schmidt, and J. U. Bowie. 2005. 
Transmembrane glycine zippers: physiological and pathological roles in membrane 
proteins. Proc. Natl. Acad. Sci. U.S.A.102:14278-14283. 
175. Grossman, T. H., L. S. Frost, and P. M. Silverman. 1990. Structure and function of 
conjugative pili: monoclonal antibodies as probes for structural variants of F pili. J. 
Bacteriol.172:1174-1179. 
 
 
160
176. Wang, X., M. Bogdanov, and W. Dowhan. 2002. Topology of polytopic membrane 
protein subdomains is dictated by membrane phospholipid composition. EMBO  J. 
21:5673-5681. 
177. Geibel, S., J. H. Kaplan, E. Bamberg, and T. Friedrich. 2003. Conformational 
dynamics of the Na+/K+-ATPase probed by voltage clamp fluorometry. Proc. Natl. 
Acad. Sci. U.S.A.100:964-969. 
178. Hu, J., M. Kornacker, and A. Hochschild. 2000. Escherichia coli one- and two-hybrid 
systems for the analysis and identification of protein-protein interactions. Methods. 
20:80-94. 
179. Bogdanov, M., P. N. Heacock, and W. Dowhan. 2002. A polytopic membrane 
protein displays a reversible topology dependent on membrane lipid composition. 
EMBO J. 21:2107-2116. 
180. Dang TA, Zhou XR, Graf B, Christie PJ. 1999. Dimerization of the Agrobacterium 
tumefaciens VirB4 ATPase and the effect of ATP-binding cassette mutation on th 
eassembly and function of the T-DNA transporter. Mol. Microbiol. 32: 1239-53. 
181. Chen, L., C. M. Li, and E. W. Nester. 2000. Transferred DNA (T-DNA)-associated 
proteins of Agrobacterium tumefaciens are exported independently of virB. Proc. 
Natl. Acad. Sci. U.S.A.97:7545-7550. 
182. Schandel, K. A., M. M. Muller, and R. E. Webster. 1992. Localization of TraC, a 
protein involved in assembly of the F conjugative pilus. J. Bacteriol. 174:3800-3806. 
183. Schandel, K. A., S. Maneewannakul, R. A. Vonder Haar, K. Ippen-Ihler, and R. E. 
Webster. 1990. Nucleotide sequence of the F plasmid gene, traC, and identification 
of its product. Gene. 96:137-140. 
184. Maneewannakul, S., P. Kathir, D. Moore, L. A. Le, J. H. Wu, and K. Ippen-Ihler. 
1987. Location of F plasmid transfer operon genes traC and traW and identification 
of the traW product. J. Bacteriol. 169:5119-5124. 
185. Schandel, K. A., S. Maneewannakul, K. Ippen-Ihler, and R. E. Webster. 1987. A 
traC mutant that retains sensitivity to f1 bacteriophage but lacks F pili. J. 
Bacteriol.169:3151-3159. 
186. Ito, K., and Y. Akiyama. 2005. Cellular functions, mechanism of action, and 
regulation of FtsH protease. Annu. Rev. Microbiol. 59:211-231. 
187. Savvides, S. N. 2007. Secretion superfamily ATPases swing big. Structure. 15:255-
257. 
 
 
161
188. Haas, J. M. k., and E. Lanka. 1996. TrbK, a small cytoplasmic membrane 
lipoprotein, functions in entry exclusion of the IncP alpha plasmid RP4. J. Bacteriol. 
178:6720-6729. 
189. Jones, A. L., K. Shirasu, and C. I. Kado. 1994. The product of the virB4 gene of 
Agrobacterium tumefaciens promotes accumulation of VirB3 protein. J. Bacteriol. 
176:5255-5261. 
190. Paschos, A., G. Patey, D. Sivanesan, C. Gao, R. Bayliss, G. Waksman, D. 
O'Callaghan, and C. Baron. 2006. Dimerization and interactions of Brucella suis 
VirB8 with VirB4 and VirB10 are required for its biological activity. Proc. Natl. Acad. 
Sci. U.S.A.103:7252-7257. 
191. Yamagata, A., and J. A. Tainer. 2007. Hexameric structures of the archaeal 
secretion ATPase GspE and implications for a universal secretion mechanism. 
EMBO J. 26:878-890. 
192. Craig, L., and J. Li. 2008. Type IV pili: paradoxes in form and function. Curr. Opin. 
Struc. Biol. 18:267-277. 
193. Beaupre, C. E., J. Bohne, E. M. Dale, and A. N. Binns. 1997. Interactions between 
VirB9 and VirB10 membrane proteins involved in movement of DNA from 
Agrobacterium tumefaciens into plant cells. J. Bacteriol. 179:78-89. 
194. Llosa, M., S. Zunzunegui, and F. de la Cruz. 2003. Conjugative coupling proteins 
interact with cognate and heterologous VirB10-like proteins while exhibiting 
specificity for cognate relaxosomes. Proc. Natl. Acad. Sci. U. S. A. 100:10465-
10470. 
195. Gilmour, M. W., J. E. Gunton, T. D. Lawley, and D. E. Taylor. 2003. Interaction 
between the IncHI1 plasmid R27 coupling protein and type IV secretion system: 
TraG associates with the coiled-coil mating pair formation protein TrhB. Mol. 
Microbiol. 49:105-116. 
196. Ward, D. V., O. Draper, J. R. Zupan, and P. C. Zambryski. 2002. Peptide linkage 
mapping of the Agrobacterium tumefaciens vir-encoded type IV secretion system 
reveals protein subassemblies. Proc. Natl. Acad. Sci. U. S. A. 99:11493-11500. 
197. Baron, C., Y. R. Thorstenson, and P. C. Zambryski. 1997. The lipoprotein VirB7 
interacts with VirB9 in the membranes of Agrobacterium tumefaciens. J. Bacteriol. 
179:1211-1218. 
 
 
162
198. Das, A., L. B. Anderson, and Y. H. Xie. 1997. Delineation of the interaction domains 
of Agrobacterium tumefaciens VirB7 and VirB9 by use of the yeast two-hybrid 
assay. J. Bacteriol. 179:3404-3409. 
199. Postle, K., and R. J. Kadner. 2003. Touch and go: tying TonB to transport. Mol. 
Microbiol. 49:869-882. 
200. Postle, K. 2007. TonB system, in vivo assays and characterization. Methods 
Enzymol. 422:245-269. 
201. Postle, K., and R. A. Larsen. 2007. TonB-dependent energy transduction between 
outer and cytoplasmic membranes. Biometals. 20:453-465. 
202. Christie, P. J., and E. Cascales. 2005. Structural and dynamic properties of bacterial 
type IV secretion systems (review). Mol. Membr. Biol.  22:51-61. 
203. Larsen, R. A., T. E. Letain, and K. Postle. 2003. In vivo evidence of TonB shuttling 
between the cytoplasmic and outer membrane in Escherichia coli. Mol. Microbiol.  
49:211-218. 
204. Terradot, L., N. Durnell, M. Li, D. Li, J. Ory, A. Labigne, P. Legrain, F. Colland, and 
G. Waksman. 2004. Biochemical characterization of protein complexes from the 
Helicobacter pylori protein interaction map: strategies for complex formation and 
evidence for novel interactions within type IV secretion systems. Mol. Cell. 
Proteomics. 3:809-819. 
205. Williamson, M. P. 1994. The structure and function of proline-rich regions in 
proteins. Biochem.  J. 297 ( Pt 2):249-260. 
206. Ruan, W., E. Lindner, and D. Langosch. 2004. The interface of a membrane-
spanning leucine zipper mapped by asparagine-scanning mutagenesis. Protein Sci. 
13:555-559. 
207. Rego, A. T., V. Chandran, and G. Waksman. Two-step and one-step secretion 
mechanisms in Gram-negative bacteria: contrasting the type IV secretion system 
and the chaperone-usher pathway of pilus biogenesis. Biochem. J.  425:475-488. 
208. Tomlinson, A. D., and C. Fuqua. 2009. Mechanisms and regulation of polar surface 
attachment in Agrobacterium tumefaciens. Curr.  Opin.  Microbiol. 12:708-714. 
209. Pitzschke, A., and H. Hirt. New insights into an old story: Agrobacterium-induced 
tumour formation in plants by plant transformation. EMBO J. 29:1021-1032. 
210. Benz, R., and K. Bauer. 1988. Permeation of hydrophilic molecules through the 
outer membrane of gram-negative bacteria. Review on bacterial porins. Eurp. J. 
Biochem.  FEBS. 176:1-19. 
 
 
163
211. Nikaido, H. 1992. Porins and specific channels of bacterial outer membranes. Mol. 
Microbiol. 6:435-442. 
212. Nikaido, H. 1994. Porins and specific diffusion channels in bacterial outer 
membranes. J. Biol. Chem. 269:3905-3908. 
213. Allen, N. E., and T. I. Nicas. 2003. Mechanism of action of oritavancin and related 
glycopeptide antibiotics. FEMS Microbiol. Rev. 26:511-532. 
214. Reynolds, P. E. 1989. Structure, biochemistry and mechanism of action of 
glycopeptide antibiotics. Eurp. J. Clin. Microbiol. Infect. Dis. 8:943-950. 
215. Rida, S., J. Caillet, and J. H. Alix. 1996. Amplification of a novel gene, sanA, 
abolishes a vancomycin-sensitive defect in Escherichia coli. J. Bacteriol. 178:94-
102. 
216. Rajagopal, S., N. Sudarsan, and K. W. Nickerson. 2002. Sodium dodecyl sulfate 
hypersensitivity of clpP and clpB mutants of Escherichia coli. App. Envir.  Microbiol. 
68:4117-4121. 
217. Shimoda, N., A. Toyoda-Yamamoto, S. Aoki, and Y. Machida. 1993. Genetic 
evidence for an interaction between the VirA sensor protein and the ChvE sugar-
binding protein of Agrobacterium. J. Biol. Chem. 268:26552-26558. 
218. Pettersson, J., R. Nordfelth, E. Dubinina, T. Bergman, M. Gustafsson, K. E. 
Magnusson, and H. Wolf-Watz. 1996. Modulation of virulence factor expression by 
pathogen target cell contact. Science.  273:1231-1233. 
219. Andrup, L., and K. Andersen. 1999. A comparison of the kinetics of plasmid transfer 
in the conjugation systems encoded by the F plasmid from Escherichia coli and 
plasmid pCF10 from Enterococcus faecalis. Microbiology. 145 ( Pt 8):2001-2009. 
220. Maneewannakul, S., P. Kathir, and K. Ippen-Ihler. 1992. Characterization of the F 
plasmid mating aggregation gene traN and of a new F transfer region locus trbE. J. 
Mol. Biol. 225:299-311. 
221. Willetts, N., and B. Wilkins. 1984. Processing of plasmid DNA during bacterial 
conjugation. Microbiol. Rev. 48:24-41. 
222. Higgs, P. I., P. S. Myers, and K. Postle. 1998. Interactions in the TonB-dependent 
energy transduction complex: ExbB and ExbD form homomultimers. J. Bacteriol. 
180:6031-6038. 
223. Howard, S. P., H. G. Meiklejohn, D. Shivak, and R. Jahagirdar. 1996. A TonB-like 
protein and a novel membrane protein containing an ATP-binding cassette function 
together in exotoxin secretion. Mol. Microbiol. 22:595-604. 
 
 
164
224. Andrzejewska, J., S. K. Lee, P. Olbermann, N. Lotzing, E. Katzowitsch, B. Linz, M. 
Achtman, C. I. Kado, S. Suerbaum, and C. Josenhans. 2006. Characterization of 
the pilin ortholog of the Helicobacter pylori type IV cag pathogenicity apparatus, a 
surface-associated protein expressed during infection. J. Bacteriol. 188:5865-5877. 
225. Smit, J. 1987. Localizing the subunit pool for the temporally regulated polar pili of 
Caulobacter crescentus. J. Cell Biol.105:1821-1828. 
226. Newman, J. R., and C. Fuqua. 1999. Broad-host-range expression vectors that 
carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC 
regulator. Gene. 227:197-203. 
227. Yen, K. M. 1991. Construction of cloning cartridges for development of expression 
vectors in gram-negative bacteria. J. Bacteriol. 173:5328-5335. 
228. Khan, S. R., J. Gaines, R. M. Roop, 2nd, and S. K. Farrand. 2008. Broad-host-range 
expression vectors with tightly regulated promoters and their use to examine the 
influence of TraR and TraM expression on Ti plasmid quorum sensing. Appl. Envir. 
Microbiol. 74:5053-5062. 
229. Daehnel, K., R. Harris, L. Maddera, and P. Silverman. 2005. Fluorescence assays 
for F-pili and their application. Microbiology. 151:3541-3548. 
230. Clarke, M., L. Maddera, R. L. Harris, and P. M. Silverman. 2008. F-pili dynamics by 
live-cell imaging. Proc. Natl. Acad. Sci. U.S.A.105:17978-17981. 
231. Machleidt, T., M. Robers, and G. T. Hanson. 2007. Protein labeling with FlAsH and 
ReAsH. Methods in molecular biology (Clifton, N.J 356:209-220. 
232. Arencibia, A., ed. 2000. In Plant Genetic Engineering: Towards the Third 
Millennium. Elsevier Science BV, Amsterdam. 
233. Kado, C. I. 2000. The role of the T-pilus in horizontal gene transfer and 
tumorigenesis. Curr. Opin. Microbiol.  3:643-648. 
234. Chesnokova, O., J. B. Coutinho, I. H. Khan, M. S. Mikhail, and C. I. Kado. 1997. 
Characterization of flagella genes of Agrobacterium tumefaciens, and the effect of a 
bald strain on virulence. Mol. Microbiol.  23:579-590. 
235. Fuqua, C., Indiana University. Agrobacterium tumefaciens C58 strain fliR deletion. 
In unpublished lab strain, Bloomington,IN. 
236. Chan, C. S., M. R. Zlomislic, D. P. Tieleman, and R. J. Turner. 2007. The TatA 
subunit of Escherichia coli twin-arginine translocase has an N-in topology. 
Biochemistry. 46:7396-7404. 
 
 
165
237. Wu, J., and H. R. Kaback. 1996. A general method for determining helix packing in 
membrane proteins in situ: helices I and II are close to helix VII in the lactose 
permease of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A.93:14498-14502. 
238. Akiyama, Y., T. Yoshihisa, and K. Ito. 1995. FtsH, a membrane-bound ATPase, 
forms a complex in the cytoplasmic membrane of Escherichia coli. J. Biol. Chem. 
270:23485-23490. 
239. Wessel, M., S. Klusener, J. Godeke, C. Fritz, S. Hacker, and F. Narberhaus. 2006. 
Virulence of Agrobacterium tumefaciens requires phosphatidylcholine in the 
bacterial membrane. Mol.  Microbiol.  62:906-915. 
240. Aktas, M., M. Wessel, S. Hacker, S. Klusener, J. Gleichenhagen, and F. 
Narberhaus. Phosphatidylcholine biosynthesis and its significance in bacteria 
interacting with eukaryotic cells. Eur. J.Cell Biol. 89(12):888-94. 
241. Vecino, A. J., R. L. Segura, B. Ugarte-Uribe, S. Aguila, I. Hormaeche, F. la Cruz, F. 
M. Goni, and I. Alkorta. Reconstitution in liposome bilayers enhances nucleotide 
binding affinity and ATP-specificity of TrwB conjugative coupling protein. Biochim.  
Bioph. Acta. 1798:2160-2169. 
242. Llosa, M., J. Zupan, C. Baron, and P. Zambryski. 2000. The N- and C-terminal 
portions of the Agrobacterium VirB1 protein independently enhance tumorigenesis. 
J. Bacteriol. 182:3437-3445. 
243. Hubber, A., A. C. Vergunst, J. T. Sullivan, P. J. Hooykaas, and C. W. Ronson. 2004. 
Symbiotic phenotypes and translocated effector proteins of the Mesorhizobium loti 
strain R7A VirB/D4 type IV secretion system. Mol. Microbiol. 54:561-574. 
244. Schroder, G., and C. Dehio. 2005. Virulence-associated type IV secretion systems 
of Bartonella. Trends Microbiol. 13:336-342. 
245. Sutten, E. L., J. Norimine, P. A. Beare, R. A. Heinzen, J. E. Lopez, K. Morse, K. A. 
Brayton, J. J. Gillespie, and W. C. Brown. Anaplasma marginale type IV secretion 
system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a 
protective bacterial membrane vaccine. Infect. Immun. 78:1314-1325. 
246. Hilleringmann, M., W. Pansegrau, M. Doyle, S. Kaufman, M. L. MacKichan, C. 
Gianfaldoni, P. Ruggiero, and A. Covacci. 2006. Inhibitors of Helicobacter pylori 
ATPase Cagalpha block CagA transport and cag virulence. Microbiology.  
152:2919-2930. 
247. Araujo, F. R., C. M. Costa, C. A. Ramos, T. A. Farias, Souza, II, E. S. Melo, C. 
Elisei, G. M. Rosinha, C. O. Soares, S. P. Fragoso, and A. H. Fonseca. 2008. IgG 
 
 
166
and IgG2 antibodies from cattle naturally infected with Anaplasma marginale 
recognize the recombinant vaccine candidate antigens VirB9, VirB10, and 
elongation factor-Tu. Memor. Instit. Oswaldo Cruz. 103:186-190. 
 
 
 
 
 
 
167
 
 
168
VITA 
Jennifer Evangeline Kerr was born in Atlanta, GA on March 2, 1982 the daughter of Mary 
Brock Kerr and William Henry Kerr. After completing her work at Druid Hills High School, 
Atlanta, Georgia in 2000, she entered Wesleyan College in Macon, Georgia. She received 
the degree of Bachelor of Arts with majors in biology and chemistry and minors of 
neuroscience and studio art from Wesleyan in May, 2004. In August of 2004, she entered 
The University of Texas Health Science Center at Houston, Graduate School of Biomedical 
Sciences.  
 
 
 
Permanent address: 
1780 Ridgewood Drive 
Atlanta, GA 30307 
 
